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Abstract
The prevalence of diabetes, a metabolic disorder characterized by hyperglycemia, is increas-
ing rapidly worldwide. According to the world health organization (WHO), almost 422
million people in the world have diabetes. Vascular dysfunction, that is distinctively observed
in diabetic patients, also leads to the high chance of cardiovascular diseases. The cellular
mechanisms of vascular dysfunction in diabetes are not completely elucidated because of
the high-level complexity involved. There are some recent studies in literature about the
vascular smooth muscle cell (VSMC) dysfunction associated with diabetes. These studies
imply that the dysfunction of diabetic VSMC is related to the alterations of functions of
gap junctional intercellular communication (GJIC) and calcium handling proteins such as
sarcoplasmic reticulum calcium ATPase (SERCA), inositol trisphosphate receptor (IP3R),
and ryanodine receptor (RyR). The main purpose of the thesis is to explore the importance of






dynamics in VSMCs and investigate the related consequences in the perspective of diabetes.
As a powerful tool to investigate extremely complex biological systems, we have devel-
oped a mathematical model of VSMC to accomplish our research aims. The sarcoplasmic
reticulum (SR) was modelled as a single luminally continuous store with homogeneous
luminal calcium. None of the VSMC mathematical models has used sequential binding of
calcium and IP3 for the activation of IP3R. As calcium is the central attention of the study,
we have incorporated a simplified 4-state sequential-binding IP3R model.
The change of SERCA, IP3R or RyR level shifted the oscillatory state of intracellular
calcium to steady and vice versa at a constant agonist concentration. Especially, increasing
SERCA level move the oscillatory region to high agonist concentrations whereas increasing
IP3R or RyR level shift the oscillatory region to lower agonist concentrations. The shift of
oscillatory region was significant at low SERCA levels and at low IP3 levels. The model
results indicate that using the same agonist concentration for studying the existence of
intracellular concentrations in the absence of IP3R or RyR may lead to contradictory findings
because of the shift of oscillatory region.
The model results showed that Vm-mediated signalling mechanism plays dominant role
in the propagation of calcium rise whereas the activation of IP3R acts as a limiting step to
x
make the IP3-mediated calcium propagation ineffective. It seems that the penetration depth
and the wave velocity of intracellular calcium oscillations in coupled VSMCs are strongly
related to the GJIC if the regenerative propagation was not extended to all the non-stimulated
cells. The downregulation of IP3R and RyR reduced the penetration of intracellular calcium
propagation in VSMCs. The SERCA regulation of the frequency of intracellular calcium
oscillations and penetration of regenerative propagation are biphasic.
Based on the model results, our hypothesis is that if an external environment influences
the agonist-induced calcium transients, the VSMC may alter the levels of SERCA, IP3R
and/or RyR expressed in the SR to restore intracellular calcium transients matched with the
functional need.
The reduced SERCA level is a possible mechanism for the “smoothed" calcium transients
in diabetic VSMCs. The SERCA level tends to be the regulating factor of intracellular
calcium in both the activation and relaxation phases of oscillations. Also, the model results
indicate that the functional changes due to altered level of IP3R in diabetic VSMCs might
be regulated by altering the level of the RyR protein and vice versa. However, the impaired
intracellular calcium dynamics due to reduced SERCA levels can not be restored by changing
IP3R or RyR levels because of the reduced intra-SR calcium load. These findings lead to the
fact that reduced SERCA level is probably the primary factor responsible for the reduced
intracellular calcium transients and the reduced contractility in diabetic VSMCs even though
all the three proteins, SERCA, IP3R and RyR, are varied.
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Agonist-induced calcium signalling in
VSMCs
1.1 Introduction
The human vascular system supplies oxygen and nutrients to all the tissues of the body, (refer
to Figure 1.1), carries carbon dioxide to the lungs and other products of metabolism to the
kidneys, distributes hormones and other agents that regulate cell function and have function
in the regulation of body temperature. The blood, the carrier of these substances, is pumped
through a closed system of blood vessels. The average volume of blood in a human body is
approximately 5 litres.
Oxygenated blood is pumped from the left ventricle of the heart to the aorta, reaches
major arteries and from there travels to the arterioles and capillaries, where blood exchanges
substances and gases with the interstitial fluid. From the capillaries, blood drains through
venules into the veins and reaches the right atrium of the heart. From there, deoxygenated
blood enters the right ventricle, is pumped to the pulmonary arteries and reaches the lungs
where the blood gets oxygenated. This blood returns to the left atrium and from there to the
left ventricle.
The proper working of the vascular system is essential for maintaining the functions
of every organ of the body. Adequate blood flow should reach the retinal blood vessels
for the vision provided by the eyes, the renal arteries for the excretion of waste products
from the body, the cerebral and vertebral arteries to maintain neuronal functions and so
on. Any abnormality in the vascular system will severely affect the tissues and lead to the
malfunctioning. For example, organ damage occurs in diabetic patients because of vascular
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dysfunction and affect almost every part of the body, especially the brain, heart, kidneys,
skin, and eyes.
The circulation of blood is controlled by various regulatory systems which maintain
adequate capillary blood flow to all organs of the body. The most important component of
the regulation is the pumping of the heart. Others include diastolic recoil of the walls of the
arteries, compression of veins by the skeletal muscles and the negative pressure in the thorax
during inspiration. The blood flow to each tissue is regulated by local chemical, general































Fig. 1.1 Human vascular system
The circulatory system consists of both arterial and venous systems. It includes different
blood vessels such as aorta, arteries, arterioles, capillaries, venules, veins, and vena cava.
The arteries conduct blood away from the heart and the veins towards the heart. The arteries
have a thick vascular wall which is capable of stretching to accommodate blood pulses when
the heart pumps. When the heart is in systole, arteries are stretched and store energy. During
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the diastolic phase of the heart, arteries release the stored energy and maintain the blood
pressure. This cycle is repeated in each cardiac cycle and helps to achieve continuous blood
flow between heartbeats.
The major arteries branch progressively into smaller arteries to reach deeper parts of
the organs. The smaller arteries then branch into arterioles, (refer to Figure 1.2). Arterioles
have an average diameter of 30 µm. Arterioles are capable of controlling the blood flow in
responds to the needs of the tissues by changing their diameter. Arterioles lead to capillary
bed. The capillary is a microscopic channel with thin a wall and has plenty of capillary
pores in the wall. Exchange of oxygen, nutrients and other substances between the blood and
surrounding cells and tissue fluid occurs in the capillaries. The diameter of the capillaries




Fig. 1.2 Schemtic representation of arterial tree
An artery/arteriole is made up of three tissue layers, tunica intima, tunica media and
tunica adventitia, (see Figure 1.3). Tunica intima is the inner layer of an artery and is made
up of a single layer of endothelial cells (ECs) and an internal elastic lamina. Tunica media
is the middle layer and is rich in vascular smooth muscle cells (VSMCs). The number of
smooth muscle layers varies in arteries and arterioles. Large arteries contain up to 20 VSMC
layers while the smallest arterioles may have only one or two layers of VSMCs. The outer
layer, tunica adventitia, consists of connective tissue proteins and an external elastic lamina
which is the inner boundary of the layer.
1.2 Vascular smooth muscle cell (VSMC)
VSMCs are essential for the structural integrity and functioning of arteries and arterioles. The
primary characteristic of a VMSC is its ability to change the diameter of the blood vessel by




Fig. 1.3 Schematic representation of an artery
contraction and relaxation. The contractile property of VSMCs plays a significant functional
role in the vasculature, as it allows dynamic regulation of the blood pressure. This property,
in turn, controls blood flow and the distribution of nutrients and oxygen to a particular tissue.
1.2.1 Mechanism of VSMC contraction
The contractile property of a VSMC is obtained by the interaction between myosin and actin
filaments. Myosin and actin occupy a major volume of the VSMC. VSMCs contain a large
number of actin filaments which are connected to dense bodies. These bodies are either
dispersed inside the cell or attached to the cell membrane. Myosin filaments are thicker and
have a diameter more than twice that of actin filaments. Myosin filaments contain a globular
head region and a long tail. Myosin filaments are interspersed with actin filaments and in
between the dense bodies. The actin filaments extend from the dense bodies, and the myosin
filament overlaps the ends of actin filaments. A VMSC contains approximately ten times as
many actin filaments than myosin filaments.




Fig. 1.4 VSMC contraction: Actin-myosin filaments slide over each other.
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During a contraction, the globular heads of myosin filaments get bound to actin and form
a cross-bridge. This binding allows the myosin to act as a motor driving the actin filaments to
slide, (see Figure 1.4). The motor activity of myosin moves its globular heads over the actin
filament and the head binds to actin at a specific position. After binding firmly to actin, the
myosin head bends in the neck. This bend slides/"pulls" the actin filament over the myosin
filament towards the centre of the contractile unit, causing contraction.
1.2.2 Role of intracellular calcium in the regulation of VSMC contrac-
tion





. An intracellular calcium rise initiates binding of myosin to actin. The intra-
cellular calcium in the VSMC binds to the calmodulin protein forming calcium-calmodulin
complex (Ca-CaM) complex. This complex activates myosin light chain kinase (MLCK),
an enzyme which is capable of phosphorylating the chain of each myosin head in the pres-
ence of adenosine triphosphate (ATP). With myosin light chain (MLC) phosphorylation,
the myosin head binds to an actin filament and forms the cross-bridge between myosin and
actin filaments. If the MLC is not phosphorylated, the binding of a myosin head to an actin
filament does not occur, which leads to relaxation. A schematic representation of the whole
process is given in Figure 1.5.
Calcium Calmodulin
Ca2+-calmodulin 
     complex
MLCK activation MLCK inactivation 
MLC phosphorylation MLC dephosphorylation 
Contraction Relaxation 
Fig. 1.5 Increase of intracellular calcium initiates myosin binding to actin.
Intracellular calcium in VSMCs is also known as a secondary messenger for many other
cellular functions, such as proliferation, migration, and apoptosis, which is increasingly
important in vessel remodelling by changing the number of cells and the connective tissue
composition. A rise in intracellular calcium may lead to an increase in intranuclear calcium
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by passive diffusion through the nuclear pores. The simultaneous increase of intracellular and
nuclear calcium with the Ca-CaM complex promotes cell proliferation [96]. Spontaneous
calcium transients are likely to be essential for the migration of VSMCs [151]. Alteration in
the cellular calcium homeostasis is one of the causes of apoptosis or cell death in smooth
muscle cells [165]. Therefore, a tight control over intracellular calcium is necessary for the
proper functioning of VSMCs.
1.3 Agonist-induced calcium signalling mechanisms in VSMCs
The activation of contractility in VSMCs occurs as a subsequent event after an increase of
intracellular calcium. There are various components which modulate intracellular calcium in
VSMC; vasocative agonist is one of them. The vasocative agonists mediate several signalling
pathways to induce intracellular calcium rise in VSMCs. The agonist-induced signalling
pathways depend on the type of G-protein coupled to the receptor on which the agonist ligand
binds. Gq, Gs and Gi are three types of G-protein which are commonly found in VSMCs. The
activation of Gs-protein enhance the production of cyclic adenosine monophosphate (cAMP)
whereas the activation of Gi-protein suppresses the production of cAMP. The Gq-protein
activation leads to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG)
molecules.
A G-protein is coupled to different types of receptors present in the cell membrane of
VSMCs. An agonist binds only to a respective receptor on which it has affinity. The most com-
mon vasoactive agonists which activate on G-protein-coupled receptors in VSMC membrane
are phenylephrine (PE), norepinephrine (NE), acetylcholine (ACh), vasopressin, endothelin-1
and angiotensin II (AII). To activate Gq-protein, NE and PE bind to α1-adrenoceptors, AII
binds to the AT1 receptor, endothelin-1 binds to the ETA receptors, vasopressin binds to the
V1 receptor and ACh binds to the M3 receptor.
In experiments, agonists are applied by microinjection near the cell membrane or by
circulating them in the superfusion liquid. For microinjection, micropipettes are filled with
the agonist solution, which is then applied perpendicular to the cell membrane [157, 60]. In
the latter method, the agonist solution is added to the superfusion liquid, which is circulated
through the VSMC strip under investigation [95].
G-protein mediated agonist stimulation of VSMCs leads to a series of molecular levels
events and generates secondary messengers such as IP3 and DAG. Many mathematical models
have been developed to describe the entire process of agonist binding on the receptor to the
hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) [101, 100, 141, 27]. According to
these models, binding of an agonist ligand to the G-protein coupled receptor is the first step
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of the agonist stimulation. The binding of an agonist is a part of several receptor activities
such as phosphorylation of the receptors, sequestration or internalization of the receptors,
coupling, and uncoupling of receptors from the G-protein, dephosphorylation and recycling
of receptors.
The figure 1.6 shows a schematic representation of the molecular events from agonist
binding to DAG and IP3 production. First of all, an agonist ligand binds to the receptor.
The ligand bound receptor is subjected to phosphorylation. The phosphorylated receptors
are internalized and then dephosphorylated back as recycled receptors to the membrane.
The unphosphorylated ligand-bound receptors strongly activate G-protein. The activated
G-protein activates the phospholipase C (PLC). The full activation of PLC depends on the
intracellular calcium concentration. The activated PLC hydrolyzes PIP2 to form IP3 and





Fig. 1.6 Agonist stimulation of VSMC
1.3.1 Measurement of calcium in VSMCs
Enormous efforts have been made by previous researchers to understand the agonist-induced
calcium signalling mechanisms in VSMCs. The improvement in experimental techniques
to measure and visualize intracellular calcium in the VSMC advanced the understanding
of calcium signalling mechanisms. A good example is the development of experiments
using calcium sensitive fluorescent dyes [21, 175]. The fluorescent properties of calcium
sensitive dyes change when a calcium ion is bound to the dye. Most commonly, these
dyes shift the excitation wavelength or increase the fluorescent quantum intensity when
binding to a calcium ion. The change in the fluorescent property of the dye is measured
and quantified. Based on the ratio of calcium bound and unbound dyes, the intracellular
calcium concentration is calculated. Along with the quantification of intracellular calcium,
laser-scanning confocal microscopes are used to image the fluorescent dye. The development
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of charge-coupled device (CCD) cameras along with improved calcium sensitive dyes makes
it possible to provide the spatial detailing of calcium signalling with high temporal resolution
on a subcellular and multicellular level [60].
1.3.2 Role of sarcoplasmic reticulum (SR)
The sarcoplasmic reticulum (SR) is a major calcium releasable store in VSMCs. The SR is a
membranous tubular system and its parts are close to the cell membrane as well as the deep
within the cell. The SR is referred as peripheral SR when it is close to the cell membrane or
central when it is away from the cell membrane.
In general, the possible sources of calcium for intracellular calcium rise in a VSMC
are, 1) calcium influx from extracellular space 2) calcium release from the SR. The main
calcium handling proteins in the SR are sarcoplasmic reticulum calcium ATPase (SERCA),
inositol trisphosphate receptor (IP3R), and ryanodine receptor (RyR). The voltage-operated
calcium channel (VOCC) is the main calcium channel present in cell membrane that transport
extracellular calcium to the cytosol.
Agonist-induced calcium increase in VSMCs, from the mesenteric artery and the pul-
monary artery, is unaffected by the removal of extracellular calcium or by the application
of blockers of calcium channel in the cell membrane[67, 10, 55]. In the Hamada et al. [61]
study on VSMCs from a canine pulmonary artery, intracellular calcium oscillations gradually
disappeared in the absence of extracellular calcium, but were unchanged in the presence of
calcium channel blockers such as nifedipine, and verapamil. Similar to this, Bolton et al. [20]
reported that the entry of calcium from the intracellular store, not from the voltage-sensitive
calcium channels, is the leading cause of agonist-induced contraction. Recent experiments
of Shmigol et al. [163] show that the agonist-induced calcium rise is associated with a
simultaneous decrease in intra-SR calcium. Leijten et al. [99] showed that the intracellular
calcium increase during agonist stimulation is coming from the intracellular store, the SR.
These experiments suggest that the majority of calcium rise in the cytosol during agonist
stimulation is due to the calcium release from the SR.
1.3.3 CICR and IICR mechanisms
The calcium-induced calcium release (CICR) and IP3-induced calcium release (IICR) are
two well-known calcium release mechanisms in the VSMCs. The IP3 is identified as a
secondary messenger involved in the calcium release mechanisms in VSMC. In experiments,
the addition of IP3 raised intracellular calcium in VSMCs. The amount of calcium released by
the addition of IP3 to the cell was enough to produce contractions in the VSMCs [167, 168].
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In the early years of research, the IICR mechanism was assumed to be only dependent on the
concentration of IP3. The later studies provided more insights to the regulation of IICR and
showed that IICR depends not only on IP3, but also on intracellular calcium. The calcium
regulation of IICR is identified as biphasic. The IICR mechanism is activated with the
increase of calcium up to ≈300 nM and inhibited when calcium is increased above 300 nM.
The biphasic nature of calcium regulation provide positive and negative feedback controls of
IICR mechanism [69, 132].
The CICR mechanism is described as the release of calcium from the SR triggered by
calcium rise. The CICR was recognized in the experiments as a calcium “flash”. The calcium
“flash” was observed as a response of the cell to caffeine. In some cases, the caffeine-induced
calcium release from SR was enough to produce contractions in VSMCs [73]. Unlike IICR,
CICR mechanism was activated at high calcium concentrations, above 1 µM [43].
The caffeine-induced calcium release from SR were blocked by an akaloid called ryan-
odine [64, 73]. The ryanodine showed high affinity to a protein in SR membrane. Experiments
show that SR is sensitive to calcium [102]. Later on, the ryanodine binding protein was iden-
tified as a calcium ion channel, called RyR channel, with high conductance. The application
of ryanodine locks the RyR channel leads to a low conductance of calcium and suppresses
CICR.
In general, it is assumed that the RyR channel is responsible for CICR and IP3R channel
is responsible for IICR. Since both IP3R and RyR are present in the SR, calcium release from
the IP3R channel may influence the RyR channel because of its calcium sensitivity. There is
evidence for cross-talk between IP3R and RyR in portal vein myocytes and retinal arteriolar
myocytes [53, 177].
1.3.4 Intracellular calcium oscillations: Role of IP3R and RyR
The IP3R and RyR tend to be involved in the agonist-induced calcium release as the SR
is the main component responsible for the intracellular calcium rise in the VSMC. The
cyclic behaviour of calcium needs to be generated in the VSMCs for intracellular calcium
oscillations. If only IP3R is present in the SR, cyclic opening and closing of IP3R may
contribute to the existence of calcium oscillations. The calcium regulation of the IP3R
channel is complex and biphasic as reported in the studies of Bezprozvanny et al. [18] and
Iino [68]. The bell-shaped curve of IP3R open probability for dependence on calcium gives
the maximum probability of opening at an intracellular concentration of ≈250 nM. Out
of the three subtypes of IP3R, type 1 IP3R is predominantly found in VSMCs [180, 184].
The presence of 80% type 1 IP3R is found in the aorta and A7r5 VSMCs. The functional
importance of type 1 IP3R in agonist stimulation is that the calcium regulation of type 1 IP3R
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is biphasic. This strongly suggests that type 1 IP3R might be the main subtype involved in
the agonist-induced calcium oscillations.
Similar to IP3R, the calcium-dependent open probability of RyR is biphasic. The open
probability of RyR reaches a maximum in micromolar concentrations of intracellular calcium
and the calcium deactivation of RyR happens at a higher intracellular concentration of ≈100
µM [18]. Within the physiological range of intracellular calcium, IP3R experiences both
positive feedback and negative feedback for calcium release while RyR acts as a calcium-
induced calcium channel.
The agonist-induced calcium oscillations disappear when IP3R inhibitors, such as D-myo-
Inositol 1,4,5-tris-phosphate trisodium salt and heparin, are used [19, 184, 110, 196]. This
indicates the possibility of an IP3 mediated pathway in agonist-induced calcium oscillations.
When PLC blockers, U73122 or neomycin, are used in the experiments, agonist-induced
calcium oscillations disappear [200, 61, 67, 55]. Activation of PLC is essential for the
production of IP3. The need for PLC activation confirms the existence of an IP3 mediated
calcium signalling pathway in agonist stimulation.
The agonist-induced calcium oscillations are unaffected by the inhibition of RyR in
VSMCs from pulmonary arteries [61]. McCarron et al. [115] showed that RyR was not
required for IP3 induced calcium oscillations in the SMC and IP3R alone was sufficient.
In contrast to this, agonist-induced calcium oscillations were not completely blocked by
RyR inhibitors, though the calcium rise reduced to some extent [19, 53]. In the study of
Bai et al. [8] on airway smooth muscle cells, application of the RyR antagonist ryanodine
had no effect on the agonist-induced calcium oscillations but with another RyR antagonist,
tetracaine, agonist-induced calcium oscillations were inhibited in a concentration-dependent
manner. Similar to that, Tumelty et al. [177] study on retinal arteriolar smooth muscle cells
showed that RyR inhibitor, tetracaine, blocks agonist-induced calcium oscillations. Since
the experimental evidence is not entirely consistent, the role of RyR on the agonist-induced
calcium oscillations is still debatable.
1.3.5 Intracellular calcium oscillations: Role of SERCA
The termination of the calcium release from the SR happens when IP3R and RyR are
inactivated. The raised calcium in the cytosol is either extruded to the extracellular space or
reloaded to the SR. Shmigol et al. [163] showed that intra-SR calcium would recover to the
baseline even if the VSMC is continuously exposed to the agonist. Also, they showed that
the increase of intra-SR calcium is analogous to intracellular calcium decrease, it indicates
that calcium in the cytosol is taken for partial filling of the SR.
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The calcium transporter of SR responsible for the sequestration of calcium is the SERCA
pump. ATP hydrolysis and enzyme phosphorylation of SERCA causes conformational
changes to SERCA and result in translocation of calcium ions from the cytosol to a high-
affinity site of SERCA. The translocated ions, most commonly two calcium ions, are then
released to the SR [195]. Three genes of SERCA proteins are identified, SERCA 1, SERCA
2 and SERCA 3. SERCA 2a and SERCA 2b are expressed in VSMCs [180, 41]. However,
SERCA 2b is the most common and abundantly present in VSMCs [108]. Wu et al. [195]
reported that SR of VSMCs from thoracic aorta contained 90% SERCA 2b proteins.
In most of the experiments, agonist-induced calcium oscillations disappear when the
SERCA pump is inhibited [61, 67, 163, 200]. As the major calcium rise for agonist-induced
calcium oscillations comes from the SR, refilling of intra-SR calcium is necessary for the
onset of calcium oscillations. The SERCA pump would therefore be an essential calcium
handling protein in the SR for the occurrence of agonist-induced calcium oscillations. Also,
SERCA function plays a vital role in maintaining low intracellular calcium needed for the
relaxation of the VSMC.
1.3.6 Calcium extrusion to extracellular space
Besides calcium translocation by the SR, calcium in the cytosol is extruded into the extra-
cellular space during agonist stimulation by sodium/calcium exchanger (NCX) and plasma
membrane calcium ATPase (PMCA) calcium transporters. NCX is an electrogenic antiporter
and can transport calcium ions into or out of the cytosol [50]. At normal concentrations
of sodium in the extracellular space, calcium is extruded to the extracellular space. It is
reported that one calcium ion is exchanged for three sodium ions [143]. Meaning to say that,
the exchange process of NCX is electrogenic causing the membrane potential to be more
positive. Moreover, alteration of the membrane potential of the VSMC would change the
calcium extrusion rate by the PMCA, leading to a change in intracellular calcium [50].
The PMCA pump belongs to the family of P-type ATPase. There are 4 genes of PMCA.
PMCA-1 and PMCA-4 are commonly expressed in VSMCs. PMCA pumps calcium ions by
consuming one ATP molecule. Since PMCA pumping is coupled with a proton uptake, it may
lead to pH changes in the VSMC [6]. The molecular ratio, Ca2+:H+, of 1:1 is commonly
accepted. This ratio makes PMCA an electrogenic pump which affects the membrane
potential of the VSMC. However, the stoichiometry ratio of Ca2+:H+ is still controversial.
The specific use of NCX and PMCA to extrude calcium to the extracellular space may
vary in VSMC. In general, NCX is a low calcium affinity channel with a high capacity
of calcium extrusion, while PMCA is a high-affinity channel with a low capacity calcium
transport. PMCA is likely to be responsible for keeping intracellular calcium at resting
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conditions. On the other hand, the main function of NCX seems to be to maintain the
intracellular calcium level within the physiological range during cell stimulation. PMCA
tends to be active in a concentration range at which NCX is apparently inactive. The extrusion
of intracellular calcium is significantly reduced in the absence of extracellular sodium, which
in turn reduces the calcium exchange of NCX. The primary calcium extrusion in arterial
smooth muscle is happening through NCX as compared to PMCA [5].
1.3.7 Calcium influx from extracellular space
The VOCC is identified as the primary calcium channel present in the VSMC. L-type
(CaV1.2), P/Q -type (CaV2.1) and T-type (CaV3.1 and CaV3.2) voltage-operated calcium
channels are expressed in VSMCs. Among these, the L-type (CaV1.2) calcium channel plays
the dominant role in agonist-induced calcium dynamics [124]. Depolarization of the cell
triggers the VOCC and leads to calcium entry to the cytosol.
The extrusion of calcium to extracellular space may cause a dynamic loss of calcium
released to the cytosol from the SR. To compensate the loss of intracellular store calcium,
calcium influx from the extracellular space is needed. It is observed that the recovery of the
SR is not blocked by the removal of extracellular calcium, but the recovery was less than
75% [163]. However, the rate of refilling of the SR is sped up when extracellular calcium is
restored. This indicates the need of the VOCC for the complete recovery of intra-SR calcium.
The activation of non-selective cation channels (NSC) like the transient receptor potential
cation (TRPC) channels and ligand-gated cation channels also enhance intracellular calcium.
TRPC3, TRPC6, and TRPC7 are the most common NSC channels found in the VSMC.
TRPC channels are activated either by depletion of intra-SR calcium or after a receptor
occupancy. The former one is commonly called a store-operated cation (SOC), and the later
one is known as a receptor-operated cation (ROC) channel.
The cell membrane and its components are under the influence of membrane potential.
The membrane potential is determined by the ionic concentration gradient between the
cytosol and the extracellular space, permeability of ions through their particular ion channel
and the activity of electrogenic pumps and exchangers. The most common membrane
potential regulated ion channels in VSMCs are potassium channels like the voltage-dependent
potassium (KV) channel and the calcium-activated potassium channel (KCa), the calcium
activated chloride channel (CACC), the VOCC and the non-selective cation channel (NSC).
The membrane potential also regulates the electrogenic pumps and exchangers such as the
sodium/potassium pump (NaK), PMCA pump, and NCX exchanger.
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1.3.8 Features of agonist-induced intracellular calcium oscillations
In general, the agonist-induced contraction of the VSMC is associated with a series of
cyclic rises of intracellular calcium, called intracellular calcium oscillations. Upon agonist
application, first calcium increase is obtained in a short time, mostly less than 10 seconds,
followed by a series of regular oscillations of intracellular calcium [55, 61]. The peak value
of agonist-induced intracellular oscillation is less than 1 µM. The frequency varies from 5 to
30 oscillations per minute. The frequency of oscillation depends on the agonist concentration
and the type of tissue used for the experiment. In the Hamada et al. [61] study, 0.1 to 10 µM
of PE produced intracellular calcium oscillations of 0.5 to 1.36 cycles/min in VSMCs from
the pulmonary artery. In the study of Ruehlmann et al. [147], 0.1 to 10 µM of PE produced
high-frequency calcium oscillations of 1.2 to 30 cycles/min in VSMCs from the inferior
vena cava. Though the range of frequency of oscillations varies in different tissue beds used,
it is consistent that concentration of agonist strongly modulates the frequency of calcium
oscillations.
1.4 Propagation of intracellular calcium in VSMCs
The application of a vasoactive agonist induces contraction not only at the point of application
in the artery, but also at the region far from the stimulation point. The local contraction
propagates to downstream or upstream. The propagation of vasomotor response was reported
in arteries of different tissues. Dietrich [39] observed conduction of NE-induced constriction
in arterioles of rat mesentery at a distance of 400 µm. ACh and NE-induced vasomotor
responses were observed in the arterioles of hamster cheek pouch [155]. The spread of ACh
triggered vasodilation was found in feed arteries and arterioles of hamster skeletal muscle
[156]. These experiments were conducted in endothelium-intact blood vessels. There might
be the contribution of myoendothelial and EC coupling along with VSMC coupling in the
conducted vasomotor responses.
Welsh and Segal [188] showed that agonist-induced depolarization and constriction were
initiated and conducted along VSMCs, and these responses were independent of the endothe-
lium. The NE and PE vasoactive agonists were used in their study to stimulate arterioles
supplying blood to the hamster cheek pouch. Seppey et al. [158] conducted a detailed study
to understand the role of the endothelium, in particular on arterial vasomotion. They have
demonstrated that ECs are not needed for the occurrence of vasomotion. Contractions were
generated on the endothelium-denuded artery at lower agonist concentrations than on the
endothelium-intact artery. Endothelium showed only a modulating role in their study. Later,
Seppey et al. [157] showed the propagation of intracellular calcium waves in the mesenteric
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artery after a local stimulation with PE. This calcium propagation was unchanged in the
presence and absence of endothelium. Bartlett and Segal [12] demonstrated that PE-induced
agonist vasoconstriction was initiated and propagated within the VSMC layer alone. Con-
versely, ACh-induced vasodilation was initiated in endothelial cells (ECs) and propagation of
the vasodilation signal was carried along VSMCs as well as ECs.
As discussed above, intercellular signalling between VSMCs is sufficient for the propa-
gation of contraction and rhythmic oscillations of contraction-relaxation. The intracellular
calcium in the layer of VSMCs regulates the contractile property of an artery. The intracellu-
lar calcium is the main regulator of many other cellular activities in VSMCs. The signalling
mechanisms of propagation of intracellular calcium might be similar in all the cellular activi-
ties of VSMCs. Therefore, understanding the propagation of intracellular calcium dynamics
in VSMCs would help us to explain the intercellular signalling mechanisms of propagation
of vasomotor response on the endothelium-denuded artery and the other cellular activities.
The propagation of intracellular calcium between the cells seems to be different to passive
diffusion of calcium from the stimulated cell to the non-stimulated cells. The peak amplitude
is expected to reduce in passive propagation. In most of the experiments, the peak amplitude
of calcium oscillations was not different from the stimulated cell [200, 157]. The regenerative
nature of intracellular calcium propagation in VSMCs was reported in colonic SMCs by
Young et al. [200]. In their study, the propagation was extended to all the cells of the system
under consideration. In the study of Seppey et al. [157] using VSMCs, the propagation was
not entirely regenerative; the propagation stopped after a distance of 385 µm. Halidi et al.
[60] also observed the same level of calcium rise in the non-stimulated cells.
The propagation velocity of intracellular calcium oscillations between the cells by a
local stimulation was unchanged for all the cells irrespective of their position relative to the
stimulated cells [200, 157]. The calcium propagation velocity in cultured colonic SMCs was
approximately 20 µm/s in the Young et al. [200] study. In cultured VSMCs, the calcium
propagation velocity was not different from colonic SMCs [60]. Seppey et al. [157] reported
a higher propagation velocity of 100 ± 21 µm/s in a strip of VSMCs .
Seppey et al. [157] demonstrated that calcium propagation is not possible in the absence
of extracellular calcium. The use of nifedipine, a VOCC inhibitor, also abolished calcium
propagation in their study. According to them, the propagation of depolarization might be
necessary for the propagation of intracellular calcium as the opening of VOCC depends on
membrane potential.
Young et al. [200] and Halidi et al. [60] showed that propagation does not fully depend on
influx from the extracellular space. The calcium propagation was obtained in the absence of
extracellular calcium, though the peak amplitude and propagation velocity reduced. The peak
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calcium level in the non-stimulated cell was decreased by 25% in the absence of extracellular
calcium. When a VOCC inhibitor was used in Halidi et al. [60], the calcium propagation was
similar to that in the absence of extracellular calcium.
The inhibition of IP3R significantly suppressed calcium propagation in the study of
Halidi et al. [60]. The average calcium increase was reduced by 72%. However, inhibition
of the RyR receptor had no effect on either the calcium peak or the propagation velocity of
calcium oscillations, similar to Young et al. [200] study. When inhibitors of PLC were used,
the propagation of calcium wave was totally abolished. The blocking of PLC affects the
formation of IP3. This indicates that IP3 is a possible intercellular messenger for calcium
propagation.
1.4.1 Gap junctional intercellular communication (GJIC)
Propagation of intracellular calcium from a stimulated cell to distant cells requires commu-
nication between cells. Intercellular communication is possible by chemical and electrical
communications. Paracrine signalling and gap junctional intercellular communication (GJIC)
are two main pathways responsible for intercellular communication. In the process of
paracrine signalling, a cell releases a signalling molecule to the extracellular space. The
signalling molecule diffuses through the extracellular space and binds to the membrane recep-
tors of the neighbouring cell. GJIC is the result of transport of cytosolic ions and molecules
through the gap junction which connects the cytosols of the two cells. GJIC is necessary to
spread and synchronize the vascular tone along the vessel wall [36, 29, 40]. Paracrine sig-
nalling in VSMCs may be avoided because the propagation of intracellular calcium vanishes
when the gap junctions are blocked [157, 200, 60]. Therefore, GJIC is considered as the key
pathway that enables the propagation of intracellular calcium in VSMCs.
The gap junctions are made of two connexons, each containing six connexin (Cx) proteins,
of the same or different types. Four different connexins are commonly found in the vascular
bed; Cx37, Cx40, Cx43, and Cx45. The connexins Cx40 and Cx37 are found predominantly
in ECs and Cx43 is expressed widely in SMCs. Cx45 is also found in SMCs. The expression
of these connexin proteins at the gap junction vary between different types of vascular beds
and between the same vascular beds of different species. The connexin expression at the
gap junction is dynamically controlled in healthy vessels and in vessels during a disease
progression [159, 94, 26, 47]
The permeability of a gap junction is defined as its ability to allow passage of certain
molecules or ions through it. The gap junctions are larger in diameter than the ion channels,
and they permit the passage of cytoplasmic ions and molecules with molecular weight slightly
smaller than 1000 kDa. The gap junctions are permeable to many cytoplasmic molecules
16 Agonist-induced calcium signalling in VSMCs
and ions such as calcium (Ca2+), potassium (K+), sodium (Na+), chloride (Cl−), IP3,
cyclic guanosine monophosphate (cGMP), cAMP, adenosine diphosphate (ADP), and ATP.
There is a scarcity of experimental data for getting a conclusive opinion about the selective
permeability of a gap junction. Therefore, one can assume little selective permeability as
gap junctions have a large pore. However, rapid diffusivity of cAMP is seen through Cx43
compared to Cx45 and Cx40 [81, 14].
The conductance is defined as the rate of passage of permeable molecules or ions through
the gap junction. The conductance of different gap junction channels varies based on the pore
topography. Homotypic or heterotypic channels are the two types of gap junctions based on
the assembly of their connexins. A homotypic gap junction contains two identical connexons.
A heterotypic gap junction consists of two distinct connexons and each connexon contains
identical connexins. For the most common homotypic channels in the EC and SMC, the
unitary conductance is in the order, Cx37 (300pS)>Cx40 (140pS)>Cx43 (60pS)> Cx45
(30pS). Commonly found heterotypic channels in the vascular bed are Cx37-Cx40, Cx43-45,
Cx37-Cx43, Cx40-Cx45 and Cx40-Cx43. Prediction of unitary conductance of heterotypic
channels from homotypic channels is extremely difficult since some heterotypic channels
(Cx37-Cx43) have configuration-dependent conductance. However, Cx43-Cx40 (100-150pS)
and Cx43-Cx45 (52pS) channels have conductance in agreement with homotypic channel
conductances in series.
Gap junction channels are sensitive to membrane potential, Vm, and transjunctional
voltage difference, Vgj. The gating mechanism of Cx45 is a good example [11]. The
conductance of Cx45 increases upon depolarization of the cell. Vm gating of a Cx45
hemichannel depends on the Vm of the cell to which it is connected. This observation
suggests that a Cx45 channel contains two Vm dependent gates in series, one in each
hemichannel. On the other side, the conductance of Cx45 decreases when Vgj is varied
from zero to positive or negative values. Vm and Vgj gating mechanisms are different and
independent. Similarly, pH sensitive gating mechanisms exist in some connexin channels
[54].
1.5 Research motivation: Vascular dysfunction in diabetes
Diabetes is a metabolic disorder characterized by hyperglycaemia as a result of defects in
insulin action, insulin secretion or both. The prevalence of diabetes is increasing rapidly
worldwide. According to the world health organization (WHO), almost 422 million people
in the world have diabetes. The main reason for the death of more than 1.5 million people
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worldwide is diabetes [131]. In Australia, almost 1.2 million people are affected by diabetes
[7], whereas in New Zealand almost 210,000 people have diabetes [48].
The long-term dysfunction and damage of various organs of the body like blood vessels,
nerves, heart, eyes and kidneys, occur at the chronic stage of hyperglycaemia of diabetes,
that leads to renal failure, potential loss of vision, foot ulcers, cardiovascular diseases and
sexual dysfunction. Vascular dysfunction that is distinctively observed in diabetic patients
leads to the high prevalence of cardiovascular diseases (CVD) including stroke, coronary
artery diseases (CAD), cerebral vascular disease and peripheral arterial diseases (PAD). The
cardiovascular disease was the cause of death of 70% of diabetes in Australia [7]. In New
Zealand, almost 50% of diabetics have died because of cardiovascular diseases [48]. Diabetic
patients have a high risk for atherosclerosis as well, in particular for patients with type 2
diabetes mellitus. Almost 90% of diabetic patients have type 2 diabetes mellitus [32].
The vascular dysfunction in diabetes causes vast complications in the circulatory system,
which includes regulation of blood flow to the tissues. The cellular mechanisms behind
vascular dysfunction in diabetes are not completely elucidated because of the increased
complexity like the involvement of multiple cell types, like VSMCs and ECs, and extended
effects of the clotting factors, local production and function of vasoactive agents [74, 119].
The EC dysfunction associated with diabetes has been extensively studied in the literature
[171]. VSMC dysfunction is exhibited in the microcirculation as well as in macrocirculation
[123]. There are some experimental evidence to support the VSMC dysfunction in diabetic
condition. However, the different factors that cause VSMC dysfunction in diabetes and
its implications are not well addressed in the literature. This needs more investigation to
understand the vascular dysfunction associated with diabetes.
Sharma et al. [161] reported that transforming growth factor (TGF)-β plays an essential
role in VSMC dysfunction by modulating intracellular calcium dynamics. TGF-β inhibits in-
tracellular calcium transients by reducing IP3 sensitivity in VSMCs [201]. The IP3 sensitivity
is related to the TGF-β -induced downregulation of IP3R [162]. TGF-β downregulation of
IP3R expression is found in diabetic VSMCs of aorta by Sharma et al. [161], (refer to Figure
1.7). In their study, the impaired intracellular calcium transients were restored by anti-TGF-β
antibodies. Based on this, they have suggested that suppression of IP3R expression might be
the reason for the vascular dysfunction in diabetics.
Searls et al. [154] also reported downregulation of IP3R expression in diabetic VSMCs
of the aorta and femoral arteries. Expression of all three types of IP3R protein, (refer to
Figure 1.8) and IP3-mediated calcium transients were reduced in diabetic-affected VSMCs.
The impaired calcium transients and the change in IP3R level in diabetic VSMCs matched
closely with the same kind of experiments with VSMCs in a high-glucose medium. These
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Fig. 1.7 Downregulation of IP3R in diabetic VSMCs from aorta. The comparison of type 1
IP3R in normal VSMC, diabetic VSMC and diabetic VSMC with anti-TGF-β antibodies is
given. Reproduced from Sharma et al. [161] paper.
observations lead to the hypothesis that hyperglycemia could be the reason behind the
downregulated IP3R in diabetes causing impaired intracellular calcium transients.
Ma et al. [109] reported that a significant reduction of α1-adrenoceptor agonist-induced
contraction (PE used) in the diabetic aorta is related to the downregulation of IP3R. According
to them, the IP3-induced calcium release (IICR) pathway plays a crucial role in the vascular
dysfunction in diabetes.
The B-cell lymphoma (Bcl)-2 and Bcl-xL proteins are upregulated in the VSMCs of
diabetic patients and exposed to a high-glucose medium [148, 149, 105]. The IP3-dependent
activation of IP3R was found directly related to the Bcl-2 and the Bcl-xL protein levels
[104, 182]. Velmurugan and White [182] observed Bcl-2-dependent increases in the IP3R
excitability and in the IP3R-dependent calcium release in diabetic VSMCs. The Bcl-2 and the
Bcl-xL-induced IP3R excitability might involve in the dysregulation of intracellular calcium
in diabetic VSMCs.
In the study of Searls et al. [154], downregulation of SERCA 2 and SERCA 3 isoforms
were found in diabetic VSMCs. The distribution of SERCA proteins was also altered. The
alteration of SERCA expression in diabetic VSMCs was similar in VSMCs of high glucose
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Fig. 1.8 Downregulation of SERCA and IP3R proteins in diabetic VSMCs from aorta.
Reproduced from Searls et al. [154] paper (open-access article).
Fig. 1.9 Downregulation of RyR in VSMCs from cerebral arteries of type 2 diabetic mice.
Reproduced from Rueda et al. [146] paper (open-access article).
fed rat models, suggesting hyperglycemia could be the reason for the altered levels of SERCA
in diabetic VSMCs. Downregulation of SERCA is also reported in cardiac cells with diabetes.
In the study of Kim et al. [88], the maximal calcium uptake of the SR was reduced due to the
reduced level of SERCA in the diabetic cardiac cell.
Regardless of the type of diabetes, expression of RyR was found reduced in aortic and
cerebral VSMCs [146, 109]. In these experiments, agonist-induced intracellular calcium rise
was significantly reduced with the reduction of RyR expression. Rueda et al. [146]’s study
on cerebral VSMCs of obese type 2 diabetic mice shows reduced spatiotemporal dynamics
of intracellular calcium. The average calcium peak, full duration at half maximum, full width
at half maximum and mean rising rate were decreased. The expression of downregulated
RyR in the diabetic mouse was reported as the reason for the reduced calcium dynamics,
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(refer to Figure 1.9). In contrast to this, increased expression of RyR is shown in Searls et al.
[154]’s study on VSMCs of the aorta and femoral artery from diabetic Wistar rats. A similar
change in the RyR level was obtained in A7r5 cells grown in hyperglycemic condition.
Fig. 1.10 (left) Increased phosphorylation of Cx43 in VSMCs from a bovine thoracic aorta
under high glucose medium. Reproduced from Kuroki et al. [92] paper (permission granted
from American diabetes association to reuse in the thesis, license number: 3852141143899).
(right) Downregulation of Cx43 in retinal pericytes under high glucose medium. HG stands
for high glucose. Reproduced from Li et al. [103] paper (permission granted from Association
for Research in Vision and Ophthalmology (ARVO) by email contact)
Fig. 1.11 Increased phosphorylation of Cx43 in the cardiac cell from a diabetic rat. Repro-
duced from Inoguchi et al. [71] paper (permission granted from Springer to reuse in the thesis
and the license number is 3851261318462).
Vascular dysfunction in diabetes is also related to the alteration in connexins of gap
junctions between VSMCs [92, 25, 71]). Kuroki et al. [92] showed increased protein kinase
C (PKC) activity and reduced GJIC in VSMCs exposed to the high-glucose medium. The
addition of calphostin C, an inhibitor of PKC, restored the GJIC in diabetic VSMCs. This
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relation showed PKC-mediated inhibition of GJIC in the diabetic. The Cx43 is a phosphopro-
tein which exists in multi-phosphorylated forms in VSMCs such as P1, P2, and P3 along with
nonphosphorylated form P0. The high-glucose content enhanced phosphorylation of Cx43,
especially the P3 form, leads to the inhibition of GJIC, (refer to Figure 1.10). One possible
mechanism for the inhibition of Cx43 function was the PKC-mediated phosphorylation
of Cx43. When PKC activator, 12-O-Tetradecanoylphorbol-13-acetate (TPA), was used,
phosphorylation of Cx43 was significantly increased, (refer to Figure 1.10). Based on these
results, they have suggested that PKC-mediated inhibition of Cx43 might be the reason for
the reduced GJIC between VSMCs in diabetics. Similar findings were reported by Inoguchi
et al. [71] in the cardiac cells of diabetic rats, (refer to Figure 1.10). PKC β isoform was
found to be the main isoform that causes the phosphorylation of Cx43. The reduction in
ventricular conduction was related to the increased phosphorylation of Cx43. The high
glucose level also reduces the expression of Cx43 in aortic ECs [92], microvascular ECs, and
retinal pericytes [103]. Altogether, these studies indicate that inhibition of Cx43 function
might be the reason for reduced GJIC in VSMCs.
Diabetes increases PKC activity [70], TGF-β production [161] and expression of Bcl-2
and Bcl-xL [182] in VSMCs. In diabetic VSMCs, the PKC-mediated phosphorylation of
Cx43 inhibited GJIC, the TGF-β induced downregulation of IP3R and Bcl-2 and Bcl-xL
promote IP3R activation. The expressions of SERCA, IP3R and RyR are also altered in
VSMCs under diabetic and high-glucose conditions. Interestingly, these modification in
diabetes related to the intracellular calcium dynamics by affecting the calcium release from
the SR and GJIC.
The experimental studies imply that impaired intracellular calcium dynamics in diabetic
VSMCs is related to the alteration of the expression of calcium handling proteins such as
SERCA, IP3R, and RyR and the altered expression of Cx43 stands for the impaired GJIC
in VSMCs. As intracellular calcium is a key component that defines the functioning of the
VSMC, the impaired intracellular calcium dynamics might be the reason for the VSMC
dysfunction in diabetes. This arises the need of research to understand how altered levels of
SERCA, IP3R, RyR and GJIC influence the intracellular calcium dynamics of VSMC. This
study would help us to better understand the VSMC dysfunction in diabetes.
1.6 Research Aims
• Many experimental studies in the past aimed to understand the reason behind the
impaired calcium dynamics in diabetic VSMCs. Some of these studies suggested
that altered expression of calcium handling proteins in the SR such as SERCA, IP3R
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and RyR is related to the impaired calcium dynamics in diabetic VSMCs. However,
the individual role of these proteins on the impaired calcium dynamics in diabetes is
not clearly understood. This might be because of the difficulty in doing experiments
to control the expression of each protein and to pinpoint the functional role of each
protein. Therefore, it is important to study the implications of altered levels of each
proteins, SERCA, IP3R and RyR, on the intracellular calcium dynamics. Mathematical
modelling can help us to do a systematic study and to unveil the knowledge gap that
experiments may not able to explore in diabetic VSMCs.
• The experiments provided an indication of reduced GJIC due to the phosphorylation of
Cx43 or downregulation of Cx43 expression in diabetic VSMCs. The GJIC controls the
propagation of intracellular calcium which in turn affects the propagation of vasoactive
agonist response. The experiments provided an indication of GJIC in diabetic VSMCs
but failed to give a qualitative or quantitative relationship between the altered levels
of GJIC and the propagation of intracellular calcium. To fully understand the VSMC
dysfunction in diabetes, we have to figure out the cellular mechanisms of propagation
of intracellular calcium in VSMCs and the implications of altered GJIC.
• None of the studies have reported the influence of altered levels of SERCA, IP3R and
RyR on the propagation of intracellular calcium. Since SERCA, IP3R and RyR are
altered in diabetic VSMCs, it is necessary to know whether the altered levels of these
proteins have any role in the propagation of intracellular calcium.
Chapter 2
Mathematical models of VSMCs: A
Review
Mathematical modelling is a powerful tool to investigate extremely complex biological
systems such as connected cells and tissues. The computational models help researchers
to advance the understanding of cellular processes, molecular interactions, and signalling
pathways. New understanding would help us to develop cellular level reasoning of pathologi-
cal conditions. Mathematical modelling is also capable of making a systematic approach to
develop a hypothesis which may provide new directions for novel therapeutic strategies.







dynamics in VSMCs, the need of mathematical models
was recognised by early researchers. The main focus of the mathematical modelling was
to describe intracellular calcium handling and the associated nature of membrane potential.
However, not much progress has been made in the mathematical modelling of VSMCs.
Especially, only a few VSMC mathematical models investigating agonist-induced calcium
dynamics are available in the literature. Tsoukias [176] reported a detailed review on
mathematical modelling of VSMCs. We have made a review of the existing mathematical
models that describe agonist-induced calcium dynamics in VSMCs.
2.1 Single VSMC mathematical models
Meyer and Stryer [120] developed a molecular model for periodic calcium spiking induced
by a constant stimulus. The intracellular calcium oscillations were assumed to be the result
of cross coupling between intracellular calcium and IP3. The calcium dependency on the
production of IP3 was modelled by including calcium activation of PLC. In this model, the
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balance between IP3 induced calcium release from the SR and intra-SR calcium reloading
by SERCA defines the concentration of intracellular calcium. The intra-SR calcium was
assumed as constant in this study. Later, Goldbeter et al. [52] developed a minimal model for







but eliminated IP3 oscillations. Calcium influx and efflux
through the cell membrane were added to the intracellular calcium dynamics. The SR was
assumed as a combination of two physically separate stores of which one was IP3-sensitive
and the other one was IP3-insensitive. The calcium oscillations were regulated by the cycling
of calcium between the IP3-insensitive store and the cytosol. Calcium release from the
IP3-sensitive pool regulated the cyclic calcium release from the IP3-insensitive pool by
CICR. The model accounted for the effect of IP3 by including the IP3 sensitive calcium store.
Moreover, the Goldbeter et al. [52] model shows that continuous agonist-induced calcium
oscillations are possible in the absence of IP3 oscillations.
Fig. 2.1 Schematic representation of Goldbeter et al. [52] model. IP3-sensitive and IP3-
insensitive calcium pools are used to model the calcium release from the intracellular calcium
store. Reproduced from Goldbeter et al. [52] paper (permission is not needed to resuse in a
thesis/dissertation for educational use).
Wong and Klassen [192] proposed a model to describe both electrical activity and
intracellular calcium regulation induced by a PE agonist in the VSMC. The transmembrane
calcium influx through an L-type calcium channel, the VOCC, was included in the model to
account for membrane potential. Similar to the Goldbeter et al. [52] model, the intracellular
store was divided into two calcium pools, IP3-insensitive and IP3-sensitive stores. However,
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the two calcium pools were not physically separate. The IP3-sensitive store was filled by
calcium from the IP3-insensitive store and ca-uptake pump while IP3-insensitive store was
refilled by taking calcium directly from the extracellular space. This model was extended
by Wong and Klassen [193] to study both intracellular calcium dynamics and electrical
activity induced by the endothelin-1 (E1) agonist. In this model, the ionic currents of an
L-type calcium channel, a calcium-activated potassium channel (KCa), a voltage-dependent
potassium channel and a NSC determine the membrane potential state of the cell. The NSC
was modelled as an agonist-receptor complex and intracellular calcium dependent channel.
Fig. 2.2 Schematic representation of minimal model of Parthimos et al. [135]. Transmem-
rbane components of the model along with the direction of ionic flow are given. The role
of each component on the regulation of membrane potential is indicated. This model as-
sumes intracellular store as being two physically distinctive calcium pools, where one is
IP3-sensitive and the other one is ryanodine-sensitive. The CICR mechanism is incorporated
in the ryanodine-sensitive calcium pool while the IICR is used in the IP3-sensitive calcium
pool. Reproduced from Parthimos et al. [135] paper (permission is not needed to resuse in a
thesis/dissertation).
Parthimos et al. [135] developed a minimal model to analyse arterial chaos by coupling
membrane and calcium oscillators, (refer to Figure 2.2). Two physically distinct stores,
ryanodine-sensitive and IP3-sensitive, were used in the model to represent calcium induced
calcium release (CICR) and IP3 induced calcium release (IICR) respectively, similar to the
Goldbeter et al. [52] model. In addition to the VOCC and the KCa, transmembrane currents
through a chloride channel, NCX and Na/K pump were included in the model. Kinetics
of the KCa channel activation and inactivation were used to study the temporal variation of
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KCa open probability. They have used this model to explain complex non-linear calcium
dynamics observed in different experimental conditions. Koenigsberger et al. [89] extended





























Fig. 2.3 Schematic representation of interaction between receptors (R) and ligands (L),
receptor endocytosis, receptor recycling, G-protein interaction (G), PLC activation, PIP2
hydrolysis and IP3 & DAG formation from the Lemon et al. [101] model. Reproduced from
Lemon et al. [101] paper (permission granted from Elsevier to reuse in the thesis, license
number: 3856741143867).
An electrochemical model of the VSMC with material balance equations of Na+, K+ and
Ca2+ was later developed by Yang et al. [197]. Voltage-clamp experimental data of isolated
cells, mostly from cerebrovascular arteries, was used to validate the behaviour of model
components. Additional transmembrane components used in this model were the stretch-
activated channel and inward-rectifier potassium channel. Goldman–Hodgkin–Katz (GHK)
model ionic current equations were used to model the stretch-activated current. A four-state
kinetic model was used to find the open probability of the RyR channel. A second order
gating of RyR was applied to calculate the ionic current as two activation sites were assumed
in each RyR. In the following publication by the same group, an nitric oxide (NO)/cGMP
signalling pathway was added to their VSMC model [198]. The NO/cGMP signalling
pathway contains soluble guanylyl cyclase (sGC) activation, sGC-catalyzed production of
cGMP, cGMP regulation of the KCa channel, and cGMP-mediated MLC phosphorylation.
The NO regulation of the KCa channel was also included.
Later, Jacobsen et al. [76] formulated cGMP regulation of the CACC and studied the role
of cGMP in converting calcium waves to whole-cell calcium oscillations in VSMCs. Model
equations for cGMP-sensitive CACCs were validated against experimental data from the
mesenteric artery. Their studies [76, 75] indicated that the essential role was played by the
cGMP-sensitive CACC which allowed the membrane potential to move into an oscillatory
state and induce vasomotion. However, their model was based on a single calcium efflux
channel to simulate CICR. Importantly, Sanders [150] showed that both IP3R and RyR
channels were needed for VSMC oscillatory behaviour.












































VOCC SOC ClCa NaKCl BKCa
Fig. 2.4 Schematic representation of theVSMC model developed by Kapela et al. [83].
This model contains three compartments, cytosol, cell membrane, and the SR. The SR is
compartmentalised into uptake and release compartments. An arrow is used to show the
direction of the flow of ions or molecules through each SR and transmemrbane components
of the model. The IP3, DAG, calcium and NO/cGMP -mediated signalling mechanisms are
shown. Reproduced from Kapela et al. [83] paper (permission granted from Elsevier to reuse
in the thesis, license number: 3850771065526)
Lemon et al. [101] developed a mathematical model to account for the production of IP3
following the application of an agonist to G-protein coupled receptors and subsequent intra-
cellular calcium dynamics. A schematic representation of this model is given in Figure 2.3.
The main components of the model were receptor activity, G-protein cascade, and calcium
dynamics. Modelling of receptor activity is accomplished by connecting activities, such as
binding to ligand agonist, phosphorylation, sequestration, dephosphorylation, coupling and
uncoupling with the G-protein and recycling back to the cell membrane. The main elements
of the G-protein cascade part of the model were G-protein activation, PLC activation, and
hydrolysis of PIP2. The G-protein dynamics were modelled by using the direct relationship
of G-protein activation to ligand bound receptors and inactive G-proteins. The equation for
the production of IP3 was formed by linking calcium activation of PLC, replenishment of
PIP2 and degradation of IP3. The net release of calcium from the SR was used to model
the temporal variation of intracellular calcium. The net calcium from the SR was modelled
by balancing the calcium release through the IP3 sensitive store, the SR calcium leak and
calcium uptake of the SR pump.
This model was later extended to study spontaneous transient outward current (STOC) in
VSMCs [100]. The SR was represented as two physically separate compartments, a central
SR and a peripheral SR. The main calcium release channels in the central SR and peripheral
SR were IP3R and RyR, respectively. Both compartments contain SR calcium pumps and
leak channels. A kinetic scheme was used to model the RyR open probability. The STOC was
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calculated as the ionic current through the BKCa channel as a response to the calcium release
from the peripheral SR. The model equation for IP3 production was simplified compared to
the Lemon et al. [101] model by assuming no depletion of PIP2 and no calcium activation of
PLC. Based on that, the differential equation for the rate of change of PIP2 was eliminated.
Bennett et al. [15] further extended this model to study the contraction of blood vessels
following NE stimulation.
Kapela et al. [83] developed a detailed VSMC model to study agonist-induced calcium dy-
namics by integrating most of the identified transmembrane channels, pumps, and exchangers
along with new descriptions for sub-cellular processes (refer to Figure 2.4). Electrophysiolog-
ical data from VSMCs of a mesenteric artery were used to model the majority of components
of the model. Ionic current equations of the VOCC, BKCa and NSC were modelled using
the GHK equation. The relaxation effect of NO was modelled by including a dependency of
the BKCa channel opening on NO and cGMP. The regulatory effects of cGMP on CACC,
NCX, and sodium-potassium-chloride cotransport (NaKCl) were also incorporated. The
role of DAG, produced along with IP3, on the depolarization of the cell was modelled by
including a DAG-induced NSC channel. This model was capable of providing opposing
effects of NE-induced intracellular calcium rise and NO-induced reduction of intracellular
calcium. The main attractive feature of this model is that it can be used as a building block
for studying the cellular behaviour of a specific interest by eliminating unwanted components
or by including a new description of components and new signalling mechanisms.
2.2 Coupled VSMCs mathematical models
Koenigsberger et al. [89] studied calcium dynamics in a population of VSMCs by coupling
the membrane potential, IP3 and calcium between the adjacent cells. Gap junctional electrical
coupling was modelled like an ohmic resistance by multiplying gap junctional conductance
with the membrane potential gradient between adjacent cells. Similarly, a linear approx-
imation of the molar flux across a gap junction directly proportional to the concentration
gradient, was used to formulate coupling equations for calcium and IP3. They have used the
coupled cells model to analyse synchronisation of calcium oscillations in coupled smooth
muscle cells. The study was conducted on a two-dimensional brick meshing of rectangular
cells. Each cell communicates with six neighbouring cells. According to them, rather than
IP3 coupling, weak calcium coupling was crucial for synchronisation of calcium oscillations.
The electrical coupling alone could produce propagation of calcium oscillations even if the
number of coupled cells were increased.
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The same group [90] has shown that propagation of intracellular calcium in VSMCs
might result from the electrical coupling. This opinion was based on matching the simulation
results, regarding propagation velocity, with the experimental studies of Seppey et al. [157]
[90]. The influence of electrical coupling, VOCC conductance, CICR amplitude and chloride
channel amplitude on propagation velocity were investigated. The time needed for generating
a calcium ‘flash’ was the reason for the lowered propagation velocity of calcium oscillations
compared to the electrical signal. The calcium ‘flash’ is defined as the rapid elevation of
intracellular calcium in the cell. According to their study, CICR is essential for generating
calcium ‘flash’ while the VOCC initiates calcium entry after depolarization.
Jacobsen et al. [75] used an additive electrodiffusion equation, similar to the Nernst-Plank









Where F - Faraday’s constant, z - ion valency, R - universal gas constant, T - temperature, P -
permeability of an ion, ‘σA’ represents the area of contact between the cells, ∆[ion] is the
concentration difference between two the cells and [∆ion] is the average ion concentration
between two cells. In contrast to Koenigsberger et al. [89] model, they integrated the influence
of the calcium concentration gradient and the voltage gradient into a single ionic equation.
This implies that gap junctional current by the passage of an ion is generated as a result of the
concentration gradient of that ion and the electrical potential gradient across the gap junction.















Where gap junctional current flows from cell n to cell m. All the four ions (Ca2+, K+, Na+
and Cl−) were coupled between the cells in this way. The permeability was assumed to be the
same for all four ions. Permeability was calculated from the whole-cell resistance of the gap
junction whose values for some vascular beds are available in the literature. For IP3 coupling,
molar flux was assumed to be directly proportional to the concentration gradient between two
adjacent cells; this was similar to the Koenigsberger et al. [89] model. They have coupled
VSMCs and ECs to study the effect of myoendothelial communication on vascular reactivity.
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Most of the single cell mathematical model studies focused on the calcium signalling
mechanisms in the VSMC and the role of different cellular components in the signalling
[192, 120, 52, 76]. First, tissue-specific mathematical modelling in the VSMC was done by
Yang et al. [197]. Their study aimed to investigate VSMC calcium dynamics and contraction
in the cerebrovascular artery. The Lemon et al. [100] have used their model to study
STOC generation in vascular A7r5 smooth muscle cells. The Kapela et al. [83]’s study
aimed at mesenteric artery VSMCs. Coming to coupled VSMC models, propagation and
synchronisation of intracellular calcium oscillations were mainly investigated [90, 75]. None
of the modelling efforts aimed to understand the intracellular calcium dynamics of VSMCs
in a pathological condition such as diabetes.
2.3 Thesis Objectives
1. Development of a VSMC model to analyse agonist-induced intracellular calcium
dynamics
Using Kapela et al. [83]’s VSMC model as a building block, we develop a new mathe-
matical model by adding new or modified descriptions to the NCX exchanger, IP3R
channel, NSC channel, agonist-induced IP3 production, SR structure, and functioning.
The model takes only the most relevant channels, pumps and exchangers needed for
the agonist-induced calcium dynamics from Kapela et al. [83] for the kind of study we
do. The essential features of the model results will be validated against experimental
results. We develop a numerical method, an integration of the Back-Euler method
and fixed-point iteration, to solve the model equations. The numerical solver is pro-
grammed in ‘C’ code using Eclipse software, version: Juno service release 2 from
http://eclipse.org/, installed on a local machine.
2. Analysis of the effects of altered levels of SERCA, IP3R and RyR on intracellular
calcium dynamics of a single VSMC.
We conduct a detailed systematic investigation on the intracellular calcium dynamics in
the presence of altered activation levels of SERCA, IP3R, and RyR. In our knowledge,
the cellular mechanism that alters the expression of SERCA, IP3R, and RyR in diabetic
VSMCs are not fully known. In the absence of such a mechanism, we change the level
of a protein or a combination of two proteins, and the resulting dynamics of VSMCs
are studied. This approach helps us to study the effects of different combinations of
SERCA, IP3R and RyR on the intracellular calcium dynamics in VSMCs. This method
is reasonable as the aim of the research is to document the altered calcium dynamics
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due to the altered expression of these proteins. We validate the results against available
experimental results.
3. Analysis of altered levels of SERCA, IP3R, RyR and gap junctional coupling on
the propagation of intracellular calcium in coupled VSMCs
We investigate the effects of altered levels of GJIC between VSMCs on the propagation
of intracellular calcium. We alter the level of GJIC by changing the number of gap
junctions. In addition to that, we alter the level of SERCA, IP3R and RyR in the coupled
cells and the resulting propagation of intracellular calcium will be analysed. We extend
the numerical method used for single VSMC to coupled VSMCs by incorporating
tridiagonal matrix algorithm (TDMA).
2.4 Thesis Overview
The overview of the thesis is illustrated in Figure 2.5. Chapter 1 provides a detailed discussion
of the agonist-induced calcium dynamics in VSMCs. The chapter starts with an introduction
to the human vascular system, then gives a brief explanation of the VSMC contraction
mechanism and the role of calcium in the contraction. Sections 1.3 and 1.4 cover the calcium
signalling mechanisms in VSMCs, the role of the SR, calcium release from the SR, CICR
and IICR mechanisms, calcium translocation by the SR, calcium extrusion mechanisms,
calcium influx mechanisms, the common features of agonist-induced calcium oscillations,
intercellular signalling mechanisms, and GJIC. The research motivation and aims are states
at the last sections of this chapter.
Chapter 2 describes the existing mathematical models of VSMCs, especially studying
agonist-induced calcium dynamics. Both single cell and coupled cells models are reviewed.
Thesis objectives and the overview of the thesis are given at the end of the chapter 2.
The methodologies of mathematical modelling in cell physiology are given in Appendix
A, which will help to understand the model equations given in chapter 3. The development
of a new VSMC model, the important changes made compared to previous model attempts,
model equations and the comparison of model results against experimental studies are given
in the chapter 3. The numerical method used to solve the model equations is also explained.
Backward-Euler and fixed point iteration methods used to develop the numerical algorithm
are given in Appendix B. The discretization of model equations, initial values of model
variables and model parameters are supplied in Appendices C, D, and E respectively.
The VSMC model developed in the chapter 3 is used to study the effects of altered levels
of SERCA, IP3R and RyR on the intracellular calcium dynamics of VSMC, which is detailed
in chapter 4. The combination of different parameters needed for the occurrence of calcium
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Fig. 2.5 Thesis roadmap
oscillations in the VSMC is investigated on the basis of bifurcation points of the system. The
model results are discussed in the context of diabetes at the end of chapter 4.
Chapter 5 describes the propagation of intracellular calcium dynamics using the model
developed in chapter 3. The coupled cells model equations are solved using a TDMA along
with the numerical algorithm developed in chapter 3. The TDMA is detailed in Appendix
B. A study was conducted on an in-silico VSMC strip of 100 serially coupled VSMCs in
which first 51 cells were stimulated. The intracellular calcium propagation mechanisms in
the model results are discussed and the dominant components are synthesised. The results
are compared with the available experimental results. Appendix F gives definitions of some
of the terms used in chapters 5 and 6.
The coupled cell model is extended to study the effects of altered levels of SERCA, IP3R,
RyR and gap junctional coupling on the propagation of intracellular calcium in VSMCs.
The wave velocity and the penetration depth are analysed to describe the effects of each
component investigated. The wave velocity and the penetration depth are calculated based on
the regenerative calcium rise in the non-stimulated cells. The coupled results are discussed
in the context of diabetes at the end of this chapter.
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Finally, the whole thesis is summarised in chapter 7. The contributions of the research to
the proposed research aims are explained from the model results. The possible directions of





The recent increasing experimental study in VSMCs is bringing new insights to the VSMC
calcium dynamics. It is so important to advance the existing mathematical models as they
provided significant understandings to the calcium dynamics in VSMCs. We have used
Kapela et al. [83] model as a building block to develop the new mathamatical model for
VSMC. We have included new or modified description to NCX exchanger, IP3R channel,
NSC channel, agonist-induced IP3 production, SR structure, and functioning.
In the past, the experimental difficulties to determine the SR structure drove researchers
to use functional studies to understand the arrangement of SR. The functional studies have
shown that SR is sensititive to calcium and IP3. Some studies reported that the calcium-
sensitive depletion via RyR of internal calcium store did not affect the IP3-sensitive calcium
release via IP3R. It was interpreted as there would be two separate stores in VSMC, calcium-
sensitive store contains only RyR and IP3-sensitive store contains only IP3R [174, 57, 77].
In contradiction to this, some researchers proposed that SR is a single calcium store with
both IP3R and RyR expressed in it [133, 178]. In their experiments, RyR-mediated depletion
of the internal calcium store terminated the IP3R-mediated calcium release.
Goldbeter et al. [52] assumed internal calcium store as a combination of two physically
separate stores of which one is IP3-sensitive and the other one is IP3-insensitive in their
minimal model for agonist-induced calcium oscillations. Similar to Goldbeter et al. [52]
model, Parthimos et al. [135] developed a minimal mathematical model for VSMC by
assuming two distinct internal calcium stores, ryanodine-sensitive and IP3-sensitive. Kapela
et al. [83] modelled SR as a single store but with two compartments, uptake compartment
and release compartment. The uptake compartment contains a SERCA pump and a IP3R
channel whereas RyR is the main calcium release channel in the release compartment.
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The recent development of advanced digital imaging techniques has improved the un-
derstanding about the structural organisation of SR. Picht et al. [139] showed that there
is no major temporal delay in calcium recovery between junctional and longitudinal parts
of SR. The calcium diffusion in the SR lumen is rapid, which nullifies the spatial calcium
gradient in the SR during cell excitation. A recent experiment of McCarron and Olson [117]
confirms that SR is a luminally continuous entity in which both IP3R and RyR are expressed.
The same level of intra-SR calcium is freely accessed by both IP3R and RyR [142, 117].
Therefore, there is no need to model SR as two compartments with differential expression of
calcium handling proteins on each compartments. One can assume that the SR is a single
luminaly continuous store with homogeneous luminal calcium. This concept is used in the
current study to model SR.
IP3R is tetrameric with four subunits forming a single calcium-conducting channel. The
opening of the IP3R channel is regulated by calcium ions and IP3 molecules. Calcium-
mediated regulation of IP3R is biphasic; it enhances channel opening at low calcium concen-
trations and deactivates channels at high calcium concentrations.
Goldbeter et al. [52] modelled the IP3-sensitive calcium release as a “constant" and the
value of “constant” was changed to represent the IP3-sensitive calcium release for different
agonist concentrations; similar to Parthimos et al. [135]. Koenigsberger et al. [89] used an
equation similar to the Michaelis-Menten equation to model IP3R-mediated calcium release,
which is directly proportional to the IP3 concentration. Bennett et al. [15] has included the
biphasic regulation of IP3R channel along with the IP3 activation; the same is used in the
Kapela et al. [83] model.
According to a detailed review on the existing IP3R models by Shuai et al. [164],
sequential-binding of calcium and IP3 messengers should be included in the IP3R model
in order to fit the open probability to experimental observation. They have compared the
existing model results with the patch clamp experiments for single IP3R channels in Xenopus
oocyte to draw the given conclusion. None of the existing VSMC models has implemented
sequential binding of calcium and IP3 for the activation of IP3R. We have incorporated a
simplified sequential-binding IP3R model in our VSMC model since calcium is the central
attention of the study.
The equation of the NCX is modified by incorporating the allosteric factor. A different
description is given to the ionic current equation of the NSC channel. The Lemon et al.
[101] model for agonist-induced IP3 production is simplified by eliminating receptor activity
regulation. The details of these modifications can be found in the respective sections of this
chapter.
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The VSMC model contains only the most relevant channels, pupms and exchangers
for the agonist-induced calcium dynamics. For the specific study we are doing, we have
eliminated the following components of the original Kapela et al. [83] model; NO/cGMP
signalling, sodium-potassium pump (NaK), voltage-dependent potassium channel (KV),
potassium leak channel (Kleak) and NaKCl.
In this chaper, the model components and their respective model equations are discussed
in the first sections. Following that, the numerical methods used and numerical algorithm
developed are discussed. The model response to varying agonist concentrations is discussed
in the start of the results section. The model response is compared against the available
experimental results. The responses of the model to varying extracellular concentrations are
tested against experimental results. The intracellular calcium signalling mechanism of the
model is detailed in the discussion section. We propose that this model (in comparison with
[83]) is minimal in that it provides the required phenomena of Ca2+ dynamics with a reduced
number of parameters and ion channels. The model limitations are listed at the end of the
chapter.
3.2 Model Development
A schematic representation of the model is shown in Figure 3.1. The model contains three
fluid compartments, extracellular space (e), cytosol (cyt), and SR, which are separated by
cell and SR membranes. Ion transport across cell membrane is given by four ion channels, a
large conductance calcium-activated potassium channel (BKCa), a voltage-operated calcium
channel (VOCC), a NSC channel and a calcium-activated chloride channel (CACC), one
plasma membrane calcium ATPase pump (PMCA), and one Na/Ca exchanger (NCX). Three
calcium channels, an IP3R channel, an RyR channel, an SR leak channel (SRleak), and
a SERCA pump are included in the SR membrane. Calcium buffering in the cytosol is
considered as the sum of calmodulin and other buffers. The buffering of intra-SR calcium is
ignored in the current study [197, 135]. Action of an agonist on adrenergic receptor cascade
and the resulting formation of IP3 and DAG are included in the model. In contrast to other
models such as [83, 85] the SR is treated as a single domain and we have not included the
NO/cGMP pathway mediating the BKCa channel.
We define an ionic current, I, specific to a channel k by Ik. For an ion channel in the cell
membrane,
Ik = GkPk (Vm −Eion) (3.1)
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Where ‘ion’ represents Ca2+, K+ or Cl−, F is Faraday’s constant, R is universal gas con-
stant, z is ion valency and T is temperature.








Where Qk is the maximum rate of calcium flux and ‘f’ is a function of intracellular calcium.












The membrane potential of the cell is defined based on the lumped Hodgkin-Huxley formula-






(IBKCa + IVOCC + INCX + IPMCA + INSC + ICACC) (3.5)
Calcium levels in the cytosol and in the SR are estimated by balancing fluxes of calcium
























ISERCA − IIP3R − IRyR − ISRleak
)
(3.7)
Where ρ is a calcium buffering parameter.















Where BCM and BF are the concentrations of calmodulin and other buffers, respectively. kCM
and kB are the dissociation constants of calmodulin and other buffers, respectively.
α = zCaFVolcyt and β = zCaFVolSR (3.9)


































Fig. 3.1 Schematic diagram of SMC model: BKCa - large conductance calcium-activated
potassium channel, PMCA - plasma membrane calcium ATPase, VOCC - voltage-operated
calcium channel, NCX - Na/Ca exchanger, NSC -non-selective cation channel, CACC -
calcium-activated chloride channel, IP3R - IP3 receptor channel, RyR - Ryanodine receptor
channel, SRleak - SR leak channel, SERCA - SR calcium ATPase, L - agonist, GP - G-protein,
R - receptor, CaM - calmodulin, CaB - other calcium buffers.
40 VSMC Model Development
3.2.1 Cell membrane channels, pumps and exchangers
3.2.1.1 Large conductance calcium-activated potassium channel (BKCa)
The BKCa channel plays an important role in setting the membrane potential and is the main





cyt and Vm, allows this channel to coordinate electrochemical signals.
The increased intracellular calcium during stimulation will trigger the BKCa channel and
results in an outward flux of potassium ions (K+). This is considered as a spontaneous
transient outward current (STOC) forcing the Vm to return to its basal level. BKCa channels
are known to be important for myogenic activities of VSMC and in the pathophysiology of
hypertension [199, 183]. The model equation for BKCa current is given below,
IBKCa = GBKCaPBKCa (Vm −EK) (3.10)
Where GBKCa and PBKCa are the whole cell conductance and open probability of the BKCa
channel. EK is the Nernst potential of potassium. The open probability of the BKCa channel
is modelled as a combination of fast and slow activation processes. The empirical equation
for the open probability of the BKCa channel is taken from the Kapela et al. [83] model.
PBKCa = 0.17pf +0.83ps (3.11)
Where pf and ps are the fast and slow activation variables which are modelled based on the














Where τpf and τps are the fast and slow activation time constants. p̄o is the steady state open







Where C1 = 18.25 mV. The V0.5BKCa provides the calcium dependency of the BKCa channel.








Where C2 = 128.2 mV.
3.2.1.2 Voltage-operated calcium channel (VOCC)
The VOCC channel is a key channel which is responsible for the influx of calcium into the
cell from the extracellular space. VOCC channels respond to membrane potential signals
and release calcium to the cytosol accordingly. The L-type VOCC is found to be responsible
for myogenic activities in VSMCs of the microcirculation [124, 34]. Modulation of L-type
VOCCs is identified as a major pathway that controls myogenic contraction in cerebrovascular
smooth muscle cells [116]. The model equation for VOCC is as follows,
IVOCC = GVOCCdLfL (Vm −ECa) (3.15)
Where GVOCC is the whole cell conductance of VOCC and is calculated from the whole-cell
voltage-current (V-I) curve published in Nikitina et al. [129]. dL and fL represent activation
and inactivation variables of the VOCC respectively. ECa is the Nernst potential of the
calcium ion. The activation and inactivation of VOCC are modelled as, (refer to Section A.6













Where d̄L and f̄L are the steady state activation and inactivation variables of the VOCC
respectively. τdL and τfL are the activation and inactivation time constants respectively. The












Where C3 = 8.3 mV, C4 = 42 mV, and C5 = 9.1 mV.

















Where C6 = 40 mV, C7 = 30 mV, C8 = 35 mV, and C9 = 25 mV.
3.2.1.3 Sodium/Calcium exchanger (NCX)
The NCX channel exchanges three sodium ions (Na+) into the cell and one calcium ion
out of the cell [143]. This electrogenic transfer causes depolarization of the cell at the
expense of intracellular calcium. This bidirectional exchange mechanism and its increased
activity at higher calcium concentrations after agonist stimulation is identified in VSMCs
[126]. The NCX channel is a low affinity-high capacity calcium efflux pathway. The NCX is
allosterically regulated by calcium. The calcium binds to the allosteric site of the NCX at
low calcium concentrations and changes the activity of the NCX. The full equation for NCX
is obtained by incorporating allosteric factors into the electrochemical term [186].
INCX = ĪNCXPNCX,alloPNCX,elec (3.20)
Where ĪNCX is the scaling factor of NCX. NCX is alloseterically regulated in a way that
NCX can get deactivated at low calcium concentrations [121]. The allosteric factor, PNCX,allo,
through binding of calcium to the regulatory site is expressed as a Hill equation, (refer to












Where kNCX is the dissociation constant for the allosteric component and fixed to 125 nM
based on the study of Weber et al. [186]. The equation for the electrochemical term, PNCX,elec,
stands for the exchange of ions due to electrochemical potential [83, 35, 186]. The mathe-
matical expression of PNCX,elec is taken from the Kapela et al. [83] model.




























Where dNCX = 0.0003, φF and φR represent the dependency of the model on the membrane












Where γ is the position of the energy barrier of the NCX in the membrane electric field.
3.2.1.4 Calcium-activated chloride channel (CACC)
An increase in intracellular calcium by the calcium activated chloride (Cl−1) channel is
observed following agonist stimulation [189, 140]. CACC currents have been reported to be
activated spontaneously. These spontaneous CACC currents are produced in synchronization
with BKCa currents [80, 97]. The CACC seems to be activated mainly by intracellular
calcium and is also sensitive to cyclic guanosine monophosphate (cGMP) [76]. Since the
cGMP calcium signalling pathway is not included in the model, the open probability of
CACC is assumed to depend on intracellular calcium only. The model equation of the CACC
is,
ICACC = GCACCPCACC (Vm −ECl) (3.24)
Where GCACC and PCACC are the whole cell conductance and open probability of CACC.
GCACC is calculated from the whole cell V-I data in Matchkov et al. [114]. ECl is the Nernst












Where kCACC is dissociation constant of CACC. The dissociation constant (kCACC) reported
in the literature varies from 63 nM [28, 4] to several µMs [152]. Ni et al. [127] used an
experimental protocol to have negligible channel run down of CACC which is considered as
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one of the main reasons for the discrepancies of kCACC in the literature. This is the reason
for choosing kCACC, 587 nM, from Ni et al. [127]. A similar kCACC value is reported by
Angermann [3] for CACC in pulmonary arterial smooth muscle cells. It is well known that
the Hill coefficient of CACC is larger than one. The Hill coefficient of CACC in the Ni et al.
[127] study equals 3.8 at -40 mV, whereas in Angermann [3], it varies from 2 to 2.5 for a
change of membrane potential from -40 mV to 0 mV. For the same voltage range, the Hill
coefficient is given as less than 1.5 in the Arreola et al. [4] study and is less than 3 in the
Kuruma and Hartzell [93] study. The Hill coefficient of 3.8 in the Ni et al. [127] study is
high compared to the other above mentioned studies. Based on the above observations we
have therefore fixed the Hill coefficient of CACC to 2. Interestingly, the same Hill coefficient
is used in the Kapela et al. [83] model of VSMCs.
3.2.1.5 Non-selective cation channel (NSC)
Agonist stimulation in smooth muscle cells induces a cation current which is not activated
by calcium and is different from the BKCa and CACC currents. This cation current causes
depolarization of the cell and plays an important role in the influx of calcium [2, 72].
Experiments by Soboloff et al. [166] show that when the L-type Ca channel (VOCC) is
inhibited, transmembrane calcium influx induced by DAG is blocked. Intracellular calcium
rise due to DAG activation of the NSC channel is contributed mainly by the VOCC channel
and not by the calcium flux through the NSC channel. Thus, we have not included the direct
contribution of calcium flux through NSC channel. The transient receptor potential cation
channel, (TRPC6), is identified as an alpha-adrenoceptor evoked NSC channel in VSMC
[79, 38]. Membrane potential and diacylglycerol (DAG) regulate the opening of the NSC
channel. The model equation of the NSC channel current is given below,
INSC = GNSCPNSC,VmPNSC,DAG (Vm −ENSC) (3.26)
Where GNSC is the whole cell conductance of the NSC channel and is determined from the
whole cell V-I data given in Helliwell and Large [63]. ENSC is the reverse potential of the
NSC channel. PNSC,Vm and PNSC,DAG represent the dependency of channel open probability
on Vm and DAG respectively. PNSC,Vm is fitted to the V-I relationship reported in Helliwell
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There is a scarcity of experimental data that discusses the open probability of the NSC
channel with respect to DAG concentration. When oleoyl-2-acetyl-sn-glycerol (OAG), a
DAG analogue, is used, activation of TRPC6 is obtained with micromolar concentrations
of OAG [63, 166]. Based on these observations, the dissociation constant for the NSC is
assumed as 1 µM.
3.2.1.6 Plasma membrane calcium ATPase (PMCA)
PMCA plays a vital role in maintaining the resting concentration of intracellular calcium.
PMCA removes calcium from intracellular space at the expense of energy from ATP hydrol-
ysis [23]. PMCA has high affinity to calcium but its pumping capacity is low [122, 111]. It
can operate in a concentration range where NCX is relatively inactive. Michaelis-Menten
kinetics is used to model PMCA current and the model equation of PMCA is,
IPMCA = αQPMCAPPMCA (3.29)










Where kPMCA is the Michaelis constant of the PMCA pump. As noted, PMCA has a high
affinity to calcium and is the main component responsible for maintaining the resting calcium
concentration. The PMCA operates at a low calcium range where the NCX is relatively
inactive [23]. Kapela et al. [83] used a Michaelis constant of 170 nM whereas Jacobsen
et al. [76] used a value of 200 nM. In Jacobsen et al. [76] study, the intracellular calcium
at the resting state was 100 nM which is slightly higher than the corresponding value of
80 nM in our model. To account the difference in intracellular concentration with Jacobsen
et al. [76] study, Michaelis constant, kPMCA, of 150 nM is used for PMCA and to satisfy the
experimental observation of the high affinity to calcium and the kPMCA is within the range of
values used in the previous models.
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3.2.2 Sarcoplasmic Reticulum (SR) channels and pump
3.2.2.1 Sarcoplasmic reticulum calcium ATPase (SERCA) pump
SERCA pumps utilize energy from ATP to pump calcium back to the SR. The SERCA pump
is activated at high cytosolic calcium levels to bring back both intracellular and intra-SR
calcium concentrations to basal conditions. Thus the pump helps to complete the cycle
of contraction and relaxation [137]. SERCA activity is controlled mainly by changes in
intracellular calcium [9, 91]. A Michaelis-Menten kinetics equation is used to model the
SERCA pump.
ISERCA = αQSERCAPSERCA (3.31)
Where α is defined by Equation 3.9. QSERCA is the maximum rate of calcium efflux of the












Where, kSERCA is the Michaelis constant of the SERCA pump. The value of QSERCA is taken
from the experiment of Balke et al. [9]. In their experiment, the Michaelis-Menten equation
was fitted to two slope factors of 2 and 4. Wimsatt et al. [191] reported a Michaelis constant
of 500 nM with a slope factor of 1.6. Based on these observations, we have used a Michaelis
constant of 500 nM and a slope factor of 2.
3.2.2.2 SR leak channel (SRleak)
SRleak is the calcium release that is different from the calcium release due to cell excitation
and is more prevalent during the relaxation phase. SRleak acts as a counterbalance to
the SERCA pump and plays an important role in maintaining the intra-SR calcium load
[202, 22, 17]. SRleak is significantly raised at high intra-SR calcium. The change of SRleak
with respect to intra-SR calcium is matched to an exponential function in the Zima et al.
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Where λ is maximum rate of calcium leak and kleak is a growth factor of the exponential
function, 145 µM [202] .
3.2.2.3 IP3 receptor channel (IP3R)
A sequential-binding four state model developed by Swaminathan et al. [170] is used to find
the open probability of IP3R. In this, IP3R is modelled as having four equal and independent
subunits. Each subunit has three distinct binding sites, one for IP3 activation, one for calcium
activation and the third one for binding inhibitory calcium. Calcium can bind to its activation































Fig. 3.2 Schematic representation of sequential-binding IP3 model [170]. X00, X10, X01 and
X11 are the four states of a subunit.
Figure 3.2 shows the schematic diagram of the sequential-binding four state model. Xi, j
represents the different intermediate states and the probability of IP3R in the corresponding
state (i,j). For Xi,j, the first subscript "i" represents the calcium activating site and "j" the
calcium inhibiting site. "0" means not bound and "1" means bound. X1,0 is the open state
among the 4 states of IP3R. Other states can be read based on the value of "i" and "j". X0,0 is
the state with no calcium bound to the sites, X0,1 is the state with calcium bound to only an
inhibition site and X1,1 is the state with calcium bound to both sites. Transition from one
state to another depends on the concentrations of IP3 and calcium. Subunit dynamics of the
IP3R model are given by the following differential equations [170].
























































Where ai and bi are binding and dissociation constants as given by Swaminathan et al [170]
as given in Table E.5. The IP3R channel opens when all four or any three subunits are in the








The calcium and IP3 regulation of IP3R opening are shown in the left and right-hand panels
of Figure 3.3 respectively. The open probability variation with IP3 is monotonic increasing,
reaching a maximum value of 1.7 ×10−2 at IP3R = 10 µM [172, 185]. The open probability
of IP3R with respect to calcium gives a bell-shaped curve [18], as expected for biphasic regu-
lation. The open probability of IP3R increases at low calcium concentrations and decreases





which matches the experimental studies [86, 18].












Where β is defined by equation 3.9. QIP3R is the maximum rate of the IP3R channel.
Swaminathan [169] used 4625 s−1 for QIP3R and 0.5 mM for intra-SR calcium concentration
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Fig. 3.3 (Left) Variation of steady state open probability of IP3R channel with respect to[
Ca2+
]
cyt for different IP3 concentrations, [IP3] = 1000 nM (dash dotted), [IP3] = 400 nM
(dotted), [IP3] = 200 nM (dashed), [IP3] = 100 nM (solid). (Right) Variation of steady state




cyt = 1000 nM.
to obtain calcium puffs lifetimes and amplitudes consistent with the experiments. In our
model, intra-SR calcium equals to 1.2 mM at the resting state. A value of 2000 s−1 is used
for the QIP3R in order to account the difference in intra-SR calcium with the Swaminathan
et al. [170] study.
3.2.2.4 Ryanodine receptor channel (RyR)
RyR channels are functionally and structurally comparable to IP3R channels and are sensitive
to intracellular calcium concentrations. These channels get activated when intracellular
calcium increases from nM to µM, whilst at mM levels of intracellular calcium, RyR is
inhibited. A multiple state kinetic model proposed by Yang et al. [197] is used to find calcium
activation of RyR. The four states of the RyR in the model are R00 is free receptor, R01 is
the receptor with a calcium ion bound to the inactivation site, R11 is the state with a calcium
ion bound to both the activation and inactivation sites and R10 is the state with a calcium ion
bound to the activation site. Two calcium activation sites are assumed in a single RyR. The











































R00 = 1−R01 −R10 −R11 (3.44)
Where Kr1 and Kr2 are the activation and inactivation rate constants, respectively. K−r1 and
K−r2 are unbinding rate constants from activation and inactivation, respectively.
The open probability of the RyR channel, PRyR, is given by the solution of the time-
dependent equations of the four states and the open probability of the RyR is a quadratic
function of the variable R10 as shown below,
PRyR = R210 (3.45)












Where QRyR is the maximum rate of RyR. β is defined as before.
3.2.3 G-protein cascade and IP3 formation
We have used a simplified mathematical model of Lemon et al. [101] eliminating receptor
activity regulation to model G-protein activation and subsequent IP3 formation. The agonist
ligand (L) gets bound to the receptor and forms a ligand occupied receptor, LR. The G-protein
is activated by the ligand occupied receptor. The rate of G-protein activation is dependent on
the number of active receptors (LR) and the number of inactive G-proteins, see the Eq.3.47.
The deactivation of G-protein is related to the amount of active G-protein present.
dGP
dt
= ka (δ +ρr)(GPT −GP)−kdGP (3.47)
Where GP denotes G-protein, ka is the rate of G-protein activation, kd is the rate of G-protein
inactivation, GPT is the total number of G-protein molecules in a VSMC, δ is G-protein
intrinsic activity parameter and ρr is the ratio of agonist-bound receptors to the total receptors.





Where [L] is the agonist concentration and kR is the unphosphorylated receptor dissociation
constant.
PLC is fully activated only when it binds to the G-protein and to calcium. Therefore,
the activation of PLC is modelled as dependent on intracellular calcium and the G-protein,
see the Eq.3.49 to Eq.3.51. This helps to build a positive feedback system between IP3
production and intracellular calcium. Activated PLC hydrolyses PIP2 and the rate of PIP2
hydrolysis is equated to rh [PIP2,T]. The concentration of PIP2 is kept constant based on the
assumption that the degradation of PIP2 is equal to the replenishment from the cytosol [100].
The hydrolysis of PIP2 produces one molecule of each DAG and IP3. The model equations












PIP2,T −kdeg,DAG [DAG] (3.50)
Where NAV is Avogadro’s constant, PIP2,T is the total number of PIP2 molecules in a VSMC,
kdeg,IP3 is rate of IP3 degradation, kdeg,DAG is rate of DAG degradation and rh is the rate










Where η is effective signal gain parameter and kPLC is the dissociation constant for calcium
binding to PLC.
3.3 Numerical Method
There are a number of ways in which the coupled system of ODEs can be solved. However,
we have based the solution procedure on numerical methods developed by Rempe and
Chopp’s algorithm [145]. This is because for future work we have adapted the code to
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investigate coupled cells in branched structures such as bifurcating arteries. This makes the
transition to coupled cell systems easier.
Mascagni [112] developed a numerical procedure to solve Hodgkin-Huxley equations
using a backward Euler method and fixed point iteration, see Appendix B for a general
description. Later on, Rempe and Chopp [145] implemented it in a branched neural network.
A similar procedure is implemented in our study as follows. The model equations can be
written in a general form, for a particular state variable xi.
ẋi = xigi (x1, ....,xn)+hi (x1, ....,xn) (3.52)
In the interests of brevity we provide an example of the procedure based on the variable
membrane potential Vm.
The backward Euler method is used to discretize the differential equations, see Appendix
C for the discretized model equations. For Vm the membrane potential, the discretized



























































−GNCXPt+∆tNCX,alloPt+∆tNCX,elec +GCACCPt+∆tCACCECl −αQPMCAPt+∆tPMCA (3.54)
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As shown in the supplementary material, for the state variable X00, Eq 3.34 gives







and hi = (b4k3 +b2)
X01
1+k3
+b5X10. Similarly, gi and
hi functions are obtained for all 16 model equations. The discretized equations of all state
variables can written in the form to give,
xi (t +∆t)(1−∆t gi (x1 (t +∆t) , ....,xn (t +∆t))) = xi (t)+∆t hi (x1 (t +∆t) , ....,xn (t +∆t))
(3.57)
A fixed point iteration method is used to solve the above equation at a given time step
[145, 112]. Functions g and h are calculated explicitly at each iteration using xi from the















Where superscript k represents the iteration number. For k = 1, we choose xki = xi(t) and a
series of approximations xki (k = 2,3, . . .) to xi(t +∆t) is obtained using the equation 3.58.
When the fixed point iterations converge, xk+1i is a solution to the equation 3.57. In the
current model, iteration is continued until all the state variables converge to an error tolerance
limit such that xk+1i − xki ≤ 10−4 for all i and time step is fixed to 0.1 ms.
3.3.1 Running time and Error analysis
The time step required to obtain estimated relative error of 10−4 with the proposed numerical
method is obtained from the relative error plot, (Figure 3.4). This plot shows how the relative
error changes with the time step (∆t). The relative error is calculated by taking the result
with ∆t = 10−7 seconds and tolerance limit 10−6 as the exact solution. The relative error
decreases as the time step decreases. Error is always higher if no iteration is used. Iteration
significantly improves the accuracy of the result.
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Fig. 3.4 Solver dependency: Running time (top) and relative error (bottom) of the solver is
plotted against time step at different tolerance values of iteration, 10−2 (solid), 10−4 (dashed)
and 10−6 (dotted) and with no iteration (dashdotted).
Running time is calculated as the total CPU time required to finish 150 seconds real time
simulation. CPU time increases when time step is decreased, (see Figure 3.4). Similarly, the
decreasing tolerance limit raises the required CPU time. For any time step, running time is
low if no iteration is used. Though reducing the time step improves the accuracy, it slows the
simulation. To get the required accuracy in a reasonable running time, we have used a time
step of 10−4 seconds and a tolerance limit of 10−4.









Calculate g and h functions using
state variables at (k-1)th iteration
Calculate state variables 
       at kth iteration
















time = time + time step
Start
Assign state variables from previous 
time step as state variables at 0th iteration
Fig. 3.5 Computer algorithm: Contains 5 parts 1) define model constants/parameters, 2)
memory allocation, 3) initialization, 4) fixed point iteration and 5) writing output data. Part
of the algorithm for fixed point iteration is given in the dashed box.
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A computer code is developed in ‘C’ language using Eclipse software, version: Juno
service release 2 from http://eclipse.org/, to run the VSMC model. The developed computer
algorithm is divided into 5 parts, (see Figure 3.5). The first part of the code defines the model
constants and parameters. All the model constants given in the Appendix E are defined
globally, so that they can be accessed at any part of the program. The simulation control
parameters such as final time, time step tolerance limit, file writing frequency etc. are defined
locally in the main file. The second part is allocating memory for the assigned variables
in the code. All the state variables are initialized in the third part using the values given in
Appendix D.
Once initialization is complete, the solution of the problem is calculated using a fixed
point iteration algorithm, (refer to Figure 3.5). All the operations inside the dashed line box
in Figure 3.5 represent the iteration algorithm. At the start of the algorithm, g and h functions
are calculated using the state variables from the previous iteration, (k-1)th. To calculate the g
and h functions for the first iterative step, state variables from the previous time step are used.
Using these g and h values, state variables are calculated in the new iteration, kth. The state
variables calculate in the (k-1)th and kth iterations are compared to check for tolerance limit.
If the tolerance limit is not satisfied, iteration algorithm is repeated.
The last part of the code is to save the results in the desired formats. The code saves the
output data in two formats, .txt and .vtk. Vtk files are used to visualize the problem and
.txt files are imported into Matlab for plotting and analysing the results. The frequency of
saving output data is based on the file writing frequency defined in the first step. The last two
parts of the code, fixed point iteration and writing files, are repeated until the final time is
reached. We have uploaded the source code to a public area of the Github repository; the link
is “https://github.com/BlueFern/VSMC-SC”.
3.4 Model parameters and resting state values
The values of state variables at resting state (no agonist) are given in Table D. Experimental
studies show that intracellular calcium at the resting state is less than or equal to 100 nM
[128, 200, 55]. We use this evidence to choose 80 nM in our model. Studies by Picht et al.
[139] and Esfandiarei et al. [44] show that intra-SR calcium concentration at resting state
stays in between 1 mM and 1.3 mM. Therefore, we have adjusted the SR leak parameter
to obtain a value of 1.2 mM. The initial value of Vm is fixed to -54 mV based on the
experimental observation of Harder and Sperelakis [62] in VSMCs of mesenteric artery.
Once intracellular calcium, intra-SR calcium and Vm are fixed, other state variables, GP, IP3,
DAG, R10, R01, R00, X10, X01, X00, pf, ps, dL and fL, at resting state are calculated based on
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the steady state equations given in Appendix D. The [Na+cyt] value is taken from the model of
Kapela et al [83] and this value is used to find the NCX current.
All model parameters appear in Tables E.1, E.2, E.3, E.4, and E.5. The SRleak parameter,
λ , is obtained from the intra-SR calcium balance at resting state. All the other terms in the
intra-SR calcium equation (see Equation 3.7), are known at resting state. The maximum rate
of calcium efflux of PMCA, QPMCA, is calculated by solving the intracellular calcium balance
at resting state, (refer to Equation 3.6). The NCX current at resting state is almost negligible.
The BKCa channel parameter, GBKCa , is obtained by balancing membrane potential equation
at resting state, (refer to Equation 3.5). The scaling factor of NCX, ĪNCX, is fixed by adjusting
it to get the intracellular calcium concentration within the physiological range, less than
1µM, [128, 200, 55] upon agonist stimulation.
3.5 Results
3.5.1 Model response to varying agonist concentrations
The simulations are carried out for varying concentrations of agonist, zero nM to 800 nM. At
the beginning of the simulation, zero agonist is set, so the VSMC will be in the resting state.
The agonist concentration is imposed from the first time step onwards.
The temporal variations of intracellular calcium, membrane potential, intra-SR calcium,
IP3, and DAG at 350 nM and 600 nM for the first 100 seconds are shown in Figure 3.6. Below
[L] = 237 nM concentrations, intracellular calcium increases gradually with respect to agonist
concentration with no oscillations. However, calcium transients show a repeating oscillatory
behaviour at medium agonist concentrations, greater than 237 nM. With 350 nM, the peak
amplitude of the first transient intracellular calcium wave attains a value close to 500 nM.
The maximum and minimum values of regular intracellular calcium oscillations are 445 nM
and 71.57 nM respectively. For the same agonist concentrations, Vm (-43.12 mV, -50.70 mV),
intra-SR calcium (1.12 mM, 0.06 mM), IP3 (69.68 nM, 22.37 nM) and DAG(84.9 nM,
27.99 nM) oscillate with the respective maximum and minimum values (given in the brackets).
The temporal variations of ionic currents of the VOCC, NSC, BKCa, CACC, PMCA,
NCX, RyR, IP3R, SERCA, SRleak, and the net calcium current in the SR at 350 nM are shown
in Figure 3.7. The spontaneous BKCa currents are well aligned with the CACC currents;
both of them have matching magnitudes as well. Similar to this, the CACC currents were
synchronized with BKCa currents in the studies of Kamouchi et al. [80] and Large and Wang
[97]. At the start of the oscillation, the IP3R current is slightly larger than the RyR current.
However, before intracellular calcium reaches a peak, the RyR current overtakes the IP3R
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Fig. 3.6 Temporal variations of intracellular calcium (a), membrane potential (b), intra-SR
calcium (c), IP3 (d) and DAG (e) are plotted at 350 nM (solid line) and 600 nM (dashed
line) concentrations of agonist. Dotted line indicates values of respective variables when no
agonist is present.
current. IP3R current shows a sharp decline at 45 seconds unlike the RyR current, (refer to
Figure 3.7 (d)). The peak current of RyR is two-fold larger than the peak IP3R current. The
peak amplitude of the SERCA current is slightly larger than the RyR current peak. Both
IP3R and RyR currents become negligible at around 60 seconds.
The net calcium SR-current becomes negative at the time when IP3R current overtakes
RyR current. The net calcium current from SR shows a sharp increase in magnitude at around
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Fig. 3.7 Temporal variations of ionic currents: Shows variation of different ionic currents at
350 nM concentration of agonist. (a) VOCC (solid) and NSC (dashed), (b) BKCa (solid) and
CACC (dashed), (c) PMCA (solid) and NCX (dashed), (d) RyR (solid) and IP3R (dashed),
(e) SERCA (solid) and SR leak (dashed) and (f) Net calcium current in SR (solid) and zero
reference (dashed).
45 seconds. Then it goes back to positive values and stays there up to 75 seconds. The net
SR calcium current stays in the positive values for a long time compared to the short period
of negative values, (refer to Figure 3.7 (f)). The VOCC current is always negative and never
reaches zero. The NCX current is zero at low intracellular calcium concentrations whereas
the PMCA current is comparatively higher. The magnitudes of the NCX current and the
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PMCA current are alomst equal to each other during the activation period. The magnitude of
the NSC current peak is larger than the currents of the VOCC, NCX and PMCA.
At high concentration of agonist of 600 nM, intracellular calcium shows a single oscil-
lation with a sharp peak, greater than 500 nM, immediately after agonist stimulation and
within 10 seconds mostly, (see Figure 3.6 (a)). Intracellular calcium is then gradually reduced
and reaches a steady value, 142.31 nM, which is higher than the intracellular calcium at the
resting state. A similar temporal pattern of intracellular calcium was reported in experimental
work on VSMCs of male Wistar rats by Lamboley et al. [95]. The steady state values of
Vm, intra-SR, IP3 and DAG at 600 nM are equal to -46.69 mV, 0.26 mM, 61.10 nM, and
76.37 nM respectively.
Figure 3.8 shows bifurcation diagrams as functions of agonist concentration. Bifurcation
diagrams of different state variables are plotted by finding the maximum and minimum values
at a fixed agonist concentration. The simulations are carried out for 800 seconds at a fixed
agonist concentration. The maximum and minimum values of oscillations are taken as the
average of all the oscillations which happened in between 500 seconds and 800 seconds.
We should note however that this method of finding bifurcation points is an approximate
one, but is adequate for this particular model. However, we have used MATCONT package
(version: matcontp63), a Matlab toolbox for the bifurcation study of discrete and continuous
dynamical systems, in order to understand the type of bifurcation of the given system. The
MATCONT analysis has shown that the two bifurcations are both of a Hopf type and these
points are equal to 237 nM and 545 nM.
The intracellular calcium reaches a value less than the resting condition after each peak
in oscillations when the agonist concentration is less than 425 nM in agreement with the
experimental studies of Hamada et al. [61] and Guibert et al. [55]. With other concentrations
of agonist, minimum calcium is higher than the resting value matching with the Ruehlmann
et al. [147]’s study. The peak intracellular calcium of oscillations increases up to the agonist
concentration equals 324 nM, then it decreases as agonist concentration increases. The
minimum values of intracellular calcium increase only slightly in the whole oscillatory
region (within the bifurcation points).
The maximum and minimum values of both IP3 and DAG increase as agonist concentra-
tion gets higher. The minimum intra-SR calcium value is almost unchanged in the oscillatory
region except the agonist concentrations near the highest bifurcation point, 545 nM. The
minimum Vm value increases significantly against agonist concentration but the peak Vm
values are mostly unchanged.
Frequency of intracellular calcium oscillations are plotted in Figure 3.9 top-pane. Fre-
quency is directly related to the agonist concentration. A steep increase in frequency is
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Fig. 3.8 Bifurcation diagrams of (a) DAG, (b) intracellular calcuim, (c) membrane potential,
(d) intra-SR calcium and (e) IP3.
obtained near the bifurcation points. Away from the bifurcation points, frequency increases
gradually with agonist concentration. The maximum frequency of oscillations equals 2.75 cy-
cles/min.
The time period of the activation phase and relaxation phase of the intracellular calcium
oscillations are shown in Figure 3.9 bottom-pane. The time period of the activation phase
is defined as the time taken for the intracellular calcium to go from the minimum value to
the maximum value. The time period of the relaxation phase is the time duration at which
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Fig. 3.9 Frequency (top) and time periods (bottom) of activation (solid) and relaxation
(dashed) phases of intracellular calcium oscillations against agonist concentration. Black
dots are used to represent the bifurcation points.
intracellular calcium of the cell decreases from the maximum value to the minimum value,
(refer to Appendix F for a general explanation). The time period of activation phase decreases
significantly as the agonist concentration increases. At an agonist concentration of 357.5 nM,
the time period of the activation phase equals the relaxation time period. The time period of
relaxation phase increases gradually and reaches a maximum at an agonist concentration of
433 nM, then it decreases. At the highest bifurcation point, the time periods of the activation
and relaxation phases are equal.
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3.5.2 Model response to varying extracellular concentrations
The response of the VSMC to different extracellular calcium concentrations is shown in
Figure 3.10. Extracellular calcium concentration is varied from 0.5 mM to 4 mM at a fixed
agonist concentration of 350 nM. Changes in extracellular calcium could not stop calcium
oscillations and only a slight change in amplitude is obtained. This is due to the fact that the
major contribution of the calcium rise emanates from SR rather than extracellular space.




































Fig. 3.10 Response of the VSMC model to varying extracellular concentrations: agonist
concentration is equal to 350 mM (a) Temporal variations of intracellular calcium at different
extracellular calcium concentrations. Extracellular calcium is equal to 0.5 mM at 0-150 sec-
onds, 1 mM at 150-300, 2 mM at 300-450 and 4 mM at 450-600. (b) Temporal variations
of intracellular calcium at varying extracellular potassium concentrations, 4 mM (0-150
seconds), 5 mM (150-300 seconds), 6 mM (300-450 seconds) and 10 mM (450-600 seconds)
64 VSMC Model Development

















Fig. 3.11 Frequency of intracellular calcium oscillations at different extracellular potassium
(solid) and extracellular calcium concentrations (dashed). The control values of extracellular
potassium and calcium are 5 mM and 2 mM, respectively. cpm means cycles per minute.
Increasing the extracellular potassium from 4 mM to 10 mM at a fixed agonist concentra-
tion raises the peak calcium concentration and the frequency of oscillations, (as shown in
Figure 3.10 (bottom panel)). However, when extracellular potassium is increased, the BKCa
current is reduced due to the reduction in the potassium concentration gradient across the
membrane. This causes an increased depolarization of the VSMC, thereby bringing more
calcium through the VOCC channel leading to an increase in the calcium amplitude. Calcium
oscillations disappear at potassium concentrations of the order of 10 mM and above.
To highlight the frequency changes as a function of extracellular ion concentrations, a
frequency plot for varying extracellular potassium and extracellular calcium is shown in
Figure 3.11. There is only a minimal frequency change with extracellular calcium, but
extracellular potassium significantly alters the frequency of calcium oscillations.
3.6 Discussions
We first make some comments on the model response compared to others, notably that of
Kapela et al. [83]. Although care should be taken in comparing since the equation sets
modelling the phenomena are different, the frequencies and maximum values of intracellular
calcium compare well with those of other work (c.f. Fig 5 (b) of Kapela et al. [83] with
Figures 3.8 (b) and 3.9 (top panel) of the present work). However the presented work shows
lower frequencies than that of Kapela et al. [83]. We also note that the values of external K+ext
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at which oscillations begin are significantly different. For the presented work oscillations
occur at 4mM and cease at 10 mM whereas for Kapela [83] oscillations exist in the range
K+e > 30mM. The location of the right-hand bifurcation point (a Hopf bifurcation) differs
in the two numerical models. Kapela’s point occurs at an agonist concentration of 400 nM
whilst the present model shows a bifurcation at 545 nM agonist concentration. This may
be due to the inclusion in Kapela’s model of the nitric oxide pathway including the CGMP
concentration mediation of the BKCa channel.
It is reported that the characteristics of agonist induced intracellular calcium dynamics in
VSMC is mainly subjected to the agonist concentration. The intracellular calcium oscillations
are obtained at medium agonist concentrations, 237 nM < [L] < 545 nM. This is similar
to Lamboley et al. [95] and Schuster et al. [153] experiments where mesenteric arteries
show calcium oscillations and vasomotion at medium concentrations of agonists, 400 nM to
800 nM of PE and 300 nM to 500 nM of NE respectively. Although in the experimental case
the SMCs tended to “flash” and only became synchronised at relatively high concentrations.
Our comparison here is that the numerical simulations show oscillations at the experimentally
found agonist concentrations but clearly the numerical results are a regular oscillation whereas
experiments show noisy data of calcium peaks.
The first peak of oscillations is obtained in less than 15 seconds in agreement to the study
of Nicholls et al. [128]. Repetitive calcium oscillations with constant frequency and constant
peak are obtained after the first peak, (refer to Figure 3.6). The peak of repetitive oscillations
is less than the first calcium peak [128, 55]. Both frequency and peak of calcium oscillations
increase with respect to the concentration of agonist near the first bifurcation point, 225 nM
[61]. For the agonist concentrations around 320 nM, only the frequency increases and the
calcium peak stays unchanged [147, 95, 136]. Near the second bifurcation point, 545 nM,
frequency continues to increase with agonist concentration but calcium peak decreases. The
frequency of oscillations ranges from 0.85 to 2.75 cycles/min. This is consistent with the
experimental study of Hamada et al. [61] using cultured VSMCs from pulmonary artery. In
their study, frequency of calcium oscillations was varied from 0.5 to 1.36 cycles/min when
stimulated with 0.1 to 10 µM of PE.
Extracellular calcium does not have a significant effect on intracellular calcium oscil-
lations. This is consistent with the experimental observations of Baro and Eisner [10] and
Bolton et al. [20]. However, extracellular potassium modulation of intracellular calcium
strongly affects the peak and frequency of oscillations. Oscillatory state of intracellular
calcium is shifted to steady state at higher potassium concentrations. The modulation of
intracellular calcium by extracellular potassium is similar to the experimental results of
Lamboley et al. [95].
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Agonist-induced calcium signalling mechanism
The model respnse of intracellular calcium oscillations are the result of calcium cycling
between the SR & cytosol and the cytosol & extracellular space. The former calcium cycling
is composed of intra-SR calcium release and recovery phases and the later one consists
of depolarization and repolarization phases. The agonist binding to the G-protein coupled
receptor leads to the activation of PLC and subsequent hydrolysis of PIP2 into IP3 and DAG
molecules. The DAG molecules activate the NSC channel. The opening of the NSC channel
depolarizes the VSMC. The cell depolarization increases VOCC current causing an initial rise
of intracellular calcium, (see the Figure 3.7 (a)). The positive feedback mechanism between
PLC, NSC and VOCC (PLC-NSC-VOCC) causes mutual rise of intracellular calcium and
IP3.
At medium concentrations of agonist, the mutual rise of IP3 and intracellular calcium
in the cytosol magnifies the open probability of the IP3R leading to IP3-induced calcium
release (IICR). The increased calcium will then activate RyR as well as further activation
of IP3R causing calcium-induced calcium release (CICR). The combined IICR and CICR
mechanisms mediated by RyR and IP3R produce a sharp increase in intracellular calcium.
This is clear from the sharp change in SR net current during calcium rise as shown in Figure
3.7 (f). Furthermore, intra-SR calcium is sharply declined and is analogous to the sharp
increase of intracellular calcium, in agreement to the study of Picht et al. [139]. Also, the
change in extracellular calcium showed only limited influence on the peak intracellular
calcium. These observations suggest that the major calcium influx for intracellular calcium
rise in this model is the calcium release from the SR mediated by IICR and CICR mechanisms
[20, 99].
However, at higher intracellular calcium concentrations, the open probability of IP3R is
quickly reduced due to the effect of calcium inactivation of the IP3R. This causes a sharp
decreased calcium release through the IP3R channel, (see Figure 3.7 (d)). At the same time,
high calcium boosts the pumping rate of SERCA. These two actions, inactivation of IP3R
and increased pumping of SERCA, stop a further release of calcium to the cytosol and also
the rise of intracellular calcium. The function of SERCA is to recover intra-SR calcium and
return intracellular calcium to its basal values.
During the period of calcium rise, the calcium influx to the cytosol through the VOCC
is small compared to the combined calcium efflux by the NCX and the PMCA. This means
there will be calcium loss to the extracellular space at the expense of intra-SR calcium.
Therefore, calcium influx through the VOCC is necessary for bringing the intra-SR calcium
back to the resting state level [163].
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As the intracellular calcium increases, the CACC current further depolarizes the cell.
However, the counteraction of the BKCa channel keeps the membrane potential within
physiological levels, (see Figure 3.7 (b)). Similarly, the NCX maintains the intracellular
calcium in the physiological range by increasing the pumping rate at high intracellular
calcium levels.
As the agonist concentration increases, intra-SR calcium retained in the recovery phase of
regular oscillations is gradually reduced. At an agonist concentration higher than the highest
bifurcation point, 545 nM, the increased production of IP3 along with the enhanced calcium
influx through the VOCC due to the DAG-mediated depolarization sustained activation
of IP3R and RyR. At this condition, the SERCA fails to bring the intra-SR calcium after
the first drop immeditely after the agonist stimulation to a threshold level necessary for
intracellular oscillations to occur. Therefore, after the first calcium rise, further calcuim rise
and subsequent calcium oscillations are completely disappeared.
3.7 Model limitations
Like previous mathematical models, the cytosol is assumed to be a homogeneous domain
which is not physiologically correct and we recognise this as a limitation of our model. There
are experimental observations which support spatial heterogeneity in VSMCs. Although
the SR is a single continous lumen, spatial distribution and organization of SERCA, IP3R
and RyR proteins are varied in longitudinal and junctional parts of the SR. The intracellular
calcium waves are generated at the point of simulation on the cell membrane or at the SR
and spread to other parts of the intracellular space [200, 16]. This creates microdomains
in the cytosol which can regulate cellular processes in different regions of the cell. Since
calcium signalling pathways due to beta-adrenergic agonists are not directly related to SR
function the action of beta-adrenergic agonists on he VSMC is not included in the model.
This model has not included cell membrane channels such as a store-operated channel,
stretch operated channel and also has not included nitric oxide (NO) or cyclic guanosine
monophosphate (cGMP) signaling pathways. In addition to that, the presence of mitochondria,
Golgi apparatus, a nucleus and other cellular components may have a role in the development
of calcium microdomains, particularly the mitochondria. Further improvements will be made
to the model by adding the above mentioned cellular components and signalling pathways to
the current model.
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3.8 Conclusions
As a powerful tool to investigate extremely complex biological systems, we have developed
a mathematical model of VSMC to accomplish the research aims. In the model, we have
defined new or modified descriptions to NCX exchanger, IP3R channel, NSC channel,
agonist-induced IP3 production, SR structure, and functioning. The SR was modelled as a
single luminally continuous store which contains both IP3R and RyR and with homogeneous
luminal calcium. None of the VSMC mathematical models has used sequential binding
of calcium and IP3 for the activation of IP3R. We have incorporated a simplified 4-state
sequential-binding IP3R model in our VSMC model since calcium is the central attention of
the study. The model equations were solved using a numerical model developed based on
Backward-Euler method and fixed point iteration. The time period and tolerance limit for
getting required accuracy was fixed by analysing the relative error. The code for the model is
written ‘C’ code and was implemented on a local machine.
The model results were compared qualitatively against the experimental studies. The
temporal occurrence of intracellular calcium oscillations, amplitude and frequency of intracel-
lular calcium oscillations, the response of the model to varying extracellular concentrations
of potassium and calcium and bifurcation points of the agonist stimulation are matching
with the experiments in VSMCs. The intracellular calcium signalling mechanism of the
model is discussed to know how the model responses to different agonist concentrations. The
developed model will then be used for studying the effects of SERCA, IP3R, RyR and GJIC.
The next chapter (chapter 4) will focus on the effects of altered levels of SERCA, IP3R and
RyR in a single VSMC.
Chapter 4
The effects of altered levels of SERCA,
RyR and IP3R: Single VSMC
4.1 Introduction
Agonist induced intracellular calcium dynamics depends on the functional interaction be-
tween SERCA, IP3R and RyR [53, 194, 13]. We have already seen that the intracellular
calcium dynamics of the VSMC are modified in diabetes along with altered regulation of the
calcium handling proteins in the SR such as SERCA, IP3R and RyR. The altered expression
of these proteins were found in other pathological as well as physiological conditions. The
SERCA expression was found to be downregulated in proliferating VSMC [106] and the
supression of IP3R activity reduced proliferation in cerebral VSMC [190]. VSMCs failed to
contract when RyR and SERCA were not present in the SR [180]. Interestingly, proliferation
and migration are found to be significantly increased in VSMCs of a diabetic origin [46]
whilst the contractility is decreased [138]. In addition intracellular calcium dynamics and
contractility of VSMC were altered with a reduction of SERCA and IP3R levels in the
development of atherosclerosis [45, 113]. Therefore, the current study to understand the
effects of altered levels of SERCA, IP3R and RyR on the intracellular calcium dynamics can
be used to investigate not only diabetes but also other relevant normal or disease conditions.
We have used the new VSMC mathematical model developed in our dry lab (discussed in
the chapter 4) to investigate the consequences of altered levels of SERCA, IP3R and RyR on
the intracellular calcium dynamics of VSMCs in combination with agonist stimulation. The
level of a protein is altered in the model by changing the maximum rate of the corresponding
protein function. The responses of the model to different combinations of SERCA, IP3R
and RyR levels at a fixed agonist concentration and for varying agonist concentrations are
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discussed. The model results are compared with the experimental studies and discussed with
an interest to diabetes (at the end of the discussion section).
The model results will provide information about how the intracellular calcium dynamics
of a VSMC are altered due to SERCA, IP3R and RyR. This may help to understand the
impaired calcium dynamics in pathological condition such as diabetes. Also, this study will
help to understand the combinations of SERCA, IP3R and RyR levels required to obtain
desired intracellular calcium dynamics when the agonist concentration is changed. Based
on that, our hypothesis is that if an external environment influences the agonist-induced
calcium transients, the VSMC may alter the levels of SERCA, IP3R and/or RyR expressed
in the SR to restore intracellular calcium transients matched with the functional need. The
model results based on diabetic condition leads to the fact that reduced SERCA level is
probably the primary factor responsible for the reduced intracellular calcium transients and
the reduced contractility in diabetes even though all the three IP3R, SERCA and RyR are
varied in diabetic VSMCs.
4.2 Results
The functional role of a particular calcium handling protein may depend on the total number
of that protein expressed in the SR. Changing QSERCA, QRyR and QIP3R values qualitatively
provide varying levels of SERCA, RyR and IP3R activity. For the control case, QSERCA,
QRyR and QIP3R are equal to 2.1×104 nM s−1, 4000 s−1 and 2000 s−1 respectively. The
level of SERCA, IP3R and RyR are presented as percentages of QSERCA, QIP3R and QRyR
compared to the control case.
4.2.1 Effects of varying levels of SERCA
The response of the model to varying levels of SERCA at a fixed agonist concentration
320 nM is shown in Figure 4.1. At this agonist concentration, the VSMC shows oscillations
of intracellular calcium with 100% SERCA level. When the SERCA level is decreased to
0% or increased to 200%, the oscillatory state disappears and the intracellular concentration
becomes steady. For the given system, the bifurcation points are 45% and 178% SERCA
levels, (refer to Figures 4.1 (a) and (b)). These values are an approximation as we determine
them based on the maximum and minimum values of oscillations, but is satisfactory for the
kind of study we do. The simulations are carried out for 800 seconds at a fixed SERCA
level. The maximum and minimum values of oscillations are taken as the average of all the
oscillations which happened in between 500 seconds and 800 seconds. The same procedure
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Fig. 4.1 Intracellular calcium (a), intra-SR calcium (b), frequency (c) and time periods of
activation (solid) and relaxation (dashed) phases of intracellular calcium oscillations (d).
SERCA is varied from 0% to 200%. IP3R and RyR levels are kept constant at 100%. Agonist
concentration is fixed to 320 nM. Black dots are used to represent the bifurcation points.
is followed for IP3R and RyR as well. At any SERCA levels outside the bifurcation points,
the intracellular calcium is steady and almost constant, 121.9 nM while intra-SR calcuim
shows an increasing trend as SERCA level increases. The intra-SR calcium at the lowest
bifurcation point is ≈0.35 mM, smaller than the 1.2 mM at the highest bifurcation point.
The frequency of intracellular calcium oscillations is unchanged between 45% and ≈75%
SERCA levels. Then, the SERCA level regulation of frequency is biphasic. For less than
121% SERCA levels, frequency increases and for SERCA levels higher than 121%, frequency
decreases, (refer to Figure 4.1 (c)). The frequency decrease is sharp just before the oscillation
turns to a steady state.
Figure 4.1 (d) shows the time periods of activation and relxation phases, refer to Appendix
F for definitions of activation and relaxation phases. The relaxation and activation time
periods are almost equal for SERCA levels less than ≈75%. As the SERCA level increases
further, the time period of activation phase is getting bigger than the relaxation time period.
The time period of the activation phase increases continuously and the curve is concave up.
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The relaxation time period shows a steady decrease. At higher SERCA levels, the change
of the activation time period is higher than the corresponding change of the relaxation time
period.
















































Fig. 4.2 Contour plots of minimum (a) and maximum (b) values of intracellular calcium
oscillations for different combinations of agonist concentration and SERCA level are given.
IP3R and RyR levels are fixed to 100%. Solid line shows the bifurcation points for different
SERCA levels and agonist concentrations.
The contour plots of maximum and minimum values of intracellular concentration for
different combinations of agonist concentration and SERCA level are shown in Figure
4.2. The figure also shows the bifurcation points for different SERCA levels and agonist
concentrations. The agonist concentration is varied from zero nM to 1000 nM. The SERCA
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level is changed from 0% to 200%. The calcium oscillations are not seen at SERCA levels
lower than ≈20%.
The bifurcation points increase monotonically as the SERCA level increases. The
bifurcation points at 50% SERCA levels equals [L] = 120 nM and [L] = 380 nM. Increasing
SERCA level to 200% lifted the bifurcation points to [L] = 340 nM and [L] = 735 nM.
For any agonist concentration higher than the highest bifurcation point, an increase of
SERCA level may shift the steady state of the VSMC to an oscillatory state. For example,
at [L] = 500 nM, the increase of SERCA level from 30% to 100% shifts the intracellular
calcium state from steady to oscillatory. Similarly, if the agonist concentration is lower than
the lowest bifurcation point, a decrease in the SERCA level may change the intracellular
calcium dynamics from a steady state to an oscillatory state.
When SERCA level is reduced, the area of the oscillatory region decreases with the
maximum and minimum values of the calcium oscillations also decreasing. The overall max-
imum of intracellular calcium oscillations across the entire range of agonist concentrations
decreases as the SERCA level is reduced. The definition of overall maximum is given in
Appendix F. At 100% SERCA level, the overall maximum by varying agonist concentration
is greater than 400 nM whereas the overall maximum is less than 300 nM with 50% SERCA
level. At the same time, overall minimum of calcium oscillations is increased with decreasing
SERCA levels.
4.2.2 Effects of varying levels of IP3R
The effects of altered levels of IP3R on the intracellular calcium, intra-SR calcium, frequency
and time period of relaxation and activation phases at a fixed agonist concentration, 320 nM,
are shown in Figure 4.3. The level of IP3R is varied from 0% to 200%. The intracellular
calcium equals ≈121.9 nM at 0% IP3R and is unchanged until ≈30% IP3R. The intracellular
calcium oscillations are produced when IP3R level is greater than ≈30%. When the level of
IP3R is increased to 200%, the oscillations of intracellular calcium and intra-SR calcium are
almost unchanged.
The frequency of intracellular calcium oscillations increases monotonically with IP3R
level. The frequency is increased from ≈ 1 cycles/min to 1.62 cycles/min when the IP3R level
is varied from 30% to 200%. At low IP3R levels, the frequency shows a great dependency on
IP3R level, while at higher IP3R levels, frequency is almost unchanged.
The relaxation time period increases steadily as the IP3R level increases. The time period
of the activation phase decreases faster at low IP3R levels compared to that at the higher IP3R
levels. At the same time, the time period of activation phase changes at a high rate compared
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Fig. 4.3 Intracellular calcium (a), intra-SR calcium (b), frequency (c) and time periods
of activation (solid) and relaxation (dashed) phases of intracellular calcium oscillations
as a function of IP3R level. SERCA and RyR levels are kept constant at 100%. Agonist
concentration is fixed to 320 nM. Black dots are used to represent the bifurcation points.
to the relaxation phase time period at low IP3R levels. The time periods of relaxation and
activation phases are equal at 145% IP3R.
Figure 4.4 shows the contour plots of maximum and minimum values of intracellular
calcium oscillations for different combinations of IP3R level and agonist concentration. The
bifurcation points decreases as the IP3R level increases. A strong influence of IP3R level on
the bifurcation points is seen at lower IP3R levels compared to higher IP3R levels. For 200%
IP3R level, the bifurcation points are equal to [L] = 460 nM and [L] = 180 nM whereas at
20% IP3R level, they are equal to [L] = 890 nM and [L] = 330 nM.
The overall maximum of intracellular calcium oscillations by varying agonist concentra-
tion for the given range is considerably higher at low IP3R levels than at high IP3R levels.
For 20% IP3R level, the overall maximum of calcium oscillations is greater than 500 nM
whereas the overall maximum is smaller than 450 nM at 100% IP3R level.
For any agonist concentration higher than the highest bifurcation point, a decrease of IP3R
shifts the steady state of the VSMC to an oscillatory state. For example, the reduction of IP3R
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Fig. 4.4 Contour plots of minimum (a) and maximum (b) values of intracellular calcium for
different combinations of agonist concentration and IP3R level are shown. 100% SERCA
and 100% RyR levels are used. Solid line shows the bifurcation points for different IP3R
levels and agonist concentrations.
level from 100% to 20% produces calcium oscillations at 750 nM of agonist concentration.
On the other hand, if the agonist concentration is smaller the lowest bifurcation point, an
increase of IP3R level shifts the VSMC dynamics from steady state to an oscillatory state.
For 300 nM of agonist concentration, an increase of IP3R level from 20% to 100% produces
calcium oscillations.
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Fig. 4.5 Intracellular calcium (a), intra-SR calcium (b), frequency (c) and time periods of
activation (solid) and relaxation (dashed) phases of intracellular calcium oscillations (d)
as a function of RyR level. SERCA and IP3R levels are kept constant at 100%. Agonist
concentration is fixed to 320 nM. Black dots are used to represent the bifurcation points.
4.2.3 Effects of varying levels of RyR
Figure 4.5 shows the influence of RyR level on the intracellular calcium, intra-SR calcium,
frequency and time periods of activation and relaxation phases at an agonist concentration of
320 nM. The RyR level is changed from 0% to 150%. The VSMC exhibits a steady state of
intracellular calcium at 0% RyR level. As the RyR level increases, the intracellular calcium
is unaffected until ≈25% RyR level, then it starts to oscillate. The maximum and minimum
values of intracellular calcium and intra-SR calcium are unchanged for RyR levels greater
than 70%. Below 70% RyR level, peak intracellular calcium increases with RyR level.
The frequency of oscillation increases significantly at low RyR level, (refer to Figure
4.5 (c)). However at high RyR levels, the frequency tends to be constant. The frequency
is increased from 1.21 to 1.5 cycles/min for an increase of RyR level from 30% to 70%,
whereas only an 0.05 cycles/min increase in frequency is obtained for a rise of RyR level
from 100% to 150%.
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The graph of relaxation and activation time periods with RyR looks similar to that with
IP3R. The activation time period decreases continuously as the RyR level increases whereas
the relaxation time period increases. The decrease of activation time period is more significant
at low RyR levels, (refer to Figure 4.5 (d)). The change of activation time period is large
compared to the relaxation time period at low RyR levels. The relaxation and activation time
periods are matching at 141% RyR level.










































Fig. 4.6 Contour plots of minimum (a) and maximum (b) values of intracellular calcium for
different combinations of agonist concentration and RyR level with 100% SERCA and 100%
IP3R levels. Solid line shows the bifurcation points for different RyR levels and agonist
concentrations.
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Figure 4.6 presents the effect of different combinations of RyR level and agonist on the
maximum and minimum values and the bifurcation points of intracellular calcium oscillations.
The bifurcation points increase linearly with RyR levels. At 0% RyR level, the bifurcation
points are [L] = 600 nM and [L] = 350 nM of agonist concentrations. When the RyR level is
increased to 150% RyR level, the bifurcation points are [L] = 530 nM and [L] = 160 nM.
The overall maximum of calcium oscillations increases as the RyR level increases. The
20% RyR level produces an overall maximum less than 300 nM whereas the overal maximum
is greater than 440 nM for an RyR level of 80%. If the agonist concentration is smaller than
the lowest bifurcation point, an increase of RyR level may shift the VSMC dynamics from
the steady state to the oscillatory state. For example, At [L] = 250 nM, intracellular calcium
is not oscillating at 30% RyR level but increasing the RyR level to 150% makes the calcium
oscillate.
4.2.4 Effects of varying combinations of SERCA, IP3R and RyR levels
The maximum and minimum values of intracellular calcium oscillations at different com-
binations of SERCA & IP3R and SERCA & RyR are shown in Figures 4.7 and 4.8. The
bifurcation points of intracellular calcium oscillations are also plotted in these figures. The
agonist concentration is fixed to 320 nM. The intracellular calcium oscillations are obtained
in the absence of IP3R and RyR but not in the absence of SERCA. The upper limit of the
SERCA level required for intracellular calcium oscillations increases significantly as the
levels of IP3R or RyR increase whereas the change of the lower limit of the SERCA level
is minimal. For an increase of IP3R or RyR level from 25% to 70%, the upper limit of the
SERCA level is increased from ≈100% to ≈150% respectively. For the same change in IP3R
level or RyR level, the lower limit of SERCA level shows only a small change from 36.04%
to 39.99% for IP3R and 34.53% to 39.68% for RyR.
The overall maximum of calcium oscillations produced by varying IP3R or RyR for the
given range increases as SERCA level increases, refer to the upper panes of Figures 4.7
and 4.8. For example, at 50% SERCA level, the overall maximum of calcium oscillations
produced by varying IP3R level from 0% to 200% is less than 350 nM while the overall
maximum is higher than 550 nM at 200% SERCA level. Similarly, the overall maximum of
clacium oscillations by varying RyR levels from 0% to 150% at 50% SERCA level is smaller
than that at 100% SERCA level.
The overall minimum of calcium oscillations produced by varying IP3 or RyR for the
given range decreases as SERCA level increases, refer to lower panes of the figures 4.7 and
4.8. At 50% SERCA level, the overall minimum of calcium oscillations by varying IP3R or
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Fig. 4.7 Contour plots of maximum (top) and minimum (bottom) values of intracellular
calcium for different combinations of SERCA and IP3R levels with 100% RyR level and
[L] = 320 nM. Solid line shows the bifurcation points for different SERCA and IP3R levels.
RyR level is greater than 80 nM. The overall minimum value is smaller than 60 nM at 200%
SERCA level.
The maximum and minimum values of intracellular calcium oscillations at different
combinations of IP3R and RyR are shown in Figure 4.9. The overall maximum or minimum
of calcium oscillations is not changing much with IP3R or RyR level. The RyR level required
for calcium oscillations decreases as the IP3R level increases. Similarly, the IP3R level
required for calcium oscillations decreases as the RyR level increases. When the IP3R level
is increased from 0% to 50%, the required RyR levels for calcium oscillations are 127.5%
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Fig. 4.8 Contour plots of maximum (top) and minimum (bottom) values of intracellular cal-
cium for different combinations of SERCA and RyR with 100% IP3R level and [L] = 320 nM.
Solid line shows the bifurcation points for different SERCA and RyR levels.
to 75% respectively. For the similar increase of RyR level, from 0% to 50%, required IP3R
level decreases from 122.5% to 72.5%.
The top and bottom panes of the figure 4.10 shows contour plots of frequency of calcium
oscillations with different combinations of SERCA & IP3R and SERCA & RyR respectively
at a an agonist concentration of 320 nM. The shape of the contours with different combina-
tions of SERCA and IP3R looks similar to that with SERCA and RyR. For any IP3R or RyR
level, the shape of the frequency curve for varying SERCA level looks similar to the Figure
4.1 (c).
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Fig. 4.9 Contour plots of maximum (top) and minimum (bottom) values of intracellular cal-
cium for different combinations of IP3R and RyR with 100% SERCA level and [L] = 320 nM.
Solid line shows the bifurcation points for different IP3R levels and RyR levels.
The overall frequency of calcium oscillations for the given range of SERCA levels
increases as the IP3R level or RyR level increases. The overall frequency is smaller than
1.4 cpm for 50% IP3R level and is increasing up to 1.7 cpm for an IP3R level of 150%. The
overall frequency of calcium oscillation at 30% RyR level is less than 1.4 cpm and at 150%
is going greater than 1.6 cpm.
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Fig. 4.10 Contour plots of frequency of intracellular calcium oscillations for different com-
binations of SERCA and IP3R with 100% RyR level (top) and different combinations of
SERCA and RyR with 100% IP3R level (bottom). Agonist concentration is fixed to 320 nM.
Solid line shows the bifurcation points for different combinations of SERCA, IP3R and RyR.
4.3 Discussions
In the absence of IP3R or RyR
The SR is responsible for a major contribution to agonist induced intracellular calcium
oscillations in the VSMC. Some of the studies reported that SR calcium release is initiated by
IP3R leading to subsequent activation of RyR to produce a large amount of calcium release
to the cytosol [19, 147]. In their studies, blocking of RyR activity abolished agonist-induced
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calcium oscillations. In contrast to this, other studies reported that activity of IP3R alone
produces agonist induced calcium oscillations without RyR contribution [115].
Our model results show that the agonist induced calcium oscillations are attainable in the
absence of either RyR or IP3R. IP3R and RyR share a common calcium pool. A complete
blockage of either of these channels provides the full calcium potential available for the
other channel. This keeps a sufficient calcium flux through the unblocked channel to produce
intracellular calcium rise. When RyR is absent, IP3R-mediated IICR and CICR produce
intracellular calcium rise in the VSMC. On the other hand, when IP3R is absent, intracellular
calcium rise is obtained due to the activation of the RyR-mediated CICR mechanism.
The blocking of IP3R or RyR can not produce calcium oscillations at the same agonist
concentration at which calcium oscillations are possible in the presence of IP3R or RyR.
This is because of insufficient calcium influx through the VOCC to activate RyR-mediated
or IP3R-mediated calcium release at the same agonist concentration. At a higher agonist
concentration, the increased production of DAG further depolarizes the cell, releasing enough
calcium to the cytosol through the VOCC needed for RyR-mediated CICR or IP3-mediated
IICR and CICR. The calcium activation of IP3R happens at low calcium concentrations,
(refer to Figure 3.3). However, the activation of RyR-mediated CICR happens only at
considerably higher intracellular calcium concentrations. Therefore, the IP3R-mediated IICR
and CICR are activated at a lower agonist concentration compared to the case in the absence
of IP3R. In the absence of RyR, intracellular calcium oscillations are obtained for an agonist
concentration of 400 nM. However the agonist concentration should be greater than 500 nM
for getting intracellular calcium oscillations in the absence of IP3R.
The contradictory statements in the experiments regarding the occurrence of intracellular
calcium oscillations in the absence of IP3R or RyR are most probably due to the different
types of agonist used for the stimulation or the use of same type of agonist in different
concentrations. The model results indicate that using same agonist concentration for studying
the existence of intracellular concentrations in the absence of IP3R or RyR may lead to
contradictory findings because of the shift of oscillatory region.
Frequency regulation
The frequency of oscillation depends on combined action of SERCA, IP3R and RyR. If the
level of any of these components is changed, it will affect both the relaxation and activation
time periods. If the level of IP3R or RyR increases, the calcium flux through these channels
to the cytosol also increases. This helps the cell to achieve the calcium peak, as a faster rate
leads to reduced activation time. This is the main reason for the increase of frequency while
IP3R or RyR level increases.
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When the SERCA level increases, pumping of calcium back to the SR is leading to
decreased relaxation time. However, if the SERCA pumping increases further, the net
calcium flux to the cytosol during the activation time decreases which leads to a longer
activation time to get a similar rise of intracellular calcium. These opposing effects of
SERCA level causes biphasic SERCA regulation of frequency.
Shift between steady and oscillatory states
Phenotypic diversity is one of the characteristics of VSMCs. Based on the contractile
properties, VSMCs are classified into either phasic or tonic. Phasic contraction is the
rhythmic contractile activity, which is a distinctive property of arterioles to control blood
pressure and flow [107]. As the contraction of VSMCs is related to intracellular calcium,
the alteration of calcium dynamics may shift the phenotypic state of VSMCs from phasic to
tonic or vice versa. The shift of oscillatory state and steady state at different combinations of
SERCA, IP3R and RyR levels may cause the phenotypic switching of VSMCs from phasic
to tonic or vice versa.
Regis et al. [144] showed that increasing SERCA expression in human coronary artery
smooth muscle cells shifts agonist-induced calcium release from steady to an oscillatory
state. This is associated with increased intra-SR calcium load. The current model produces
results similar to these experimental observations. In addition, the model results show that a
reduction of SERCA level would shift the intracellular calcium state in the opposite direction
[98, 107] and supports the fact that reduction or blocking of SERCA expression/function
stops calcium oscillations in the smooth muscle cell. Therefore, the SERCA level acts as
a controlling parameter for the intracellular calcium oscillation. Similar to SERCA, IP3R
and RyR levels also significantly affect the switching of oscillatory to steady states and vice
versa of VSMCs.
One could assume that SERCA, IP3R and RyR levels are the regulating parameters
for enabling calcium oscillations at different agonist concentrations. Especially, increasing
SERCA level move the oscillatory region to high agonist concentrations whereas increasing
IP3R or RyR level shift the oscillatory region to lower agonist concentrations. The shift of
oscillatory region is large at low SERCA levels. At low IP3 levels, the shift of oscillatory
region is more significant than compared with low RyR levels.
Hypothesis
The current model results suggest that altered levels of SERCA, IP3R and RyR modulate
agonist-induced intracellular calcium dynamics significantly. If an external environment
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influences the agonist-induced intracellular calcium transients in VSMCs, that may affect the
activities of VSMCs such as contraction. Our hypothesis is that, in such situations, VSMC
may alter the levels of SERCA, IP3R and/or RyR expressed in the SR to restore intracellular
calcium transients matched with the functional need.
Discussion in the context of diabetes
Several studies indicate that the impaired calcium dynamics in diabetic VSMCs is related to
the altered levels of calcium handling proteins in the SR such as SERCA, IP3R and RyR. The
experimental study of Searls et al. [154] in VSMCs from the aorta of diabetic rats showed that
the levels of SERCA and IP3R are significantly lowered with an approximate reduction of
25% - 50% and 50% - 75% respectively. Sharma et al. [161] and Ma et al. [109] stated 50%
and 30% reduction of IP3R respectively in diabetic VSMCs from the aorta. The RyR was
downregulated in the studies of Rueda et al. [146] using diabetic VSMCs from the aorta and
Ma et al. [109] to almost 30%. In contrast to that, Searls et al. [154] reported upregulation of
RyR to several folds.
Fig. 4.11 Angiotensin II-induced intracellular calcium transients in normal and diabetic
VSMCs from aorta. Reproduced from Sharma et al. [161] paper.
Searls et al. [154] and Sharma et al. [161] reported temporal variation of intracellular
calcium in diabetic VSMCs as a response to an agonist stimulation, (see Figures 4.12 and
4.11). According to them, diabetic VSMCs show “smoothed" calcium transients with a
decline in the overall calcium maximum. Similar to that, temporal variation of intracellular
calcium from model results looks like low amplitude oscillations effectively “smoothed"
with 50% reduction of SERCA level, (see Figure 4.13 (a)). The agonist concentration is
fixed to 320 nM. The calcium transients seems to be less smoothed when either the IP3R or
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Fig. 4.12 Vasopressin and thapsigargin (TSG)-induced intracellular calcium transients in
control and diabetic VSMCs. Reproduced from Searls et al. [154] paper.
RyR levels are reduced to 25% along with a 50% reduction of SERCA level than the case
with only 50% reduction in SERCA level, (see Figure 4.13 (a)). These model responses
suggest that the reduced SERCA level is one possible mechanism for the “smoothed" calcium
transients.
The peak intracellular calcium with 50% SERCA level shows 60% reduction compared to
that of the control case. This is closely matching with the 65% reduction of the intracellular
calcium peak in diabetic VMSCs in the study of Sharma et al. [161]. When either the IP3R
or RyR levels are reduced to 25% along with a 50% reduction of SERCA level, only 35%
reduction in the intracellular calcium peak is obtained. This is in good agreement with the
calcium peak reduction of 33% obtained in the Searls et al. [154] study in diabetic VSMCs.
When the level of RyR is upregulated to 150% along with 75% reduction of IP3R and
unchanged SERCA level, peak intracellular calcium is unaffected. The reduction of calcium
release due to the downregulation of IP3R would be compensated by the upregulation of
RyR.
When agonist concentration is varied from zero nM to 600 nM, the overall maximum
of calcium oscillations is reduced 36% for a reduction of 50% in SERCA level as shown
in Figure 4.13 (b). The reduced overall maximum is unchanged with an additional 75%
reduction of either IP3R or RyR. When the SERCA level is kept at 100%, the reduction of
IP3R to 75% along with an increased RyR level of 150% shows no reduction in the overall
maximum, meaning to say the overall maximum is matching with control case. These results
indicate that the reduction of SERCA level is one possible reason for the decrease of calcium
in VSMCs.
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Fig. 4.13 (a) Temporal variations of intracellular calcium at [L] equals 320 nM and (b)
bifurcation diagrams for control case (thin solid), for 50% reduction of SERCA (dashed),
for 50% reduction of SERCA and 75% reduction of IP3R (dash-dotted), for 50% reduction
of SERCA and 75% reduction of RyR (dotted), and for 75% reduction of IP3R and 50%
increase of RyR (thick solid)
The figure 4.13 (b) shows that a reduction in SERCA level will shift the upper and
lower limits of agonist concentration for oscillation to smaller values than the control case.
However, an additional reduction of IP3R or RyR level will raise the limits of the oscillatory
region close to the control case. This means that reducing the IP3R or RyR level would
make the VSMC produce continuous intracellular calcium oscillations at similar agonist
concentrations of the control case. The shift of the oscillatory region due to changed SERCA
level can be re-established by altering the right amount of IP3R or RyR level.
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The model results show that intracellular calcium lowering as well as intracellular calcium
rising in VSMCs is significantly affected by SERCA level changes. If the SERCA pumping
is reduced, the intracellular calcium is raised in the relaxation phase. At the same time, the
reduced reloading of intra-SR calcium causes decreases calcium influx through IP3R and
RyR, which leads to decreased intracellular calcium peaks. SERCA level is one regulating
factor of intracellular calcium in both the activation and relaxation phases of oscillations.
The altered levels of SERCA, IP3R and RyR modulate the intracellular calcium dynamics
in diabetic VSMCs. The functional implications of altered levels of IP3R or RyR in diabetic
VSMCs might be regulated by changing the levels of the other protein. The proposed
hypothesis points out this fact as a general scenario. However, the impaired intracellular
calcium dynamics due to reduced SERCA levels can not be restored by changing IP3R or
RyR levels because of the reduced intra-SR calcium load.
Diabetes leads to reduced agonist-induced vascular contractility [138]. Since altered
levels of SERCA, IP3R and RyR are observed in VSMCs of diabetics [154, 118], it was
not clear which of these components leads to reduced contractility. Our results shows that
reduced SERCA level is probably the primary factor responsible for the reduced intracellular
calcium transients and the reduced contractility in diabetics.
4.4 Conclusions
We have used the mathematical model developed during the course of our research (detailed
in the chapter 3) to investigate the effects of altered levels of SERCA, IP3R and RyR in
a single VSMC. The level of a particular channel or pump was altered by changing the
maximum rate of the corresponding channel or pump function. The responses of the model to
the altered levels of SERCA, IP3R and RyR at a fixed agonist concentration and for varying
agonist concentrations were studied.
The frequency of intracellular calcium oscillations is significantly influenced by IP3R
and RyR at its low levels. The SERCA regulation of frequency is biphasic. At low SERCA
levels, frequency increases with SERCA levels whereas at higher SERCA levels, the relation
reversed.
The role of IP3R and RyR in the occurrence of intracellular calcium oscillations was not
fully clear in the literature. Some studies claimed the need of RyR for the existence of calcium
oscillations whereas others proposed IP3R alone is enough. The model results showed that
the agonist induced calcium oscillations are feasible in the absence of RyR or IP3R. However,
higher stimulating strength is required to produce intracellular calcium oscillations in the
absence IP3R or RyR. The change in IP3R or RyR level shifts the bifurcation points of agonist-
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induced calcium oscillations. This might have been the reason for not getting the calcium
oscillations in experiments when either IP3R or RyR was blocked with the stimulation
strength. These findings provide a possible explanation for the contradictory statements
published in existing experimental studies.
The change of SERCA, IP3R or RyR level shifted the oscillatory state of intracellular
calcium to steady and vice versa at a constant agonist concentration. Especially, increasing
SERCA level move the oscillatory region to high agonist concentrations whereas increasing
IP3R or RyR level shift the oscillatory region to lower agonist concentrations. The shift of
oscillatory region was more significant at low SERCA levels and at low IP3 levels. Based on
this, our hypothesis is that if an external environment influences the agonist-induced calcium
transients, the VSMC may alter the levels of SERCA, IP3R and/or RyR expressed in the SR
to restore intracellular calcium transients matched with the functional need.
We have done a set of simulations with altered levels of SERCA, IP3R and RyR reported
in the experiments using diabetic VSMCs. The model responses suggest that the reduced
SERCA level is one possible mechanism for the “smoothed" calcium transients in VSMC.
The intracellular calcium lowering as well as intracellular calcium rising in VSMC are
significantly affected by the altered SERCA level. SERCA level tends to be the regulating
factor of intracellular calcium in both the activation and relaxation phases of oscillations.
The functional implications due to the altered level of IP3R in diabetic VSMCs might be
regulated by changing the level of RyR and vice versa. However, if the SERCA level is
low, the alteration of IP3R or RyR level can not restore the calcium dynamics in the VSMC
because of the reduced intra-SR calcium load. These results leads to the fact that reduced
SERCA level is probably the primary factor responsible for the reduced intracellular calcium
transients and the reduced contractility in diabetes even though all the three IP3R, SERCA
and RyR are varied in diabetic VSMCs.

Chapter 5
Propagation of intracellular calcium
oscillations: Coupled VSMCs
5.1 Introduction
Propagation of intracellular calcium is a spatiotemporal event with a high-level complexity
in signal transduction. The GJIC exchanges information in the form of chemical and elec-
trical signals. Advanced experimental techniques were developed to visualize and quantify
intracellular calcium propagation [21, 175, 60]. However, in the context of the difficulty
in tracking the individual coupling components with the available experimental methods,
mathematical modelling has emerged as a powerful tool to understand the mechanisms
behind the propagation of calcium oscillations.
Seppey et al. [157] hypothesized that opening of VOCCs due to the propagation of a
depolarization from the stimulated cells to the non-stimulated cells is the pathway of the
propagation of intracellular calcium. At the same time, they have reported that propagation
was not seen until the artery were globally stimulated with a minimum agonist concentration.
The production of IP3 was increased when the artery was globally stimulated. Therefore, IP3
concentration might have also been involved in the intercellular signalling pathway. This
needs further study to understand the individual roles of Vm and IP3 in the propagation of
intracellular calcium.
Halidi et al. [60] has shown that two distinctive calcium waves propagate with different
velocities and amplitudes, a fast calcium wave with low amplitude and a slow calcium wave
with high amplitude. According to them, the opening of VOCCs due to the rapid propagation
of depolarization results in fast calcium waves and the slow calcium waves require functional
IP3R. Coupling between VOCC and IP3R is observed in their study. The amplitude of slow
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calcium waves was reduced when the VOCC was blocked. However, they could not explain
the cellular mechanism that connects VOCC and IP3R; This needs a further study.
In this chapter, we have investigated propagation of intracellular calcium in coupled
VSMCs. A numerical method is developed to solve the coupled cell simulations by incor-
porating the numerical method of single cell and tridiagonal matrix algorithm (TDMA).
The coupled cells simulations are carried out in 100 serially coupled cells with a sigmoidal
distribution of agonist. The simulations are carried out by coupling both Vm and IP3, Vm
alone and IP3 alone to know the importance of Vm and IP3 -mediated intercellular signalling
mechanisms. The simulations are conducted in the presence and absence of IP3R and RyR.
The coupled cells results are qualitatively validated against the available experimental studies.
The signalling pathways of propagation of intracellular calcium mediated by IP3 and Vm and
the dominant cellular mechanisms are discussed.
5.2 Gap junctional intercellular communication (GJIC)
GJIC is the result of the passage of cytosolic molecules and ions through the gap junction.
The gap junction pore is large enough to allow the passage of cytosolic ions and many
secondary messengers such as IP3. It is necessary to know the relevance of gap-junctional
diffusion of each intercellular messenger in the physiological environment.
It is reported that diffusion of calcium ions is slower than IP3 in the cytosol even though
the calcium ion is smaller in size [1]. According to Allbritton et al. [1], diffusion coefficients
of IP3 and Ca2+ in the cytosol are approximately 285 µm2/s and 13 µm2/s respectively.
Strong buffering of calcium in the cytosol restricts the movement of calcium ions because
calcium binds with immobile or slow mobile buffers. For a single VSMC size, IP3 may act
as a global messenger but the action of Ca2+ is limited to restricted domains.
The Young et al. [200] study on the propagation of intracellular calcium in colonic
SMCs indicates that a cell may not show a calcium rise even if all the adjacent cells have a
significant calcium increase. Clair et al. [30] shows that the diffusion of calcium across gap
junctions is negligible in connected hepatocytes, (refer to Figure 5.1). In their experiments,
though calcium concentration in one cell was kept at a high value for at least 3 minutes by
applying high agonist concentration, no rise in calcium was observed in the other cell. The
experiment was able to detect the concentration of calcium at nanomolar levels. The role of
the undetected small amount of calcium to generate calcium oscillation in the neighbouring
cell was ruled out in their study. Koenigsberger et al. [90] has shown that only electrical
coupling between VSMCs produces propagation of intracellular calcium matching with the










Fig. 5.1 Absence of calcium diffusion between two connected hepatocytes: High concentra-
tions of noradrenaline or vasopressin are used to induce intracellular calcium rise. Heparin
was added to one of the cells. Heparin inhibits the binding of IP3 and IP3-induced calcium
release. The application of agonist produced high intracellular calcium rise in one of the
cells. Though the calcium rise was for 3 minutes in one of the cells, calcium diffusion to the
other cell was negligible. Reproduced from Clair et al. [30] paper (permission granted from
The Company of Biologists Ltd to reuse in the thesis, license number: 3850010553260).
experiments in VSMCs [157]. Therefore, it is reasonable to assume negligible diffusion of
calcium across the gap junction based on the above studies.
5.2.1 Modelling equations of GJIC
The passage of chemical species between two VSMCs is influenced by both potential
difference and concentration difference. In our model, we have assumed calcium transport
between two cells is negligible and assumed constant intracellular concentrations for other
cytosolic ions such as Na+, K+ and Cl−. Therefore, ionic flux carried by Na+, K+ and
Cl− across gap junctions between two VSMCs depends only on the potential difference.
Jacobsen et al. [75] used an additive electrodiffusion to model the GJIC due to the passage of
an ion between two cell compartments. This equation is a representation of a Nernst-Plank
equation, (refer to Equation 2.1), to model ionic current between two cells. Kapela et al. [85]
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used the GHK equation, (refer to Equation 2.2), to model the ionic currents throughout the
gap junctions. The reduced form of the equation with our model assumptions, no calcium








Where ‘GJ’ denotes gap junction, ∆Vm is the membrane potential difference between two
VSMCs, AGJ is the cross-sectional area of a gap junctional pore, NGJ is the total number of
gap junctions between two VSMCs, Pion is the permeability of the gap junction to an ion and
[ion] represents ion concentration in molar (moles/litre). The unit IGJ is coulombs per second
(C/s). All the terms except ∆Vm are constants. Therefore, Equation 5.1 is rewritten for ionic
current as follows,
IGJ =−NGJgGJ∆Vm (5.2)
Where gGJ is the unitary conductance of a gap junction. This relation represents an ohmic
behaviour for the gap junction. The gap junctional current is directly proportional to the
difference in Vm between the adjacent cells, similar to the studies of Koenigsberger et al.
[89] and Diep et al. [37].
Like ions, IP3 is an intercellular messenger which is also allowed to pass through gap
junctions. IP3 is not an ion; therefore, the IP3 flux across the gap junctions depends only on
the concentration difference. Based on Fick’s law of diffusion, IP3 transport, JGJ,IP3 , between





JGJ,IP3 =−NGJdIP3∆ [IP3]cyt (5.4)
Where PIP3 is the permeability of the gap junction to IP3, Volcyt is the cytosol volume,
and dIP3 is the unitary IP3 coupling coefficient of a gap junction. The unit of JGJ,IP3 is molar/s.
IP3 transport equation is linearly related to the concentration difference between two cells. A
similar kind of coupling equation for IP3 is used in the studies of Koenigsberger et al. [89]
and Kapela et al. [84].
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Fig. 5.2 Graphical representation of the coupled VSMC model: IP3 and Vm are coupled
between VSMCs. ’gj’ represents gap junction.
In the current model, VSMCs are connected serially to mimic a straight VSMC strip. One
VMSC is coupled to two adjacent VSMCs. A schematic representation of the cell coupling
is shown in Figure 5.2. Each cell is assumed as a compartment with homogenous cytosol.
For the serially coupled VSMCs, Equation 5.2 becomes,
IGJ =−GGJ(Vm,j −Vm,j±1) (5.5)
GGJ = NGJgGJ (5.6)
Where ‘j’ denotes current cell and GGJ is whole cell conductance between two VSMCs.
Similarly for IP3 flux,
JGJ,IP3 =−DIP3([IP3]cyt,j − [IP3]cyt,j±1) (5.7)
DIP3 = NGJdIP3 (5.8)
Where DIP3 is the whole cell IP3 coupling coefficient between two VSMCs.
Now, we have to find the values of NGJ, gGJ and d[IP3]. In VSMCs, the most abundantly
expressed connexin is Cx43 [24, 181, 58, 78]. van Kempen and Jongsma [181] reported
the confined and differentiated expression of Cx43 in VSMCs of an aorta and coronary
arteries. Based on this, we assume that the gap junction in VSMC is made up of Cx43. The
characteristics of Cx43 are then used to model the gap junction between VSMCs.
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The unitary conductance of Cx43 is quantified in experiments, and it is approximately
60 pS [125, 179]. Emerson and Segal [42] reported that the whole cell gap junctional
conductance between two VSMCs of a hamster feed artery was equal to 178.57 nS. In
previous work, the same research group has reported the dominant expression of Cx43 in
VSMCs of a hamster feed artery [59]. Based on that, we assume 178.57 nS as the whole cell
conductance of gap junctions made up of Cx43. By using 5.6, the average number of gap





According to our knowledge, there is no experimental data available in the literature that
provides values of dIP3 and DIP3 . In this model, we have used a value of 2 s
−1 as the whole
cell IP3 coupling coefficient, which is close to that suggested in Kapela et al. [85] and Ghanim
et al. [51]. The value of dIP3 is calculated by dividing the value of DIP3 with the total number





Weber et al. [187] calculated the permeability of Alexa dye through homotypic gap junction
channels of Cx43. According to them, the single channel permeability of homotypic Cx43 gap
junction channel equals 0.5×10−9 mm3/s. The corresponding value of dIP3 is 1.267×10−9
mm3/s, which is not different from the experimental values of permeability of Alexa dye
through homotypic Cx43 gap junction. The permeability of Cx43 depends on several
physiological parameters and this would be a subject of study in the future.
5.3 Numerical Method
The coupling equations of Vm and IP3, 5.7 and 5.5, are added to the corresponding single
cell equations, 3.5 and 3.49, respectively. The resultant model equations for coupled VSMCs
can be written in a general form, refer to section 3.3 for details, we get,
For j = 2,3, ....,NSMC −1










x1, j, ....,xn, j
)
+Dixi, j−1 +Dixi, j+1 (5.11)
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1 2 3 NSMC-1 NSMC
Fig. 5.3 Serially connected VSMCs representing a single straight VSMC strip. NSMC denotes
the number of VSMCs coupled.
For j = 1










x1, j, ....,xn, j
)
+Dixi, j+1 (5.12)
For j = NSMC










x1, j, ....,xn, j
)
+Dixi, j−1 (5.13)
Where subscript ‘j’ denotes cell number and ‘i’ is used to represent 16 state variables in
each coupled VSMCs. xi, j means the ith variable in jth VSMC. NSMC is the total number of
VSMCs couped and D is the coupling coefficient of a variable. Di represents the coupling
coefficient of the ith variable between two VSMCs. For variables other than Vm and IP3, D
is equal to zero. For Vm, D equals GGJ/Cm. High resistance is assumed at two ends, which
means no flux going out of the cells at the two ends. The backward Euler method is used to
discretize the model equations of all state variables. This will give,
For j = 2,3, ....,NSMC −1
xi, j (t +∆t)
(
1+2∆tDi −∆t gi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
))
−∆tDixi, j+1 −∆tDixi, j−1
= xi, j (t)+∆t hi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
)
(5.14)
For j = 1
xi, j (t +∆t)
(
1+∆tDi −∆t gi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
))
−∆tDixi, j+1 = xi, j (t)
+∆t hi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
)
(5.15)
For j = NSMC
xi, j (t +∆t)
(
1+∆tDi −∆t gi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
))
−∆tDixi, j−1 = xi, j (t)
+∆t hi, j
(
x1, j (t +∆t) , ....,xn, j (t +∆t)
)
(5.16)
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A fixed point iteration method whose details are given in Appendix B is used to solve
the above equations for coupled cells at a given time step [145, 112]. Functions g and h
are calculated explicitly at each iteration using xi from the previous iteration. The resultant
equation of xi, other than Vm and IP3, for the iterative procedure is obtained as follows,
x(k+1)i, j =












Where superscript k represents iteration number. Vm and IP3 equations for the iterative
procedure are as follows,
For j = 2,3, ....,NSMC −1
x(k+1)i, j
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The equations of Vm and IP3 represent a tridiagonal system of linear equations. Vm and
IP3 are solved using a tridiagonal matrix algorithm (TDMA) integrated iterative method.
For each iterative step, a tridiagonal system of equations is solved using TDMA, refer to
Appendix B, based on Gaussian elimination [33].
For k = 1, we choose xki, j = xi, j(t) and a series of approximations x
k
i, j (k = 2,3, . . .) to
xi, j(t +∆t) is obtained using the Eqn. 5.17 and solving TDMA (composed of Eqn. 5.18,
Eqn. 5.19 and Eqn. 5.20). When the fixed point iterations converge, xk+1i, j is a solution to the
discretized equation. In the current model, iteration is continued until all the state variables
have converged to an error tolerance limit such that | x(k+1)i, j − xki, j |≤ 10−4 for all i and j.
The time step is fixed at 0.1 ms. We have used the same computer algorithm of single cell
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model, (refer to Figure 3.5), to solve coupled cell simulations by incorporating the fixed
point iteration method for coupled cells.
Running time and relative error plots for the coupled cell model is shown in Figure 5.4.
The relative error is calculated by taking the results from the simulation with a time step of
10−7 seconds as the correct solution. Simulation running time increases linearly as the time
step decreases. The minimum time step needed for the coupled cell model to get a relative
error of O(10−5) is 10−4 s. Total simulation running time to solve 150 seconds real time
with a time step of 10−4 s is approximately 15 seconds.

































Fig. 5.4 Simulation running time (left) and relative error (right) plots for coupled cell model.
The total time required to solve a system of 5 cells for 150 s real time is plotted as running
time. The relative error is calculated as the error value compared to the solution with a time
step of 10−7 s.
5.4 Results
Coupled VSMCs simulations are carried out on a total of 100 VMSCs connected serially.
Assuming an VSMC width of 5 µm, 100 VSMCs correspond to a distance of 500 µm
that matches with the measurement distance used in the experiment of Emerson and Segal
[42]. At the beginning of the simulation, all the VSMCs are in the resting state, meaning
zero agonist concentration. As the simulation starts, a sigmoidal distribution of agonist
concentration is imposed over the coupled cells as shown in Figure 5.5. This kind of spatial
distribution will help us to investigate the propagation of calcium oscillations in both constant
and ‘linearly varying’ agonist concentrations [160]. To study the propagation of calcium
oscillations, the agonist concentration is distributed in such a way that some of the cells will
experience agonist concentrations greater than lowest bifurcation point, [L] = 237 nM, and
the rest of the cells have agonist concentrations smaller than the lowest bifurcation point.
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In order to get that, the agonist concentrations at two ends are kept at 400 nM and 100 nM,
respectively. With the given distribution of the agonist, the first 51 cells show an oscillatory
state if VSMCs are uncoupled. Therefore, the first 51 cells are referred as stimulated cells
and next 49 cells as non-stimulated cells.













Fig. 5.5 Sigmoidal distribution of agonist (solid) over the 100 VSMCs coupled serially.
Dashed line is used to separate stimulated cells and non-stimulated cells. With this spatial
distribution of agonist, all the cells (51 cells) on the left side of the dashed line show
oscillatory state when uncoupled and rest of the cells are in steady state.
5.4.1 Model response to spatial distribution of agonist: sigmoidal
Figure 5.6 shows contour plots of intracellular calcium, Vm and IP3 in coupled 100 VSMCs
for the first 200 seconds of simulation. Contour plots provide a spatiotemporal profile of the
corresponding variable. The maximum and minimum values of the intracellular calcium,
intra-SR calcium, Vm and IP3 in the coupled cells are plotted in Figure 5.7. The maximum
and minimum values of oscillations are taken as the average of all the oscillations which
happened in the first 500 seconds excluding the first oscillation.
Once VSMCs are coupled, calcium oscillations are seen not only in the first 51 cells
but also in all the non-stimulated cells. The calcium oscillations in non-stimulated cells,
which are located far from the stimulated cells, are not visible on the scale of the figure
5.6, but are clear in the figure 5.7. Though intracellular calcium oscillations are obtained
in all the non-stimulated cells, the amplitude of these oscillations are not equal. If the peak
intracellular calcium in the non-stimulated cell is equal or greater than 75% of the peak
intracellular calcium of the stimulated cells, it is called a regenerative calcium rise. The
propagation of regenerative calcium rise is called regenerative calcium propagation. With
the specified agonist distribution, the regenerative calcium propagation ends at the 59th cell,
refer to Figure 5.7 (a). The agonist concentration of the 59th cell equals 145 nM. Beyond this
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Fig. 5.6 Countour plots of intracellular calcium (top), Vm (middle) and IP3 (bottom): 100
VMSCs are coupled serially through Vm and IP3. The black line is used to show the boundary
between steady state and oscillatory state in uncoupled VSMCs.
cell, calcium rise due to cell coupling is minimal, and only small amplitude oscillations are
seen. The minimum value of calcium oscillation in the cells beyond the 59th cell is equal to
the steady state calcium of these cells when uncoupled.
Similar to intracellular calcium, intra-SR calcium, Vm and IP3 also oscillate in the non-
stimulated cells. Maximum and minimum values of intra-SR calcium oscillations in the
stimulated cells are unaffected by coupling. Maximum and minimum values of intra-SR
calcium oscillations in the cells from the 51st cell up to the 59th cell are matching with that
of the stimulated cells, (refer to Figure 5.7 (c)). In all the non-stimulated cells beyond 59th
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Fig. 5.7 Maximum and minimum plots of intracellular calcium (a), IP3 (b), intra-SR calcium
(c) and Vm (d) of 100 VMSCs coupled with Vm and IP3 (solid), coupled with Vm alone
(dashed), coupled with IP3 alone (dash-dotted) and uncoupled (dotted).
cell, intra-SR calcium oscillates with a small amplitude and the maximum intra-SR calcium
is identical to the steady state intra-SR calcium of the cells when uncoupled.
The peak amplitude of oscillations of Vm and IP3 are decreasing gradually in the non-
stimulated cells. In the case of IP3, maximum and minimum of calcium oscillation of the
first 50 cells are matching with that of the cells when uncoupled. Beyond the 59th cell, the
amplitude of IP3 oscillation is small, and the minimum IP3 concentration is the same as the
steady state IP3 concentration of the cells when uncoupled.
In the case of Vm, the maximum value of calcium oscillations in the stimulated cells is
lowered due to coupling compared to the uncoupled case (Figure 5.7 (d)). In those cells, the
minimum value of oscillations is almost unchanged except for some cells close to the 51st
cell. However, the peak value of Vm of the non-stimulated cells is increased significantly. In
the entire set of cells, maximum membrane potential decreases gradually as the cell position
is getting farther from the first cell, whereas the change of minimum membrane potential is
nominal. The peak value of Vm oscillations in all the non-stimulated cells beyond the 59th
cell is not diminished like intracellular calcium, intra-SR calcium and IP3. Vm oscillates with
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Fig. 5.8 Time series plots of intracellular calcium (a), IP3 (b), intra-SR calcium (c) and Vm
(d) for the 45th cell (solid), and the 55th cell (dashed) in 100 coupled VMSCs.
a considerable amplitude in the cells from the 60th cell up to the 100th cell. The intracellular
calcium, intra-SR calcium and IP3 experience more than 90% reduction in amplitude whereas
the Vm amplitude reduction is less than 65%.
Time series plots of intracellular calcium, IP3, intra-SR calcium and Vm for a stimulated
cell (45th cell), and for a non-stimulated cell (55th cell) are shown in Figure 5.8. The time
at which the intracellular calcium peak is obtained in the stimulated cell is matching with
the time at which the intra-SR calcium attains its minimum, and IP3 and Vm attain their
maxima. For the non-stimulated cell, intracellular calcium peak, IP3 peak and intra-SR
calcium minimum are reached at the same time. However the peaks of Vm happen before the
peaks of intracellular calcium.
The net calcium current from the SR and the VOCC of the 55th cell and the 70th cell are
given in Figure 5.9. The 55th cell and the 70th cell are selected to compare net SR calcium
and VOCC currents in regenerative and small amplitude intracellular calcium oscillations
respectively. The net SR calcium current of the 55th cell during the period of intracellular
calcium rise is much higher than the VOCC current. The major calcium influx to cytosol
for regenerative calcium rise is therefore contributed by the SR. Regarding the 70th cell,
104 Propagation of intracellular calcium oscillations: Coupled VSMCs




















































Fig. 5.9 Time series plots of intracellular calcium (solid), net SR current (dashed) and VOCC
current (dashdotted) are plotted for the 55th cell (top) and the 70th cell (bottom).
the intracellular calcium rise is mainly supplied by the VOCC. However, the intracellular
calcium rise in the 70th is relatively small compared to the regenerative calcium rise in the
55th cell, (refer to Figure 5.7).
The time lag of the calcium oscillations with respect to the oscillation of the first cell is
shown in Figure 5.10. The time lag increases gradually with respect to the cell position from
the first cell until the regenerative calcium rise ends, up to the 59th cell. The time lag sharply
decreases beyond the 59th cell and slowly reaches a constant value. Frequency of calcium
oscillations are almost equal for all the cells coupled. The frequency of intracellular calcium
oscillations is taken as the average of all the oscillations which happened in the first 500
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Fig. 5.10 Frequency (top) and Time lag (bottom) plots of intracellular calcium oscillations in
100 VMSCs coupled with both Vm and IP3 (solid), coupled with Vm alone (dashed), coupled
with the IP3 alone (dash-dotted) and uncoupled (dotted). cpm means cycles per minute. Time
lag is calculated by subtracting time at which intracellular calcium peak is obtained in a cell
with the time at which intracellular calcium is obtained in the first cell.
seconds excluding the first oscillation. The frequency of coupled cells calcium oscillation is
smaller than the frequency of first 40 cells when uncoupled. These cells have the highest
agonist concentration in the system.
The characteristics of propagation of intracellular calcium in all the coupled cells are
unchanged when only Vm coupling is used, (refer to Figures 5.7 and 5.11). Maximum and
minimum values of intracellular calcium, intra-SR calcium, IP3, and Vm oscillations are
unaffected when IP3 coupling between the cells is switched off. Also, the frequency and the
106 Propagation of intracellular calcium oscillations: Coupled VSMCs
























































































































Fig. 5.11 Time series plots of intracellular calcium (a,e), IP3 (b,f), intra-SR calcium (c,g) and
Vm (d,h) for the 45th (solid), 50th (dashed) and 55th (dash-dotted) cell in VMSCs with only
IP3 coupled (a-d) and with only Vm coupled (e-h).
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time lag of intracellular calcium oscillations with Vm coupling alone are matching well with
the simulation results when both Vm and IP3 are coupled.
With the given sigmoidal distribution of agonist, IP3 coupling alone is not enough to
propagate regenerative intracellular oscillations, (refer to Figure 5.7). The small amplitude
calcium oscillations disappeared when Vm coupling is blocked. The level of state variables in
the coupled cells with IP3 coupling alone matches with single cell simulations. The time lag
of oscillations in the stimulated cells increases significantly in those cells which are located
close to the 51st cell, mostly cells numbered 30 to 50, (refer to Figure 5.10). The frequency
of intracellular calcium oscillations in the first 30 cells matches closely with when these
cells are uncoupled. In other cells, the frequency of oscillations is higher compared to the
uncoupled cells.
Figure 5.11 shows the time series of intracellular calcium, IP3, intra-SR calcium and Vm
for two coupling cases, one with only IP3 coupling and the another with only Vm coupling.
The time series are taken from the 45th cell, 50th cell and 55th cell. The regenerative
intracellular calcium oscillations are aligned with the oscillations of IP3 and intra-SR calcium.
When IP3 alone is coupled, the peak of Vm is obtained at the same time as the intracellular
calcium peak. This is not happening when cells are coupled with Vm alone and coupled
with both Vm and IP3. In all three different coupling cases, intracellular calcium rising is
associated with a corresponding decrease of intra-SR calcium, (refer to Figures 5.11 and 5.8).
5.4.2 Absence of IP3R and RyR
Coupled cell model responses in the absence of IP3R and RyR are shown in Figure 5.12. It is
clear from the single VSMC simulation results that, (see Figures 4.4 and 4.6), bifurcation
points change in the absence of IP3R or RyR. For the same distribution of agonist concentra-
tion, the first 42 cells show intracellular calcium oscillations when uncoupled in the absence
of RyR. When the cells are coupled, five cells exhibit regenerative calcium propagation.
The regenerative calcium rise is limited to 4 cells when IP3 alone is coupled. The intra-SR
calcium concentration of these cells is declined analogous to their intracellular calcium rise.
With the given sigmoidal distribution, none of the cells are in the oscillatory state in the
absence of IP3R, coupled or uncoupled. To have calcuim oscillations in the absence of IP3R,
the agonist concentration should be greater than 500 nM (see Figure 4.4). Based on this fact,
agonist concentrations of the cells at two boundaries are increased to 650 nM and 250 nM
respectively. Using these boundary conditions, a new sigmoidal distribution of agonist is
imposed on the coupled cells in the absence of IP3R, (refer to Figure 5.13).
With the new distribution of agonist concentration shown in Figure 5.13, the first 46
cells oscillates in the absence of IP3R when uncoupled. The regenerative propagation
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Fig. 5.12 Maximum and minimum plots of intracellular calcium (a,c) and intra-SR calcium
(b,d) of 100 VMSCs coupled in the absence of RyR (a,b) and in the absence of IP3R (c,d)
with a sigmoidal distribution of agonist concentration given in the figure 5.5. Both Vm and
IP3 coupled (solid), IP3 alone coupled (dashed) and uncoupled (dotted).













Fig. 5.13 Sigmoidal distribution of agonist (solid) over the 100 VSMCs coupled for the set
of simulations with absence of IP3R. The dashed line is used to show the number of cells in
oscillatory state when uncoupled.
of intracellular calcium oscillations are obtained in 23 cells (Figure 5.14). Analogous to
intracellular calcium increase observed in regenerative calcium oscillations, intra-SR calcium
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Fig. 5.14 Maximum and minimum plots of intracellular calcium (left) and intra-SR calcium
(right) of 100 VMSCs coupled in the absence of IP3R with a sigmoidal distribution of agonist
given in Figure 5.13. Coupled (solid) and uncoupled (dotted).
decreases. The range of intra-SR calcium reduction in the regenerative oscillations looks
similar to that in the stimulated cells.
5.5 Discussions
Regenerative intracellular calcium propagation
The regenerative intracellular calcium propagation is observed in experimental studies of
Young et al. [200] and Seppey et al. [157]. In the Young et al. [200] study, intracellular
calcium oscillations were seen in all the cells of the visual field and over a distance up
to 180 µm away from the stimulated cell. It is also evident from the Seppey et al. [157]
study that the propagation of calcium rise can be regenerative, (see Figure 5.15). In their
study, the regenerative calcium oscillations are stopped after a certain distance away from the
stimulated region. Similar to these studies, model results establish the fact that intracellular
calcium propagation could be regenerative, but the regenerative nature of propagation is not
attainable in all the coupled cells, only some cells next to the stimulated cells.
Presence of large amplitude and small amplitude calcium oscillations
In all the different simulations, regenerative (large amplitude) intracellular calcium rise is
strongly related to the declination of intra-SR calcium. This is evident from the matching
time series plots of intracellular and intra-SR calcium, (refer to Figures 5.11 and 5.8). In
addition to that, the dominant calcium flux to the cytosol during regenerative calcium rise is
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Fig. 5.15 Regenerative intracellular calcium rise in mesenteric arterial strip of VSMCs.
Reproduced from Seppey et al. [157] paper (Permission is not required to reuse in a the-
sis/dissertation).
contributed by the SR, (refer to Figure 5.9). So, the regenerative or large amplitude calcium
rise is the result of calcium release from the SR through IP3R and RyR.
Small amplitude oscillations are obtained in the cells far from the stimulated cells. The
small amplitude calcium oscillations are seen when Vm alone is coupled and not seen with
only IP3 coupling. The amplitude of membrane potential oscillations in the far cells are not
significantly reduced as the amplitude of IP3 oscillations and intra-SR calcium oscillations
are reduced. It is evident from Figure 5.9 that the VOCC is the major contributor of the
calcium flux into the cytosol in the cells far from the stimulated cells. These finding imply
that small amplitude intracellular calcium oscillations are the result of electrical coupling
and the calcium rise in the far cells are primarily coming from extracellular calcium through
the VOCC.
As a whole, there are large amplitude and small amplitude calcium oscillations in the
coupled VSMCs. The large amplitude oscillations are obtained in the cells nearby to the
stimulated cells. The calcium release from the SR is the main contributor of large amplitude
calcium oscillations. Small amplitude oscillations occur in the distant cells, and calcium
release through the VOCC is the primary source of small amplitude oscillations. Halidi
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Fig. 5.16 Large and small amplitude intracellular calcium waves in mesenteric SMCs. Points
‘a’ and ‘b’ represents two points in the stimulated cell, points ‘c’ and ‘d’ from the adjacent cell
to the stimulated cell and point ‘e’ from the 5th cell next to the stimulated cell. Reproduced
from Halidi et al. [60] paper (permission granted from Elsevier to reuse in the thesis, license
number: 3855101478578).
et al. [60] observed large amplitude and small amplitude oscillations in the experiments of
cultured VSMCs from the mesenteric artery, (refer to Figure 5.16). According to them, large
amplitude oscillations were spatially limited, and small amplitude oscillations were seen in
all the cells of the field of view. The model results are in good agreement with the study of
Halidi et al. [60].
In the absence of IP3R or RyR
Young et al. [200] and Halidi et al. [60] reported that inhibition of RyR has no effect on
the propagation of calcium in coupled VSMCs. Likewise, regenerative propagation of
intracellular calcium is unaffected by the blocking of RyR in the model results. Further, the
regenerative intracellular calcium oscillations are possible with Vm alone coupling and with
IP3 alone coupling in the absence of RyR. In both cases, the rise of calcium is analogous
to the reduction of intra-SR calcium. In the absence of RyR, IP3R needs to be activated to
produce regenerative calcium oscillations as the SR is the major calcium contributor. This
leads to the fact that Vm and IP3 -mediated separate intercellular signalling mechanisms are
possible in the absence of RyR to produce regenerative calcium rise.
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According to Halidi et al. [60], no regenerative calcium propagation was seen when IP3R
was blocked. There was no calcium rise even in the stimulated cell in their study. Halidi
et al. [60] used the same stimulation strength in the absence and the presence of IP3R. In
agreement to this, none of the coupled cells exhibit intracellular calcium oscillations when the
same spatial distribution of agonist concentration is used in our model, (refer to Figure 5.12).
The single cell model results show that higher stimulating strength is required to produce
calcium oscillation in the absence of IP3R. This was the reason for not getting calcium rise in
the absence of IP3R. By increasing the range of agonist concentration applied over the cells,
the regenerative propagation is possible in the absence of IP3R, (refer to Figure 5.14). In
the absence of IP3R, the dominant contributor to calcium rise is the RyR channel. Since IP3
has no role in propagation in the absence of IP3R, one could say that Vm coupling alone can
mediate an intercellular signalling mechanism to generate regenerative calcium propagation
by activating RyR.






















Fig. 5.17 Vm-mediated intercellular signalling mechanism in coupled VSMCs.
Vm mediated intercellular signalling mechanism in our coupled VSMCs model is depicted
in Figure 5.17. When Vm is coupled, electrical coupling between a stimulated cell and a
non-stimulated cell causes depolarization of the non-stimulated cell, which leads to an
initial calcium rise through the activation of the VOCC. The calcium increase enhances PLC
activation, which leads to the increased production of IP3 and DAG. DAG depolarizes the
cell further by opening the NSC channel, which leads to increased activation of the VOCC.
This positive feedback mechanism between PLC-NSC-VOCC enables the mutual rise of
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intracellular calcium and IP3. The increased concentrations of calcium and IP3 activate IICR
and CICR mechanisms by enhancing the opening of IP3R and RyRs. The activation of IICR
and CICR produce regenerative calcium rise in the cell. In agreement to this, Koenigsberger
et al. [90] reported that sufficient amount of calcium influx should enter through VOCC to
activate CICR and to induce a regenerative calcium rise.





















Fig. 5.18 IP3-mediated intercellular signalling mechanism in coupled VSMCs.
Figure 5.18 shows IP3 mediated intercellular signalling in the coupled VSMCs. If the IP3
coupling between two cells attains a sufficiently high IP3 concentration in the non-stimulated
cell to activate the IP3R channel, that may lead to an initial calcium rise. The increase in
calcium boosts the activation of PLC which produces more IP3 and DAG and initiates the
positive feedback mechanism between PLC-NSC-VOCC. The simultaneous rise of calcium
and IP3 activates IICR and CICR mechanisms to generate regenerative calcium rise.
Dominant role of Vm coupling
The main difference between IP3-mediated and Vm-mediated intercellular signalling mech-
anisms is the calcium amplification mechanism that initiates the calcium rise. In the IP3-
mediated calcium signalling mechanism, IP3R should be activated to get an initial calcium
rise. The opening of IP3R depends on sequential binding of IP3 and calcium. The IP3R
channel needs to be activated for the initiation of IP3 -mediated signalling mechanism. The
IP3R is activated only if both IP3 and calcium are bound to its respective activation sites.
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Also, in the absence of IP3 bound to its activation site, calcium can not bind to its respective
activating site. This means that sufficiently high calcium and IP3 concentrations should be
present in the system to activate the IP3R channel. Since the calcium concentration in the
non-stimulated cell is low, the open probability of IP3 would be limited to low values, (refer
to Figure 3.3). Therefore, the increased IP3 concentration due to coupling alone would not be
enough to activate IP3R. This limitation makes IP3 mediated calcium signalling mechanisms
less effective in the coupled VSMCs.
In the case of Vm-mediated regenerative calcium rise, the VOCC is responsible for the
initial calcium increase. The opening of the VOCC depends only on Vm. If the electrical
coupling depolarizes the non-stimulated cell, the open probability of the VOCC increases and
there would be a calcium rise in the cell. There are no other prerequisites for the activation
of the VOCC. The dominant role of the Vm-mediated intercellular signalling mechanism
is the primary reason for getting unchanged coupled cells responses in the absence of IP3
coupling, (refer to Figure 5.7). Koenigsberger et al. [90] showed that the Vm coupling alone
reproduces the characteristics of propagation of intracellular calcium, which are observed in
the experiments. In addition to this, our study illustrates the reason for the dominant role of
Vm coupling.
The activation of IICR and CICR mechanisms is essential for the regenerative calcium
rise. IP3 and calcium are the two regulators of IICR and CICR mechanisms. To generate
regenerative calcium rise in a non-stimulated cell, there should be an initial rise of IP3 and/or
calcium in the cytosol to a level enough for the activation of IICR and CICR mechanisms. Vm-
mediated and IP3-mediated intercellular signalling mechanisms are responsible for the initial
calcium rise. For the given coupled VSMC system, Vm-mediated signalling mechanism
plays a dominant role in the propagation of regenerative calcium.
5.6 Conclusions
We have extended our single cell VSMC model to coupled VSMCs model by adding appro-
priate model equations for the GJIC between VSMCs. A numerical method was developed to
solve the coupled cell simulations by incorporating the numerical method of single cell and
TDMA. The accuracy of the numerical method was checked with the relative error analysis.
We have investigated the propagation of intracellular calcium in 100 serially coupled cells
with a sigmoidal distribution of agonist. The simulations were carried out by coupling both
Vm and IP3, Vm alone and IP3 alone to know the importance of Vm and IP3 -mediated
intercellular signalling mechanisms. The simulations were performed in the presence and
absence of IP3R and RyR.
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In agreement to the experimental studies, the model results establish the fact that intracel-
lular calcium propagation could be regenerative and the regenerative calcium propagation is
not attainable in all the coupled cells but up to some cells next to the stimulated cells. The
calcium release from SR is the main contributor of calcium rise in the large amplitude or
the regenerative calcium oscillations. The small amplitude calcium oscillations occur in the
distant cells and the calcium release through VOCC is the primary source of calcium rise in
these oscillations.
The activation of IICR and CICR mechanisms is essential for the regenerative calcium
rise. IP3 and calcium are the two regulators of IICR and CICR mechanisms. To generate
regenerative calcium rise in a non-stimulated cell, there should be an initial rise of IP3 and/or
calcium in the cytosol to a level enough for the activation of IICR and CICR mechanisms.
Vm and IP3 -mediated intercellular mechanisms for the propagation of intracellular
calcium were detailed. The Vm and IP3 -mediated mechanisms could separately generate
regenerative calcium propagation in coupled VSMCs. However, Vm-mediated signalling
mechanism plays a dominant role. The calcium and IP3 should bind to its respective activation
site on the IP3R. This limiting factor plays the major role to suppress the IP3-mediated
regenerative calcium propagation.
For a fixed agonist distribution, the regenerative propagation depends on the GJIC, and
therefore the number of gap junctions. If the number of gap junctions and the agonist
concentration are fixed in each coupled cell, then the regenerative calcium rise may depend
on the activation of IICR and CICR mechanisms. The influence of these parameters on the
regenerative calcium propagation will be discussed in the next chapter.

Chapter 6
The effects of altered levels of SERCA,
IP3R, RyR and GJIC: Coupled VSMCs
6.1 Introduction
The GJIC, SERCA, IP3R and RyR levels are altered in diabetic VSMCs [154, 146, 161,
25, 71]. GJIC controls the intracellular calcium dynamics of a cell in coupled VSMCs.
Gap junctional communication depends on the number of gap junctions, NGJ, present in
the VSMCs and the permeability of the connexins present at the gap junctions. There is a
scarcity of studies to confirm the selective permeability of different connexins to cytoplasmic
chemical species. Therefore, we define no selective permeability to gap junctions. However,
this can be a subject of study in future. As the number of gap junctions change, both GGJ
and DIP3 change accordingly, see Equations 5.6 and 5.8. This would alter the GJC between
VSMCs.
In chapter 4, we have seen that the altered levels of SERCA, IP3R and RyR would define
the intracellular calcium state of VSMC. The altered levels of these proteins may influence
the propagation of intracellular calcium oscillations. None of the studies has reported in
the literature that deals with the importance of SERCA, IP3R and RyR on the propagation
of intracellular calcium. In order to fully understand the impaired vascular function in
diabetic VSMCs, the roles of altered levels of SERCA, IP3R and RyR on the propagation of
intracellular calcium need to be investigated as well.
We have based the coupled cell model discussed in the chapter 5 to study the effects of
altered levels of GJC, SERCA, IP3R and RyR on the propagation of intracellular calcium.
The number of coupled cells are fixed to 100 and a sigmoidal distrubtion of agonist, (refer
to the figure 5.5) is imposed on the cells. The number of gap junctions between the cells is
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altered and the resultant propagation of intracellular calcium dynamics is studied. We have
analysed the influences of NGJ on the penetration depth and wave velocity of regenerative
calcium propagation. The variation of penetration depth against the varying levels of SERCA,
IP3R, and RyR is also investigated. The model results are discussed in general and on the
basis of diabetes at the end of the chapter.
6.2 Results
6.2.1 Altered levels of gap junctions
100 VSMCs are connected serially, and a sigmoidal distribution of agonist is imposed over
the cells as shown in Figure 5.5. The number of gap junctions, NGJ, is varied to get increased
coupling strengths for both Vm and IP3. For the control case, NGJ equals 1100 (refer to
Equation 5.9). The level of GJIC is represented as the percentage change in the number of
gap junctions compared to the control case.
At the beginning of the simulation, all the cells are in resting state. The spatial distribution
of agonist and the specified NGJ are imposed over the coupled cells from the first time step
onwards. Contour plots of intracellular calcium for 20% NGJ, 100% NGJ and 1000% NGJ
are given in Figure 6.1. These plots show the spatiotemporal pattern of intracellular calcium
for the first 150 seconds. The spatiotemporal pattern of intracellular calcium looks like the
sigmoidal distribution of agonist as shown in Figure 5.5. In other words, the pattern is closely
matching with the spatial distribution of agonist at high NGJ.
Figure 6.2 shows the variation of penetration depth as NGJ changes. The penetration
depth, (δRP), is defined as the number of cells that show regenerative calcium rise. As the
NGJ increases, the penetration depth increases. With 20% NGJ, regenerative propagation is
seen only in five cells. When NGJ is increased to 600%, regenerative propagation is extended
to all the cells. For the cases with 100% NGJ and 500% NGJ, the 52nd cell to 59th cell (8
cells) and the 52nd cell to 81th cell (30 cells) show regenerative propagation, (see Figures 6.2
and 6.1).
The slope of the penetration depth curve is smaller for NGJ less than 400%. Regenerative
calcium propagation extends up to the 75th cell for 400% NGJ. This indicates that change in
penetration depth is slow until the regenerative calcium propagation reaches the 72rd cell (21
cells). For NGJ greater than 400%, the regenerative calcium rise propagates at a faster rate as
the NGJ increases.
The agonist concentration at which regenerative propagation stops is also given in Figure
6.2. With 20% NGJ, regenerative propagation stops at an agonist concentration of 174 nM.
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Fig. 6.1 Varying number of gap junctions: Contour plots of intracellular calcium in 100
VSMCs coupled with different levels of gap junctional coupling, 20% (a), 100% (b) and
1000% (c). Y-axis shows cell position. Sigmoidal distribution of agonist is applied over the
cells (figure 6.4). The black line is used to distinguish cells that show steady and oscillatory
states when uncoupled.
Regenerative calcium propagation is continued to lower agonist concentrations of 145 nM
and 102 nM when NGJ is increased to 100% and 400% respectively. For NGJ greater than
400%, penetration depth increases as NGJ increases, but the agonist concentration where
regenerative caclium propagation ends is almost unchanged.
The wave velocity of the cells, except those cells which show small amplitude calcium
rise, is shown in Figure 6.3. Wave velocity, U, is calculated as the inverse of the time lag
between two adjacent cells. The time lag is calculated as the time difference between two
adjacent cells to reach peak intracellular calcium. The unit of wave velocity is cell/s. Wave
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Fig. 6.2 Penetration length (solid) and the agonist concentration (dashed) of the cell at which
regenerative calcium rise ends are plotted against the level of gap junctional coupling which
is expressed as the percentage average number of gap junctions.












Fig. 6.3 Wave velocity is plotted against cell position in 100 VSMCs coupled with varying
levels of NGJ, 20% (dotted), 100% (dash-dotted), 500% (dashed) and 1000% (solid). X-axis
shows cell position. A sigmoidal distribution of agonist is applied over the cells (Figure 6.4).
velocity decreases as the position of the cell relative to the first cell increases. A sharp
decrease in wave velocity is seen in the cells which show regenerative propagation. However,
the sharp decline of wave velocity in the regenerative calcium propagation is not seen with
high NGJ of 1000%. Instead, the wave velocity increases as the position of the cell gets
further from the stimulated cells.
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Fig. 6.4 Agonist concentration difference between two adjacent cells over the coupled 100
VSMCs
Based on the spatial distribution of agonist, (refer to Figure 5.5), the agonist concentration
difference between the adjacent cells is plotted in Figure 6.4. The profile of propagation
velocity at higher NGJ is correlated with the profile of agonist concentration difference
between the adjacent cells, (refer to Figures 6.3 and 6.4). The agonist concentration difference
graph is symmetrical about the center cell. Similar to this, the velocity plot for 1000% NGJ is
symmetrical and the centre of symmetry is around the 60th cell.












Fig. 6.5 Wave velocity plots of 100 VSMCs coupled with 20% (diamond), 100% (right
triangle), 500% (square) and 1000% (circle) levels of gap junctional coupling. A sigmoidal
distribution of agonist is applied over the cells (Figure 6.4). Closed markers are used to
differentiate the velocity of regenerative propagation in the non-stimulated cells.
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Figure 6.5 shows the variation of wave velocity with respect to agonist concentration
difference between two adjacent cells as shown in the figure 6.4. For 1000% NGJ, wave
velocity of a cell is inversely proportional to the agonist concentration difference. However,
for a few cells next to the 51st cell, the relationship is opposite. For 20% NGJ, 100% NGJ and
500% NGJ, wave velocity and agonist concentration difference are inversely related in the
first 51 cells. However, the wave velocity of the rest of the cells which exhibit regenerative
propagation is reversed and is directly proportional to the agonist concentration difference.
Noticeably, at lower NGJ, the cells in the regenerative propagation state show a sharp decline
in wave velocity. Wave velocity of a cell within the first 51 cells is greater than that of a cell
in the regenerative calcium propagation block with same agonist concentration difference
for any NGJ. For example, the 30th cell and the 70th cell experience the same agonist
concentration difference. With 1000% NGJ, the wave velocity of the 30th and the 70th cells
are 18 cells/s and 1.5 cells/s, respectively.












Fig. 6.6 Wave velocity of the 56th cell (solid) and the 30th cell are plotted against the number
of gap junctions which is expressed as percent of the total number of gap junctions. A
sigmoidal distribution of agonist is applied over the cells (Figure 6.4).
For any cell, the wave velocity increases as the NGJ increases. For the 55th cell, which
shows regenerative calcium propagation, the wave velocity increases significantly at lower
values of NGJ, (refer to Figure 6.6). The wave velocity is almost doubled when NGJ is
increased from 50% to 150%. As the NGJ is increased to a higher value, a further increase
in gap junctional coupling does not change wave velocity significantly. Similar variation in
wave velocity with respect to NGJ is observed for a cell in the first 51 cells. For example,
wave velocity of the 30th cell is given in Figure 6.6. However, at lower values of NGJ, the
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change in wave velocity with respect to NGJ is minimal in the 30th cell compared to the 55th
cell.
6.2.2 Altered levels of SERCA, IP3R, and RyR
In this section, we will study the effects of altered levels of SERCA, IP3R and RyR on the
propagation of regenerative calcium rise. To examine this, the levels of SERCA, IP3R and
RyR are changed only in the non-stimulated cell. The levels of SERCA, IP3R, and RyR in
the stimulated cells, (the first 51 cells), are unchanged and are equal to the control case. The
coupling strength is kept constant at 100% NGJ.
















Fig. 6.7 Maximum and minimum values of intracellular calcium: (dotted) Uncoupled, (solid)
Control case with 100% levels of SERCA, IP3R, and RyR. In other simulations, IP3R levels
of the 52nd cell to the 100th cell are changed to 30% (thin dash-dotted), 50% (thin dashed),
150% (thick dashed) and 200% (thick dash-dotted). SERCA and RyR levels are unchanged.
Maximum and minimum values of intracellular calcium oscillations in the coupled cells
when the IP3R level in the cells from the 52nd cell to the 100th cell are varied is shown in
Figure 6.7. The minimum calcium concentration of oscillations in a cell is unchanged if the
same cell shows regenerative calcium rise for a different IP3R level. When the IP3R level
is increased to 150% and 300%, regenerative calcium oscillations are produced in twelve
and twenty-five cells respectively, (refer to Figure 6.8). The agonist concentration of the
cell at which regenerative calcium rise stops for 150% and 300% IP3R cases are 122 nM
and 102 nM respectively. Regenerative calcium rise is obtained in all the non-stimulated
cells when the IP3R level is increased to 400%. For a decrease of 50% and 70% of IP3R
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level, regenerative propagation is restricted to only five cells and two cells, respectively. The
regenerative calcium rise stops at 174 nM and 212 nM for 50% and 70% levels of IP3R,
respectively.





















Fig. 6.8 Penetration length (solid) and the agonist concentration (dashed) of the cell at which
regenerative calcium rise ends are plotted against IP3R level
Figure 6.9 shows maximum and minimum values of intracellular calcium oscillations in
the coupled cells when RyR levels in the cells from 52nd cell to 100th cell are changed. The
minimum calcium concentration of oscillations in a cell is unchanged if the same cell shows
regenerative calcium rise for a different RyR level. The altered levels of RyR in the non-
stimulated cells cause no impact on the maximum and minimum of calcium oscillations in the
stimulated cells. The penetration depth is significantly changed with RyR level. Increasing
RyR level to 110% and 120% causes regenerative calcium oscillations in 10 and 15 cells
respectively, (refer to Figure 6.10). A further increase to 130% produces regenerative calcium
rise in all the non-stimulated cells. With 85% RyR level, only five cells show regenerative
propagation. This number is further reduced to 4 cells with 75% RyR level. The regenerative
propagation stops at an agonist concentration of 174 nM and 186 nM for 85% and 75% RyR
levels respectively. When the RyR level is raised to 110% and 120%, regenerative calcium
rise is extended to 126 nM and 110 nM, respectively.
Figure 6.11 shows maximum and minimum values of intracellular calcium in the coupled
cells when the SERCA level is changed in the cells from the 52nd cell to the 100th cell.
The penetration depth of regenerative calcium rise with 100% SERCA level is 8cells. The
penetration depth is reduced as the SERCA level increases in non-stimulated cells. For 125%
SERCA level, regenerative propagation is reduced to only five cells, and the corresponding
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Fig. 6.9 Maximum and minimum values of intracellular calcium: (dotted) Uncoupled, (solid)
Control case with 100% levels of SERCA, IP3R, and RyR. In the other four simulations,
RyR levels of the 52nd cell to the 100th cell are changed to 75% (thin dash-dotted), 85% (thin
dashed), 110% (thick dashed) and 120% (thick dash-dotted). SERCA and IP3R levels are
unchanged.





















Fig. 6.10 Penetration length (solid) and the agonist concentration (dashed) of the cell at
which regenerative calcium rise ends are plotted against RyR level.
regenerative calcium rise stops at an agonist concentration of 174 nM, (see Figure 6.12).
Regenerative propagation is then restricted to only three cells when the SERCA level is
increased to 135%. The regenerative propagation for 135% SERCA ends at 199 nM.
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Fig. 6.11 Maximum and minimum values of intracellular calcium: (dotted) Uncoupled, (solid)
Control case with 100% levels of SERCA, IP3R, and RyR. In the other four simulations,
SERCA levels of the 52nd cell to the 100th cell are changed to 150% (thin dash-dotted), 125%
(thin dashed), 70% (thick dashed) and 50% (thick dash-dotted). RyR and IP3R levels are
unchanged.
On the other hand, when the SERCA level is reduced to 70%, the regenerative calcium
oscillations are obtained in eleven cells, three cells more than the control case. Though
reduction of SERCA level increases penetration depth, peak intracellular calcium is relatively
low. However, for 50% SERCA level, regenerative calcium oscillations are seen only in 4
cells. The calcium rise in the rest of the non-stimulated cells is increased compared to a
higher SERCA level. Further reduction of the SERCA level suppresses calcium rise in all
the non-stimulated cells. For 70% and 50% SERCA levels, regenerative calcium rise ends at
126 nM and 186 nM respectively. For the SERCA levels greater than 70%, penetration depth
decreases as SERCA level increases whereas for SERCA levels lower than 70%, penetration
depth increases as the SERCA level increases, (refer to Figure 6.12).
6.3 Discussions
We have studied the effects of NGJ, SERCA, IP3R and RyR on the propagation of regenerative
calcium waves in coupled VSMCs. The study mainly focused on the penetration depth and the
wave velocity of regenerative calcium oscillations, which are the two important characteristics
of calcium propagation.
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Fig. 6.12 Penetration length (solid) and the agonist concentration (dashed) of the cell at
which regenerative calcium rise ends are plotted against SERCA level.
Wave velocity of the cells close to the two boundaries of the coupled cell system is con-
siderably high compared to the other cells. This might be due to the boundary effects. There
are no neighbouring cells for two ends cells to damp the coupling components such as Vm
and IP3. The absence of one adjacent cell makes the ends cells attain a higher depolarization
and an increased IP3 concentration, which leads to an enhanced wave propagation. The
boundary effects are limited to only a few cells.
Regulation of penetration depth and wave velocity by GJIC
It is clear from the model results that penetration depth is proportional to the coupling
strength. This has to be read along with the agonist concentration at which regenerative
propagation ends, because, the increased coupling extended the regenerative calcium rise
to a cell with a lower agonist concentration. The combined effect of agonist concentration
and coupling strength is clearly visible in Figure 6.2. The increased coupling strength helps
the cells with low agonist concentration to attain increased depolarization and a greater
concentration of IP3. The increased depolarization in the cells enhances the opening of the
VOCC leads to increased intracellular calcium and the subsequent rise of IP3. If the increased
calcium and IP3 are enough to enable IICR and CICR mechanisms, the cells at low agonist
concentration exhibit regenerative calcium rise at a higher coupling strength.
The regenerative calcium rise is propagated to all the cells when the coupling strength
is increased to 600% NGJ. In the study of Koenigsberger et al. [90], fully regenerative
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calcium waves were achieved at an increased coupling strength of 180%. The difference
in the minimum coupling strength required to produce fully regenerative calcium waves
might be because of the difference in the VSMC systems studied. The stimulated cells
were depolarized to ≈-30 mV in Koenigsberger et al. [90]’s study which is comparatively
high compared to ≈-43 mV in our model (refer to Figure 5.7). The large difference in
membrane potential between the stimulated and non-stimulated cells might have enhanced
the propagation of regenerative calcium waves in Koenigsberger et al. [90] study.
Irrespective of the cell position and agonist concentration, the wave velocity increases
as the NGJ increases. The dependency on the NGJ is more prevalent in the cells which are
located at the end of regenerative propagation. However, the wave velocity reaches a constant
at higher coupling strength in all the cells irrespective of their position. At a high value of
NGJ, coupled cells would attain a maximum possible GJIC in the given system. This might
cause no change in wave velocity at high coupling strengths. If the value of NGJ is high
enough to produce the regenerative calcium rise in all the coupled cells, the wave velocity
is inversely proportional to the difference in agonist concentration between the adjacent
cells. The wave velocity profile is simply the mirror image of the profile of the agonist
concentration difference between the adjacent cells.
It seems that the penetration depth and the wave velocity of intracellular calcium oscilla-
tions in coupled VSMCs are strongly related to the NGJ. Therefore, one could say that GJIC
between VSMCs plays an essential role in the propagation of intracellular calcium.
Dominant role of RyR in the propagation of regenerative calcium rise
Regenerative calcium propagation is enhanced when IP3R or RyR level is increased. In
these cases, the regenerative calcium propagation extends to lower agonist concentrations.
IP3R and RyR are integral parts of IICR and CICR mechanisms. When IP3R level or RyR
is increased, it may enhance the activation of IICR and CICR mechanisms to generate
regenerative calcium rise for the same agonist concentration. Therefore, the increased levels
of IP3R and RyR boost the regenerative calcium rise in VSMCs, which leads to greater
penetration depth. Interestingly, the level of IP3R required to enhance the same penetration
length is high compared to the RyR level. For getting regenerative calcium rise in almost 11
cells, the level of IP3R should be 150% whereas 110% level of RyR is enough. This means
that influence of RyR is dominant on the propagation of regenerative calcium rise compared
to IP3R. This is expected as the maximum rate of RyR function is assumed two-fold higher
than that of IP3R.
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Biphasic regulation of penetration depth by SERCA
The effect of reduced a SERCA level produces dual effects on the propagation of regenerative
intracellular calcium rise. For high SERCA levels, greater than 70%, SERCA blocks
regenerative calcium propagation whereas at low SERCA levels, lower than 70%, SERCA
enhances regenerative calcium propagation, (refer to Figure 6.12). If the SERCA level is
low, it reduces the intra-SR calcium concentration due to diminished SERCA pumping of
calcium back to the SR. The reduction in intra-SR calcium creates a decreased concentration
gradient between the SR and the cytosol available for IP3R and RyR. This would cause
reduced intracellular calcium release from the SR and a subsequent reduction in intracellular
calcium. Therefore, the VSMC fails to attain regenerative calcium rise at a low SERCA level.
As the SERCA level increases, intra-SR calcium load also increases, which leads to enough
calcium influx to the cytosol to produce regenerative calcium rise. So that, the increasing
SERCA level enhances penetration depth. However, further increase of the SERCA level
lowers the net calcium release to the cytosol. The increased pumping of SERCA keeps the
intracellular calcium low and blocks the calcium-induced activation of RyR and IP3R. This
may stop regenerative calcium rise at the same agonist concentration, leads to the shortening
of the penetration depth. The regenerative calcium rise would be reestablished at a higher
agonist concentration as the opening of IP3R and RyR are enhanced to overcome the effect
of increased SERCA level.
Discussion in the context of diabetes
According to Kuroki et al. [92], the function of Cx43 is inhibited in a high glucose medium,
which leads to reduced GJIC. To study the role of GJIC, Lucifer yellow dye was injected
into a single cell of a culture of VSMCs, (refer to Figure 6.13). The number of cells in which
the injected dye was propagated is used as a measure of GJIC. Li et al. [103] reported the
same in retinal pericytes. These experiments show that the penetration depth in VSMCs
was reduced in a high glucose medium. In agreement to this, the reduced coupling strength
shortened the penetration depth in the model results. This is expected as coupling strength is
related to the GJIC.
In the cases of IP3R and RyR, downregulation of both proteins restricts the propagation
of regenerative calcium oscillations to a smaller number of cells. Searls et al. [154] observed
upregulation of RyR along with downregulation of IP3R. Since both of these proteins have
the same effect on the propagation of calcium rise, the upregulation of RyR restores the
penetration depth of the propagation that is narrowed by the downregulation of IP3R, (refer
to Figure 6.14). This observation in coupled cells matches with the hypothesis that we
130 The effects of altered levels of SERCA, IP3R, RyR and GJIC: Coupled VSMCs
Fig. 6.13 The number of dye-coupled cells as a measure of GJIC. (left) VSMCs of a bovine
thoracic aorta during exposed to a high glucose medium. Reproduced from Kuroki et al.
[92] paper (permission granted from American Diabetes Association to reuse in the thesis,
licence number: 3852141143899). (right) Bovine retinal pericytes exposed to a high glucose
medium. HG stands for high glucose. Reproduced from Li et al. [103] paper (permission
granted from Association for Research in Vision and Ophthalmology (ARVO) by email
contact). Lucifer yellow dye is used in both experiments.
have suggested in the chapter 4, section 4.3. The impairment of penetration depth due to
altered level of IP3R or RyR might be corrected by changing the level of the other protein.
However, the downregulation of both IP3R and RyR reduces penetration of regenerative
calcium oscillations in diabetic VSMCs.
According to the model results, downregulation of SERCA level to between 25% and
50% of the control case, as seen in diabetic VSMCs [154], has mixed effects on the pene-
tration depth of calcium oscillations. In the model results, a 25% reduction of the SERCA
level extends the penetration depth. However, 50% reduction of SERCA level halved the
penetration depth. If the level of IP3R or RyR is lowered along with the reduced level of
SERCA, the penetration depth is further shortened, (refer to Figure 6.14). Though the reduc-
tion of SERCA level in diabetic VSMCs has mixed effects on the propagation of regenerative
calcium oscillations, the combined reduction of SERCA and IP3 or RyR levels diminishes
the penetration depth.
In our knowledge, there are no experimental studies, which discuss the propagation
of vasomotor response in diabetic VSMCs available in the literature. Most of the studies
focused on the signal conduction in diabetic hearts. Ventricular conduction is significantly


















Fig. 6.14 Penetration length for different combinations of SERCA, IP3R and RyR.
Signal conduction is slowed down in diabetic hearts compared to the normal heart, though the
expression of Cx43 is unchanged in diabetic heart but associated with enhanced lateralization
of Cx43. This leads to non-functional gap junctions [130]. As the function of Cx43 is
inhibited, the conduction of signal reduces. Similar to these experimental observations, the
model results show that the reduced coupling strength slows down the wave velocity of
calcium oscillations.
The calcium oscillations are essential for the contraction-relaxation of the artery. The
impaired calcium propagation may affect the long distance conduction of vasomotor response.
One could say that the reduced GJIC due to the reduced Cx43 function, lower levels of
SERCA, IP3R and RyR affects the propagation of the vasomotor response, causing impaired
propagation of vasoconstriction/vasodilation in diabetes.
6.4 Conclusions
We have evaluated the effects of altered levels of GJIC, SERCA, IP3R and RyR on the
propagation of intracellular calcium using the coupled cell model discussed in the chapter
5. We have analysed the influences of NGJ on the penetration depth and wave velocity of
regenerative calcium propagation. The level of SERCA, IP3R, and RyR in the non-stimulated
cells were altered and the results were investigated for the consequences on penetration
depth.
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The regenerative propagation is possible only if the coupling generates enough calcium
and IP3 required for the activation of IICR and CICR mechanisms, irrespective of the agonist
concentration or the position of the cell.
It seems that the penetration depth and the wave velocity of intracellular calcium oscil-
lations in coupled VSMCs are strongly related to the NGJ if the regenerative propagation
was not extended to the all the non-stimulated cells. Otherwise, the wave velocity profile is
simply the mirror image of the profile of the agonist concentration difference between the
adjacent cells.
The increased levels of IP3R and RyR enhanced the the propagation of regenerative
calcium rise in VSMCs leading to a greater penetration depth. The level of IP3R required to
enhance the same penetration length is high compared to the RyR level. Interestingly, the
SERCA regulation of the propagation of regenerative intracellular calcium rise is biphasic.
At high SERCA levels, SERCA blocks regenerative calcium propagation whereas at low
SERCA levels, SERCA enhances regenerative calcium propagation.
The reduced GJIC due to the decreased Cx43 in diabetes slows down the wave velocity
of intracellular calcium oscillations. Though the reduction of SERCA level in diabetic
VSMCs have mixed effects on the propagation of regenerative calcium oscillations, combined
reduction of SERCA and IP3 or RyR levels diminishes the penetration depth. However,
the suppression of penetration depth due to decreased level of IP3R could be restored by
increasing the level of RyR and vice versa. One could say that the reduced GJIC due to the
reduced Cx43 function is a possible factor that affect the long distance conduction as well as
propagation velocity of vasomotor response in diabetes.
Chapter 7
Concluding Remarks
Vascular dysfunction in diabetes causes vast complications in the circulatory system including
the regulation of blood flow to the tissues. The cellular mechanisms of vascular dysfunction
in diabetes are not completely elucidated because of the high-level complexity involved. The
functioning of VSMCs is impaired in microcirculation as well as in macrocirculation of
diabetic patients [123]. The experimental studies imply that impaired intracellular calcium
dynamics in diabetic VSMC is related to the alterations of functions of GJIC and calcium
handling proteins such as SERCA, IP3R, and RyR. The main purpose of the thesis was to
explore the importance of SERCA, IP3R, RyR and GJIC as modulating factors of intracellular
calcium dynamics in VSMCs and investigate the related consequences in the perspective of
diabetes.
As a powerful tool to investigate the extremely complex biological systems, we have
developed a mathematical model of VSMC which accomplishes our research aims. Kapela
et al. [83] VSMC model was used as a building block to develop the new model. We
have defined new or modified descriptions to NCX exchanger, IP3R channel, NSC channel,
agonist-induced IP3 production, SR structure, and functioning. The SR was modelled as a
single luminally continuous store with homogeneous luminal calcium. None of the VSMC
mathematical models has used sequential binding of calcium and IP3 for the activation of
IP3R. We have incorporated a simplified 4-state sequential-binding IP3R model since calcium
is the central attention of the study. The model equations were solved using a numerical
model developed based on Bakward-Euler method and fixed point iteration. The time period
and tolerance limit for getting required accuracy was fixed by analysing the relative error.
The code for the model is written in ‘C’ language and was implemented in the desktop PC.
The response of the VSMC model to varying agonist concentrations were analysed
on the basis of corresponding experimental studies. The temporal occurrence, amplitude
and frequency of intracellular calcium oscillations, and bifurcation points of the agonist
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stimulation were matching with the experiments in VSMCs. The response of the model
to varying extracellular concentrations of potassium and calcium were also qualitatively
matching with experiments. The developed model was then used for studying the effects of
SERCA, IP3R, RyR and GJIC.
We have extended our single cell VSMC model to coupled VSMCs model by adding
appropriate model equations for GJIC between VSMCs. The transport of calcium through
gap junctions was assumed negligible. Vm and IP3 were coupled between VSMCs to model
GJIC. The model equations were solved using TDMA along with the numerical method
used for the single cell. We have investigated the propagation of intracellular calcium in 100
serially coupled cells with a sigmoidal distribution of agonist. The simulations were carried
out by coupling both Vm and IP3, Vm alone and IP3 alone. The simulations were performed
in the presence and absence of IP3R and RyR.
In agreement to the experimental studies, the model results established the fact that
intracellular calcium propagation could be regenerative, however the regenerative calcium
propagation was not attainable in all the coupled cells but up to some cells next to the
stimulated cells. The calcium release from SR is the main contributor of calcium rise in the
large amplitude or the regenerative calcium oscillations. The small amplitude oscillations
were obtained in the cells far from the stimulated cells and the calcium release through
VOCC is the primary source of calcium rise in the these calcium oscillations.
The activation of IICR and CICR mechanisms are essential for the regenerative calcium
rise in the non-stimulated cells. If the intercellular coupling generates enough calcium and
IP3 concentrations in the non-stimulated cell, regenerative calcium rise will result.
Vm and IP3 -mediated intercellular signalling mechanisms for the propagation of intra-
cellular calcium were detailed. The Vm and IP3 -mediated mechanisms could separately
generate regenerative calcium propagation in coupled VSMCs. However, Vm-mediated
signalling mechanism plays a dominant role. The IP3R channel, needed for the initiation of
IP3 -mediated signalling mechanism, is activated only if both IP3 and calcium are bound
to its respective activation sites. This limitation makes IP3 mediated calcium signalling
mechanisms less effective in the coupled VSMCs. Our study could illustrate the reason for
the dominant role of the Vm coupling, which was observed in the experiments.
7.1 Findings with regard to the research questions
We investigated the effects of altered levels of SERCA, IP3R and RyR in a single cell as
well as coupled cells. The level of a particular channel or pump was altered by changing the
maximum calcium flux of the corresponding channel or pump. The responses of the model to
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the altered levels of SERCA, IP3R and RyR at a fixed agonist concentration and for varying
agonist concentrations were studied.
The frequency of intracellular calcium oscillations is significantly influenced by IP3R
and RyR at its low levels. The SERCA regulation of frequency is biphasic. At low SERCA
levels, frequency increases with SERCA levels whereas at higher SERCA levels, the relation
inverted.
The role of IP3R and RyR for the occurrence of intracellular calcium oscillations is not
fully clear in the literature. Some studies claimed the need of RyR for the existence of calcium
oscillations whereas others proposed IP3R alone is enough. The model results showed that
the agonist induced calcium oscillations are feasible in the absence of RyR or IP3R. However,
higher stimulating strength is required to produce intracellular calcium oscillations in the
absence IP3R or RyR. The change in IP3R or RyR level shifts the bifurcation points of agonist-
induced calcium oscillations. This might have been the reason for not getting the calcium
oscillations in experiments when either IP3R or RyR was blocked with the stimulation
strength. These findings provide explanation for the contradictory statements published in
experiments.
The change of SERCA, IP3R or RyR level shifted the oscillatory state of intracellular
calcium to steady and vice versa at a constant agonist concentration. Especially, increasing
SERCA level move the oscillatory region to high agonist concentrations whereas increasing
IP3R or RyR level shift the oscillatory region to lower agonist concentrations. The shift
of oscillatory region was significant at low SERCA levels and at low IP3 levels. Based on
this, our hypothesis is that if an external environment influences the agonist-induced calcium
transients, the VSMC may alter the levels of SERCA, IP3R and/or RyR expressed in the SR
to restore intracellular calcium transients matched with the functional need.
The SERCA regulation of the propagation of regenerative intracellular calcium rise is
biphasic. At high SERCA levels, SERCA blocks regenerative calcium propagation whereas at
low SERCA levels, SERCA enhances regenerative calcium propagation. The downregulation
of IP3R and RyR reduced penetration of regenerative calcium oscillations in diabetic VSMCs.
The influence of RyR is dominant on the propagation of regenerative calcium rise compared
to IP3R. The suppression of penetration depth due to decreased level of IP3R could be
restored by increasing the level of RyR and vice versa.
It seems that the penetration depth and the wave velocity of intracellular calcium oscil-
lations in coupled VSMCs are strongly related to the GJIC if the regenerative propagation
was not extended to the all the non-stimulated cells. Otherwise, the wave velocity profile is
simply the mirror image of the profile of the agonist concentration difference between the
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adjacent cells. The wave velocity of a cell is unchanged at higher GJIC irrespective of their
position.
The levels of GJIC, SERCA, IP3R and RyR are found altered in VSMCs of diabetes
[154, 118] along with impaired intracellular calcium dynamics. The reduced GJIC due to
the reduced Cx43 function is one possible factor that affect the long distance conduction as
well as propagation velocity of vasomotor response in diabetes. The model results showed
that the functional implications due to the altered level of IP3R in diabetic VSMCs might be
regulated by changing the level of RyR and vice versa. However, the impaired intracellular
calcium dynamics due to reduced SERCA levels can not be restored by changing IP3R or
RyR levels because of the reduced intra-SR calcium load. There is no other kinds of calcium
pump expressed in the SR to replace the functioning of SERCA.
The model responses suggest that the reduced SERCA level is a possible mechanism
for the “smoothed" calcium transients in VSMC. The intracellular calcium lowering as
well as intracellular calcium rising in VSMC are significantly affected with altered SERCA
level. The SERCA level tends to be the regulating factor of intracellular calcium in both the
activation and relaxation phases of oscillations. These findings lead to the fact that reduced
SERCA level is probably the primary factor responsible for the reduced intracellular calcium
transients and the reduced contractility in diabetes even though all the three IP3R, SERCA
and RyR are varied in diabetic VSMCs.
7.2 Future works
• The agonists induce several signalling mechanisms in VSMC by activating different
G-proteins like Gq, Gs and Gi protein. For example, NE activate Gq, Gs and Gi protein.
The activation of Gs-protein enhance the production of cAMP whereas activation of
Gi-protein suppresses the production of cAMP. Gq-protein activates PLC and leads to
the generation of IP3 and DAG. In the present study, we have included only the PLC
activation and subsequent signalling transduction. Adding the signalling transduction
leading to change the production of cAMP will help us to fully understand the complex
signalling mechanism and intracellular calcium dynamics in VSMC following agonist
stimulation.
• The model can be extened further by including nitric oxide (NO) or cyclic guanosine
monophosphate (cGMP) signaling pathways. NO is known as an important vasodilation
factor causing relaxation of the artery. NO is synthesized from the ECs and from there
diffuses to the neighbouring VSMCs. The cGMP is produced in the VSMC when NO
activates NO-sGC-GTP pathway.
7.2 Future works 137
• We have solved the model equations using constant time-step. One can think of
converting the constant-time step to adaptive time step which is considered to be
more efficient. This may further reduce the simulation time useful for coupling larger
number of cells.
• This model can be further extended by including selective permeability of gap junc-
tions.
• The cellular pathways that leads to the alteration of GJIC, SERCA, IP3R and RyR in
diabetic VSMCs.
Diabetes increases PKC activity [70], transforming growth factor (TGF)-β production
[161] and expression of Bcl-2 and Bcl-xL [182] in VSMCs. The TGF-β inhibits
intracellular calcium transients by reducing IP3 sensitivity in VSMCs [201]. The IP3
sensitivity is related to the TGF-β -induced downregulation of IP3R [162]. TGF-β
downregulation of IP3R expression was found in diabetic VSMCs of aorta by Sharma
et al. [161].
Kuroki et al. [92] showed reduced GJIC in VSMC exposed to the high-glucose medium
is related to the increased PKC activity. Similar findings were reported by Inoguchi
et al. [71] in the cardiac cells of diabetic rats, (refer to Figure 1.10). The reduction
of the expression of Cx43 in high-glucose medium was also reported in aortic ECs
[92], microvascular ECS, and retinal pericytes [103]. Altogether, high-glucose leads to
Cx43 function inhibition and is related to the increased PKC activity.
The Bcl-2 and Bcl-xL proteins are upregulated in the VSMCs of diabetic patients
and exposed to a high-glucose medium [148, 149, 105]. The interaction of Bcl-2
and the Bcl-xL proteins with IP3R enhances the IP3-dependent activation of IP3R
[104, 182]. Velmurugan and White [182] observed Bcl-2-dependent increases in the
IP3R-dependent calcium release in diabetic VSMCs.
We have studied the effects of altered levels of GJIC, SERCA, IP3R and RyR by
changing the maximum rate of calcium flux. One could think of modelling the cellular
pathways that leads to the alteration of GJIC, SERCA, IP3R and RyR in diabetic
VSMCs. Some of the suggestions are,
– High-glucose activation of PKC - PKC-mediated phosphorylation of Cx43 - effect
of Cx43 phosphorylation to GJIC
– High-glucose activation of PKC - PKC-mediated activation of TGF-β production
[56] - TGF-β -mediated alteration of IP3R expression
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– High-glucose and diabetes upregulation of the Bcl-2 and Bcl-xL proteins - Bcl-2
and Bcl-xL-mediated increase in IP3-dependent activation of IP3R channel
– Altered SERCA regulation in high-glucose medium
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Appendix A
Methodologies of mathematical
modelling in cell physiology
Hodgkin and Huxley [65] had published their famous work on initiation and propagation
of neuronal action potential. From then, mathematical modelling emerged as an important
research tool in cell physiology. The development of high-speed digital computers has shifted
the application of mathematical modelling from a single/many cell system to millions of
cells or a full organ. A mathematical model of a cell is a system of ordinary differential
equations to show the change of system variables over time. The differential equations are
used to represent subcellular processes inside a cell. These processes are modelled based
on appropriate kinetic laws such as the law of mass action for stoichiometric reactions
and Michaelis-Menten and Hill equations for enzyme-substrate reactions. Transport of
molecule/ion species due to concentration gradients and electric gradients are modelled using
Ficks law of diffusion, the Nernst equation and the Nernst-Plank equation. Mass balance
is used to account for the transport of molecule/ion species across the boundaries. All the
above-mentioned modelling approaches are explained below in detail.
A.1 Law of mass action
According to the law of mass action, the rate of a chemical reaction is proportional to the
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The law of mass action for forward and backward reactions can be written as,
rf = k+[A]a[B]b (A.2)
rb = k−[C]c[D]d (A.3)
where k+ and k− are rate constants for forward and backward reactions. The equilibrium





The commonly used unit of concentration of chemical species is moles per litre (mol/L). The
unit of K depends on the order of the reaction.
A.2 Enzyme-substrate reaction
A.2.1 Michaelis-Menten equation
The Michaelis-Menten equation describes the rate of an enzymatic reaction using the concen-














Where E represents enzyme, P represents product and ES represents enzyme-substrate
complex. kcat is the rate constant of enzyme-substrate conversion into a product and the
enzyme.
The rate of product formation increases as the substrate concentration increases and
reaches a maximum at a higher substrate concentration. VMAX is the maximum possible
reation rate. According to Equation A.6, the Michaelis constant, KM, is the substrate
concentration at which the reaction rate equals half-maximum.
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A.2.2 Hill equation
The Hill equation is commonly used for quantifying the cooperative binding of a ligand
to a receptor. If the binding of a ligand to a receptor is related to the concentration of the
ligand in a non-linear manner, it is called cooperative binding. There are basically two
types of cooperative bindings, positive and negative cooperativities. In the case of positive
cooperative binding, if a ligand molecule binds to the receptor, the affinity of the receptor to
bind next ligand molecule increases. This process continues untill all the binding sites of
the receptor are bound to the ligand molecules. If the binding of a ligand molecule to the
receptor reduces the affinity of the receptor to bind with another ligand molecule, it is called
negative cooperativity.
The Hill equation helps us to find the fraction of ligand-bound sites on the receptors in








Where [Ld] is the concentration of ligand, n is the Hill coefficient, Kd is the rate constant of
dissociation and KA is the ligand concentration at which half of the binding sites are occupied.
For positive cooperative binding, N is greater than 1 whereas N is smaller than 1 for negative
cooperative binding. N equal to 1 indicates noncooperative binding, which means that the
affinity of the receptor to bind to a ligand molecule is independent of the presence of any
previously bound ligand on the receptor.
A.3 Diffusion of a molecule or an ion
A.3.1 Ficks law of diffusion
According to Fick’s law of diffusion, movement of molecules from a high concentration
region to a low concentration region is driven by a concentration gradient. The law states
that the flux of the molecule, moles per unit area per second, is proportional to the spatial
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Where c is the concentration of the molecule in moles per unit volume, D is the diffusion
coefficient in unit area per unit time, x is the position and J is the molecular flux in moles per
unit area per unit time.
A.3.2 Nernst-Plank equation
Indifferent to molecules, movement of an ion depends on the electric potential gradient in
addition to the concentration gradient. The Nernst-Plank equation describes the motion of an
ion under the influence of both a concentration gradient and an electric potential gradient.













Where F is Faraday’s constant, R is the universal gas constant, T is temperature, z is valency
of the ion and φ is the electric field. The second term of the equation represents the influence
of the electric field on the movement of an ion. For a molecule, only the first term exists.
A.3.3 Nernst equation
The Nernst equation describes the distribution of an ion at electrochemical equilibrium
between two compartments separated by a membrane. The membrane channels allow the
passage of the ion of interest through it. The passage of ions across the membrane develops
a potential difference across the membrane. The potential gradient grows in magnitude
until it balances the concentration gradient. The ion is in electrochemical equilibrium when
the potential gradient and concentration gradient are equal in magnitude. The membrane
potential developed at electrochemical equilibrium is called equilibrium potential or Nernst
potential.
When a membrane separates a particular type of ions, total chemical potential of the ions
in the intracellular space equals,
µi = µ0 +RT ln[ion]i + zFV0 (A.10)
Similarly, for the chemical potential of the ions in the extracellular space,
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µe = µ0 +RT ln[ion]e + zFVi (A.11)
At electrochemical equilibrium, the chemical potential of the ions in the intracellular and in
the extracellular spaces are equal. Therefore,
µ0 +RT ln[ion]i + zFVi = µ0 +RT ln[ion]e + zFV0 (A.12)
Simplying and rearranging Equation A.12 yields,




Potential difference between the intracellular and extracellular compartments is defined as
the membrane potential, Vm. Substituting Vm into Equation A.13, and solving for Vm, we








A.3.4 Goldman-Hodgkin-Katz (GHK) equation
The Goldman-Hodgkin-Katz (GHK) equation is used to determine the ionic flux across a cell
membrane. It accounts for the contributions of transmembrane potential and concentration
gradient to the ionic flux. The GHK equation is derived by assuming a constant electric field
across a membrane [87]. Consider a case where a membrane with a thickness of L separates
two solutions, named extracellular and intracellular solutions. The concentration of an ion,
S, in the extracellular and intracellular solutions equal ce and ci respectively. If the electric




At steady state and with no production of ions, ionic flux across the membrane is constant.
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If we multiply Equation A.16 with zF, we will get an equation for ionic current density which















Mass balance is another form of conservation of mass based on the principle that, mass
is neither created nor destroyed in a closed system. Mass balance is applied to physical
systems such as a cell to calculate changes in concentration of a particular chemical species
in the system by accounting for material entering the the system, material leaving the system,
material generation and consumption within the system. A general form of a mass balance
equation for a reactive system is as follows,
Input+Generation = Output+Accumulation+Consumption (A.18)
Accumulation is the rate change of the material. For example, consider the calcium concen-
tration balance of a cell as shown in the figure,




Fig. A.1 Mass balance in a simple cell system:
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dCa
dt
= Jin − Jout + Jbuff (A.19)
The channels, pumps and exchangers are the main membrane components that contribute
to the calcium influx and calcium outflux. The release of calcium through these channels
depends on the conductance and permeability of each membrane component as well as the
concentration gradient and electric potential gradient across the cell membrane.
A.5 Whole cell current of a channel
In general, the whole cell current of a channel that allows the passage of a particular ion is,
Ik = NkgkPk(Vm −Eion) (A.20)
Where Nk is the total number of channels, gk is the conductance of a single channel, Pk is
the open probability of the channel, Eion is the Nernst potential of the ion and Vm is the
membrane potential or the potential gradient across the membrane. gk is constant unless
there is extreme voltage dependent blocking or asymmetric conditions. Therefore, G of a
particular channel is constant and is equal to Nk gk. However, open probability of a channel is
highly modulated by different cellular changes which result in a highly non-linear behaviour
of the ionic current.
A.6 Open probability of an ion channel
A channel protein contains a pore which is guarded by a single gate or several gates. Gating
of an ion channel represents the opening or closing of the channel pore. Different cellular
components regulate the gating of a channel. The main gating mechanisms are,
• Voltage gating: The opening of voltage-gated channels depend on the membrane
potential of the cell. The most common voltage-gated channels are voltage-operated
calcium channels, and calcium-activated potassium channels.
• Secondary messenger gating: In some ion channels of the cell, the opening is regu-
lated by secondary messengers. Calcium, inositol triphosphate (IP3) and diacylglycerol
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(DAG) are some of such secondary messengers. Calcium-activated potassium chan-
nels, IP3 receptor (IP3R) channels, Ryanodine (RyR) receptor channels and calcium-
activated chloride channels (CACC) are the most common calcium-gated channels.
IP3R channels and non-selective cation (NSC) channels are gated by IP3 and DAG
respectively.
In general, an ion channel exists in one of two states; open state or closed state. The
dynamic existence of these states depends on the kinetic behaviour of the chemical phe-






where ‘X0’ represents closed state and ‘X1’ represents open state. The fraction of total





Where NX1 is the number of channels in the open state and NX0 is the number of channels in









Where N is the total number of channels. Applying the law of mass action to Equation A.21


































Where τ is the time constant and fα is the equilibrium open probability of the channel.
These two functions may depend on the other cellular components. The values of these two
variables are obtained from experiments.
A.7 Hodgkin-Huxley model
The Hodgkin-Huxley model is a continuous time model which describes the initiation and
propagation of an action potential in excitable cells such as neurons and cardiac myocytes.
In this model, an excitable cell is treated as an electrical circuit in which each component
of the cell is an electrical component, (see Figure A.2). The lipid bilayer is represented
as a membrane capacitor. Each channel in the membrane is represented as a fixed resistor
or variable resistor. Voltage-gated channels are treated as variable resistors whereas a leak





Fig. A.2 Hodgkin-Huxley model
Ohm’s law is used to calculate the current flowing through each channel, which is driven
by the voltage difference,
Ik = gk(Vm −Eion) (A.28)
IL = gL(Vm −EL) (A.29)
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Where gk is the variable conductance of the channel, ‘k’, which allows the passage of a
specific ion. Eion is the Nernst potential of that specific ion. gL and EL are the conductance
and Nernst potential of the leak channel.





+ Ik + IL (A.30)
Where I is the total membrane current. Cm and Vm are the conductance and membrane






(I − Ik − IL) (A.31)
If we know the current passing through each channel, pump and exchanger present in the




B.1 Backward Euler discretization
Discretization is used to convert a continuous function to a discrete function. To determine a
discrete function, we have to discretize the time domain into N evenly spaced points. The
time difference between two points is called the time step or step size, ∆t. Now, we have
to use a discrete method for getting a discrete version of the ordinary differential equation
(ODE) under consideration.




= f (t,y) y(t = 0) = y0 (B.1)
A Backward Euler approximation of the equation B.1 gives,
y(t +∆t)− y(t)
∆t
= f (t +∆t,y(t +∆t)) (B.2)
y(t +∆t) = y(t)+∆t f (t +∆t,y(t +∆t)) (B.3)
The discretized function is unknown as it depends on the future value of y. We have to
solve an algebraic equation or fixed point iteration if the discrete function is non-linear.
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B.2 Fixed-point iteration
To find the solution of the discretized Equation B.3, a fixed-point iteration method is used on
the model. Each iterative step is denoted by superscript ‘k’. To start the fixed point iteration,
an approximation of the solution for the first iteration is taken as the initial value or previous
time converged solution. For fixed-point iteration,





For the first iteration,
y1(t +∆t) = y(t)+∆t f (t +∆t,y(t)) (B.5)
A tolerance limit is fixed to define the convergence of the fixed-point iteration. The converged
value yk(t +∆t) is taken as the solution at t+∆t, y(t +∆t).
B.3 Tridiagonal Matrix algorithm or Thomas algorithm
A tridiagonal matrix algorithm (TDMA) is an efficient way of solving tridiagonal matrices.
This method is based on the LU decomposition. For the matrix system, MY=D, the system is
rewritten as LUY=D, where A is a coefficient matrix, D is a constant matrix, U is an upper
triangular matrix and L is a lower triangular matrix.
A TDMA is implemented in two steps. In the first step, the matrix M is decomposed
into M=LU and solved for ρ using Lρ=D in a single forward sweep. In the second step, y is
solved using the equation UY=ρ in the backward sweep. For example, consider a system of
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This can be written as,







Similarly, take the second row,
a2y2 +b2y2 + c2y3 = d2 (B.8)
Substracting Equation a2 × B.7 from Equation B.8, we get,
(b2 −a2γ1)y2 + c2y3 = d2 −a2ρ1 (B.9)








We can write the above equation as,







Finally, take the third row,
a3y2 +b3y3 = d3 (B.12)
Substract Equation a3 × B.11 from Equation B.12, we get,
(b3 −a3γ2)y3 = d3 −a3ρ2 (B.13)
Divide Equation B.13 by (b3 −a3γ2), we get,





This can be written as,




Here, we have finished the first step and the matrix is converted into the form UY=ρ as given









Now the solution of the matrix UY=D is straightforward. The solution is calculated in
the second step of a backward sweep. We will start with the last row.
y3 = ρ3 (B.16)
Substitute the value of y3 in Equation B.11 and solve for y2,
y2 = ρ2 − γ2x3 (B.17)
Similarly for y1 by substituting y2 in to Equation B.7,
y1 = ρ1 − γ1x2 (B.18)
This is the end of the TDMA as full solution of the problem is obtained. TDMA is stable if,
the matrix form of the discretized ODEs in the model satisfy the condition of stability:
|bi|> |ai|+ |ci| (B.19)
Appendix C
Discretization
The Backward Euler method is used to discretize the differential equations of 16 state vari-
ables.



























































−GNCXPt+∆tNCX,alloPt+∆tNCX,elec +GCACCPt+∆tCACCECl −αQPMCAPt+∆tPMCA (C.2)
In a similar fashion the discretized equations for other variables are written below,
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+ka (δ +ρr)GPT (C.17)





















































































































































t+∆t , j=1,2,3 (C.34)
8) RyR channel




















































VSMC model: Resting state values
Experimental studies show that intracellular calcium at the resting state is less than or equal
to 100 nM [128, 200, 55]. We use this evidence to choose 80 nM in our model (This is done
by adjusting PMCA parameters). The studies by Picht et al. [139] and Esfandiarei et al. [44]
show that intra-SR calcium concentration at resting state stays in between 1 mM and 1.3 mM.








SR = 1.2149 mM
Once intracellular is fixed, the resting state values of the following state variables are












The resting state values of state variables of RyR and IP3R channels are obtained by solving
their steady state equations given below using the initial values of IP3 and intracellular
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calcium.
For IP3R,
0 = (b4k3 +b2)
X01
1+k3














































































R00 = 1−R01 −R10 −R11 (D.8)
Resulting,
R11 = 0.000002, R10 = 0.002128, R01 = 0.001004, R00 = 0.996866,
X11 = 0.001861, X10 = 0.002412, X01 = 0.206240, X00 = 0.789487
The initial value of Vm is fixed to -54 mV based on the experimental observation of Harder
and Sperelakis [62] in VSMCs of mesenteric artery.
181
Vm =−54.03 mV,
The initial variables of the rest of the state variables are simply the solution of steady
state equations,






















In the VSMC model, five parameters are referred as model estimation, kNSC, kdeg,DAG, and
kR.
Swaminathan [169] used 4625 s−1 for QIP3R and 0.5 mM for intra-SR calcium concen-
tration to obtain calcium puffs lifetimes and amplitudes consistent with the experiments. In
our model, intra-SR calcium equals to 1.2 mM at the resting state. A value of 2000 s−1 is
used for the QIP3R in order to account the difference in intra-SR calcium compared with the
Swaminathan et al. [170] study.
Kapela et al. [83] used a Michaelis constant of 170 nM whereas Jacobsen et al. [76] used
a value of 200 nM. In Jacobsen et al. [76] study, the intracellular calcium at the resting state
was 100 nM which is slightly higher than the corresponding value of 80 nM in our model. To
account the difference in intracellular concentration compared with the Jacobsen et al. [76]
study, Michaelis constant, kPMCA, of 150 nM is used for PMCA. A low value for kPMCA is
used to satisfy the experimental observation of the high affinity to calcium and the value is
within the range of kPMCA values used in the previous models.
According to Helliwell and Large [63], Soboloff et al. [166], activation of NSC is obtained
in micromolar concentrations of oleoyl-2-acetyl-sn-glycerol (OAG), a DAG analogue. Based
on these experimental observations, kNSC is fixed to 1 µM. The Kapela et al. [83] model
used a DAG activation of the NSC channel. However, the kNSC used in their model is 300
nM which appears small compared to the experiments.
In the case of kR, Lemon et al. [101] used 5 µM and Kapela et al. [83] used 10 µM. As
far as we know, there is no definite value for kR. In our model, we have adjusted this value to
60 µM, so that calcium oscillations will be obtained at medium agonist concentrations as
observed in the experimental studies of Lamboley et al. [95] and Schuster et al. [153].
Kapela et al. [83] used the degradation rate of DAG, kdeg,DAG, the same as the degradation
rate of IP3, kdeg,IP3R. Kang and Othmer [82] used different degradation rate constants for
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DAG and IP3. In their model, kdeg,DAG is smaller than kdeg,IP3R. There is not enough data to
choose a value of kdeg,DAG independently. Similar to Kang and Othmer [82], we have chosen
kdeg,DAG to be 1 s−1, smaller than the kdeg,IP3R where a value of 1.25 s
−1 is chosen.
Table E.1 Standard VSMC parameters
Cm 20 pF Capacitance
T 293.0 K Temperature
R 8341.0 mJ mol−1 K−1 Universal gas constant
F 96487.0 C mol−1 Faraday’s constant
zCa 2 Calcium valency
zNa 1 Sodium valency
zK 1 Potassium valency
zCl -1 Chloride valency[
Ca2+
]
e 2 mM Extracellular calcium
[Na+]e 140 mM Extracellular sodium
[K+]e 5 mM Extracellular potassium[
Cl−
]
e 129 mM Extracellular chloride
[K+]cyt 140 mM Intracellular potassium[
Cl−
]
cyt 59.4 mM Intracellular chloride
[Na+]cyt 8.4 mM Cytosol sodium
Volcyt 0.7 pL Cytosol volume [197]
VolSMC 1 pL VSMC volume [197]
VolSR 0.05 pL SR volume, 5% of the cell volume [194]
Table E.2 Calcium buffering parameters
kCM 260
nM
Dissociation constant of calmodulin Kapela et al. [83] and Yang et al. [197]
kB 530
nM






Concentration of other buffers
185
Table E.3 Parameters for SR channels and pumps
λ 12 nM s−1 Maximum rate of calcium leak, obtained from intra-SR cal-
cium balance at the resting condition.
kleak 145×103 nM Exponential growth factor, Zima et al. [202]
QSERCA 210×103 nM s−1 Maximum rate of calcium efflux of SERCA, Balke et al. [9]
kSERCA 500 nM Michaelis constant of SERCA, Wimsatt et al. [191]
QIP3R 2000 s
−1 Maximum rate, model estimation
Binding
constants











a5 53.9×10−3 nM−1s−1 Calcium activation
Dissociation
constants
Swaminathan et al. [170]
b1 228 s−1 IP3
b2 0.409 s−1 Calcium inhibition
b3 188.5 s−1 IP3
b4 0.096 s−1 Calcium inhibition
b5 4.52 s−1 Calcium activation
QRyR 4000 s−1 Maximum rate, model estimation and conductance of RyR
is twice higher than that of IP3R [49].
Binding
constants
Yang et al. [197]
Kr1 2.5×10−6 nM−2s−1 Activation rate constant
Kr2 1.05×10−3 nM−1s−1 Inactivation rate constant
K-r1 7.6 s−1 Unbinding rate constant from activation
K-r2 84 s−1 Unbinding rate constant from inactivation
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Table E.4 Parameters for alpha-adrenoceptor cascade and IP3 formation
kR 60 µM Unphosphorylated receptor dissociation con-
stant
Model estimation
GPT 1×105 Total number of G-protein molecules Bennett et al. [15]
kdeg,IP3 1.25 s
−1 IP3 degradation rate
ka 0.17 s−1 G-protein activation rate
kd 1.5 s−1 G-protein inactivation rate
PIP2,T 5×107 Total number of PIP2 molecules
kPLC 400 nM Dissociation constant for calcium binding to
PLC




δ 1.235×10−3 G-protein intrinsic activity parameter Lemon et al. [101]
kdeg,DAG 1.0 s−1 DAG degradation rate Model estimation
Table E.5 Parameters for membrane channels, pumps and exchangers
GVOCC 2.63 nS Whole cell conductance of VOCC, calculated from the whole-cell voltage-
current (V-I) relationship reported in Nikitina et al. [129]
GBKCa 11.1 nS Whole cell conductance of BKCa channel, obtained by balancing the mem-
brane potential equation at resting condition
τpf 0.84 ms Fast activation time constant, Kapela et al. [83]
τps 35.9 ms Slow activation time constant, Kapela et al. [83]
ĪNCX 0.25×10−3
pA
Scaling factor of NCX channel, obtained by adjusting it to get the intracellular
calcium concentration within a physiological range of values upon agonist
stimulation
kNCX 125 nM Dissociation constant for allosteric component, Weber et al. [186]
dNCX 0.0003 Kapela et al. [83]
γ 0.45 Kapela et al. [83]
GCACC 2.24 nS Whole cell conductance of CACC, calculated from the whole cell V-I data
published in Matchkov et al. [114]
kCACC 587 nM Dissociation constant of CACC, Ni et al. [127]
GNSC 0.61 nS Whole cell conductance of NSC channel, Helliwell and Large [63]
kNSC 1000 nM Dissociation constant of NSC channel, model estimation
ENSC 9 mV Reverse potential of NSC channel, Helliwell and Large [63]
QPMCA 9.993×103
nM s−1





at the resting condition.
kPMCA 150 nM Michaelis constant of PMCA, model estimation
Appendix F
Definition of terms
F.1 Activation and relaxation phases of intracellular oscil-
lations



























Fig. F.1 Activation and relaxation phases of intracellular calcium oscillations.
The activation phase is defined as the period of time during which the intracellular
calcium concentration of the cell increases from the minimum value to the maximum value.
Vice-versa, the relaxation phase is the period of time which from the minimum value to the
maximum value of intracellular calcium.
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F.2 Overall maximum and overall minimum
























Fig. F.2 Overall calcium maximum and minimum
The overall maximum is defined as the maximum of the maximum values of intracellular
calcium oscillations derived during the oscillatory region by varying a parameter. Similarly,
overall minimum is the minimum of minimum values of intracellular calcium oscillations
during the oscillatory region. The bifurcation points simply define the oscillatory region. In
the given Figure F.2, the maximum and minimum values of intracellular calcium for varying
agonist concentration are plotted. The oscillatory region, overall maximum and minimum
values are shown in the figure.
F.3 Regenerative calcium rise
If the peak intracellular calcium concentration of a non-stimulated cell equals 75% of the
calcium peak in the stimulated cell, we say that the cell attained regenerative calcium rise.
If more than one cell is stimulated, then the maximum of peak intracellular calcium of all
stimulated cells is used.
F.4 Regenerative propagation
Propagation of regenerative calcium rise is called regenerative propagation.
F.5 Penetration depth 189
F.5 Penetration depth
Penetration depth, δRP, is defined as the number of cells that attain regenerative calcium rise.
In another way, it is the length of regenerative calcium propagation.
F.6 Passive propagation
Passive propagation is the movement of a molecule from a region of higher concentration
to a region of lower concentration, similar to Fickian transport. This movement is driven
by the concentration gradient between the propagating regions and will be continued until
the gradient vanishes. If stimulation raises the concentration of a molecule in the stimulated
cell, a concentration gradient will be created with the non-stimulated neighbouring cell. This
causes passive propagation of the molecule from the stimulated cell to the non-stimulated
region. The maximum concentration of the molecule in the propagated cell might be lower
than in the stimulated cell.
For example, when two VSMCs are connected and one cell is stimulated, the IP3 con-
centration rise in the stimulated-cell creates a concentration gradient between it and the
non-stimulated cell. The difference in concentration drives IP3 to the non-stimulated cell
causing a rise in IP3 concentration. This is called passive propagation of IP3.
F.7 Mediated propagation
In mediated propagation, propagation of a molecule is achieved without the physical move-
ment of that molecule but by a mediating molecule. The mediating molecule propagates to
the non-stimulated cell and activates an amplification mechanism that increases the concen-
tration of another molecule, called mediated propagation of the latter one. The existence of
mediated propagation entirely relies on the propagation of the mediating molecule. Medi-
ated propagation of a molecule is important in situations where its passive propagation is
restricted.
For example, if the passively propagated IP3 activates IP3R in the non-stimulated cell, the
calcium release from IP3R would increase the concentration of calcium in the non-stimulated
cell. This is called IP3 mediated calcium propagation, where IP3 is the mediating molecule
and calcium undergoes mediated propagation.
